{
    "c_end": 10, 
    "c_start": 4, 
    "end": 2, 
    "mention": "septal", 
    "pid": 1, 
    "senid": 37, 
    "sent": "The septal and lateral PVs were isolated. ", 
    "start": 1, 
    "type": "Spatial_Concept"
}
{
    "c_end": 22, 
    "c_start": 15, 
    "end": 4, 
    "mention": "lateral", 
    "pid": 1, 
    "senid": 37, 
    "sent": "The septal and lateral PVs were isolated. ", 
    "start": 3, 
    "type": "Spatial_Concept"
}
{
    "c_end": 26, 
    "c_start": 23, 
    "end": 5, 
    "mention": "PVs", 
    "pid": 1, 
    "senid": 37, 
    "sent": "The septal and lateral PVs were isolated. ", 
    "start": 4, 
    "type": "Gene_or_Genome"
}
{
    "c_end": 40, 
    "c_start": 32, 
    "end": 7, 
    "mention": "isolated", 
    "pid": 1, 
    "senid": 37, 
    "sent": "The septal and lateral PVs were isolated. ", 
    "start": 6, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 15, 
    "c_start": 6, 
    "end": 2, 
    "mention": "ab-lation", 
    "pid": 1, 
    "senid": 34, 
    "sent": "After ab-lation at this site, the lateral pulmonary veins were isolated. ", 
    "start": 1, 
    "type": "Eukaryote"
}
{
    "c_end": 28, 
    "c_start": 24, 
    "end": 5, 
    "mention": "site", 
    "pid": 1, 
    "senid": 34, 
    "sent": "After ab-lation at this site, the lateral pulmonary veins were isolated. ", 
    "start": 4, 
    "type": "Spatial_Concept"
}
{
    "c_end": 41, 
    "c_start": 34, 
    "end": 8, 
    "mention": "lateral", 
    "pid": 1, 
    "senid": 34, 
    "sent": "After ab-lation at this site, the lateral pulmonary veins were isolated. ", 
    "start": 7, 
    "type": "Spatial_Concept"
}
{
    "c_end": 57, 
    "c_start": 42, 
    "end": 10, 
    "mention": "pulmonary veins", 
    "pid": 1, 
    "senid": 34, 
    "sent": "After ab-lation at this site, the lateral pulmonary veins were isolated. ", 
    "start": 8, 
    "type": "Body_Part__Organ__or_Organ_Component"
}
{
    "c_end": 71, 
    "c_start": 63, 
    "end": 12, 
    "mention": "isolated", 
    "pid": 1, 
    "senid": 34, 
    "sent": "After ab-lation at this site, the lateral pulmonary veins were isolated. ", 
    "start": 11, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 11, 
    "c_start": 4, 
    "end": 2, 
    "mention": "patient", 
    "pid": 1, 
    "senid": 38, 
    "sent": "The patient was free of any tachycardia for 6 months. ", 
    "start": 1, 
    "type": "Patient_or_Disabled_Group"
}
{
    "c_end": 20, 
    "c_start": 16, 
    "end": 4, 
    "mention": "free", 
    "pid": 1, 
    "senid": 38, 
    "sent": "The patient was free of any tachycardia for 6 months. ", 
    "start": 3, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 39, 
    "c_start": 28, 
    "end": 7, 
    "mention": "tachycardia", 
    "pid": 1, 
    "senid": 38, 
    "sent": "The patient was free of any tachycardia for 6 months. ", 
    "start": 6, 
    "type": "Finding"
}
{
    "c_end": 52, 
    "c_start": 46, 
    "end": 10, 
    "mention": "months", 
    "pid": 1, 
    "senid": 38, 
    "sent": "The patient was free of any tachycardia for 6 months. ", 
    "start": 9, 
    "type": "Temporal_Concept"
}
{
    "c_end": 4, 
    "c_start": 0, 
    "end": 1, 
    "mention": "Case", 
    "pid": 1, 
    "senid": 13, 
    "sent": "Case 3 A 74-year-old man who had drug-refractory paroxys-mal atrial flutter 2 years after circumferential pulmonary venous isolation was referred to our hospital. ", 
    "start": 0, 
    "type": "Functional_Concept"
}
{
    "c_end": 20, 
    "c_start": 9, 
    "end": 4, 
    "mention": "74-year-old", 
    "pid": 1, 
    "senid": 13, 
    "sent": "Case 3 A 74-year-old man who had drug-refractory paroxys-mal atrial flutter 2 years after circumferential pulmonary venous isolation was referred to our hospital. ", 
    "start": 3, 
    "type": "Temporal_Concept"
}
{
    "c_end": 24, 
    "c_start": 21, 
    "end": 5, 
    "mention": "man", 
    "pid": 1, 
    "senid": 13, 
    "sent": "Case 3 A 74-year-old man who had drug-refractory paroxys-mal atrial flutter 2 years after circumferential pulmonary venous isolation was referred to our hospital. ", 
    "start": 4, 
    "type": "Organism_Attribute"
}
{
    "c_end": 132, 
    "c_start": 33, 
    "end": 18, 
    "mention": "drug-refractory paroxys-mal atrial flutter 2 years after circumferential pulmonary venous isolation", 
    "pid": 1, 
    "senid": 13, 
    "sent": "Case 3 A 74-year-old man who had drug-refractory paroxys-mal atrial flutter 2 years after circumferential pulmonary venous isolation was referred to our hospital. ", 
    "start": 7, 
    "type": "Research_Activity"
}
{
    "c_end": 48, 
    "c_start": 33, 
    "end": 8, 
    "mention": "drug-refractory", 
    "pid": 1, 
    "senid": 13, 
    "sent": "Case 3 A 74-year-old man who had drug-refractory paroxys-mal atrial flutter 2 years after circumferential pulmonary venous isolation was referred to our hospital. ", 
    "start": 7, 
    "type": "Functional_Concept"
}
{
    "c_end": 77, 
    "c_start": 49, 
    "end": 12, 
    "mention": "paroxys-mal atrial flutter 2", 
    "pid": 1, 
    "senid": 13, 
    "sent": "Case 3 A 74-year-old man who had drug-refractory paroxys-mal atrial flutter 2 years after circumferential pulmonary venous isolation was referred to our hospital. ", 
    "start": 8, 
    "type": "Gene_or_Genome"
}
{
    "c_end": 75, 
    "c_start": 61, 
    "end": 11, 
    "mention": "atrial flutter", 
    "pid": 1, 
    "senid": 13, 
    "sent": "Case 3 A 74-year-old man who had drug-refractory paroxys-mal atrial flutter 2 years after circumferential pulmonary venous isolation was referred to our hospital. ", 
    "start": 9, 
    "type": "Laboratory_or_Test_Result"
}
{
    "c_end": 83, 
    "c_start": 78, 
    "end": 13, 
    "mention": "years", 
    "pid": 1, 
    "senid": 13, 
    "sent": "Case 3 A 74-year-old man who had drug-refractory paroxys-mal atrial flutter 2 years after circumferential pulmonary venous isolation was referred to our hospital. ", 
    "start": 12, 
    "type": "Temporal_Concept"
}
{
    "c_end": 105, 
    "c_start": 90, 
    "end": 15, 
    "mention": "circumferential", 
    "pid": 1, 
    "senid": 13, 
    "sent": "Case 3 A 74-year-old man who had drug-refractory paroxys-mal atrial flutter 2 years after circumferential pulmonary venous isolation was referred to our hospital. ", 
    "start": 14, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 122, 
    "c_start": 106, 
    "end": 17, 
    "mention": "pulmonary venous", 
    "pid": 1, 
    "senid": 13, 
    "sent": "Case 3 A 74-year-old man who had drug-refractory paroxys-mal atrial flutter 2 years after circumferential pulmonary venous isolation was referred to our hospital. ", 
    "start": 15, 
    "type": "Body_Part__Organ__or_Organ_Component"
}
{
    "c_end": 161, 
    "c_start": 137, 
    "end": 23, 
    "mention": "referred to our hospital", 
    "pid": 1, 
    "senid": 13, 
    "sent": "Case 3 A 74-year-old man who had drug-refractory paroxys-mal atrial flutter 2 years after circumferential pulmonary venous isolation was referred to our hospital. ", 
    "start": 19, 
    "type": "Health_Care_Activity"
}
{
    "c_end": 10, 
    "c_start": 0, 
    "end": 1, 
    "mention": "Successful", 
    "pid": 1, 
    "senid": 40, 
    "sent": "Successful ablation at the exit and entrance site could be performed without moving the catheter. ", 
    "start": 0, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 19, 
    "c_start": 11, 
    "end": 2, 
    "mention": "ablation", 
    "pid": 1, 
    "senid": 40, 
    "sent": "Successful ablation at the exit and entrance site could be performed without moving the catheter. ", 
    "start": 1, 
    "type": "Therapeutic_or_Preventive_Procedure"
}
{
    "c_end": 31, 
    "c_start": 27, 
    "end": 5, 
    "mention": "exit", 
    "pid": 1, 
    "senid": 40, 
    "sent": "Successful ablation at the exit and entrance site could be performed without moving the catheter. ", 
    "start": 4, 
    "type": "Functional_Concept"
}
{
    "c_end": 44, 
    "c_start": 36, 
    "end": 7, 
    "mention": "entrance", 
    "pid": 1, 
    "senid": 40, 
    "sent": "Successful ablation at the exit and entrance site could be performed without moving the catheter. ", 
    "start": 6, 
    "type": "Spatial_Concept"
}
{
    "c_end": 49, 
    "c_start": 45, 
    "end": 8, 
    "mention": "site", 
    "pid": 1, 
    "senid": 40, 
    "sent": "Successful ablation at the exit and entrance site could be performed without moving the catheter. ", 
    "start": 7, 
    "type": "Spatial_Concept"
}
{
    "c_end": 68, 
    "c_start": 59, 
    "end": 11, 
    "mention": "performed", 
    "pid": 1, 
    "senid": 40, 
    "sent": "Successful ablation at the exit and entrance site could be performed without moving the catheter. ", 
    "start": 10, 
    "type": "Functional_Concept"
}
{
    "c_end": 83, 
    "c_start": 77, 
    "end": 13, 
    "mention": "moving", 
    "pid": 1, 
    "senid": 40, 
    "sent": "Successful ablation at the exit and entrance site could be performed without moving the catheter. ", 
    "start": 12, 
    "type": "Organism_Function"
}
{
    "c_end": 96, 
    "c_start": 88, 
    "end": 15, 
    "mention": "catheter", 
    "pid": 1, 
    "senid": 40, 
    "sent": "Successful ablation at the exit and entrance site could be performed without moving the catheter. ", 
    "start": 14, 
    "type": "Medical_Device"
}
{
    "c_end": 4, 
    "c_start": 0, 
    "end": 1, 
    "mention": "Case", 
    "pid": 1, 
    "senid": 4, 
    "sent": "Case 2 A 33-year-old healthy male presented to the emergency department after falling from a bicycle while riding intoxicated. ", 
    "start": 0, 
    "type": "Functional_Concept"
}
{
    "c_end": 20, 
    "c_start": 9, 
    "end": 4, 
    "mention": "33-year-old", 
    "pid": 1, 
    "senid": 4, 
    "sent": "Case 2 A 33-year-old healthy male presented to the emergency department after falling from a bicycle while riding intoxicated. ", 
    "start": 3, 
    "type": "Temporal_Concept"
}
{
    "c_end": 28, 
    "c_start": 21, 
    "end": 5, 
    "mention": "healthy", 
    "pid": 1, 
    "senid": 4, 
    "sent": "Case 2 A 33-year-old healthy male presented to the emergency department after falling from a bicycle while riding intoxicated. ", 
    "start": 4, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 33, 
    "c_start": 29, 
    "end": 6, 
    "mention": "male", 
    "pid": 1, 
    "senid": 4, 
    "sent": "Case 2 A 33-year-old healthy male presented to the emergency department after falling from a bicycle while riding intoxicated. ", 
    "start": 5, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 43, 
    "c_start": 34, 
    "end": 7, 
    "mention": "presented", 
    "pid": 1, 
    "senid": 4, 
    "sent": "Case 2 A 33-year-old healthy male presented to the emergency department after falling from a bicycle while riding intoxicated. ", 
    "start": 6, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 71, 
    "c_start": 51, 
    "end": 11, 
    "mention": "emergency department", 
    "pid": 1, 
    "senid": 4, 
    "sent": "Case 2 A 33-year-old healthy male presented to the emergency department after falling from a bicycle while riding intoxicated. ", 
    "start": 9, 
    "type": "Health_Care_Related_Organization"
}
{
    "c_end": 85, 
    "c_start": 78, 
    "end": 13, 
    "mention": "falling", 
    "pid": 1, 
    "senid": 4, 
    "sent": "Case 2 A 33-year-old healthy male presented to the emergency department after falling from a bicycle while riding intoxicated. ", 
    "start": 12, 
    "type": "Finding"
}
{
    "c_end": 100, 
    "c_start": 93, 
    "end": 16, 
    "mention": "bicycle", 
    "pid": 1, 
    "senid": 4, 
    "sent": "Case 2 A 33-year-old healthy male presented to the emergency department after falling from a bicycle while riding intoxicated. ", 
    "start": 15, 
    "type": "Manufactured_Object"
}
{
    "c_end": 8, 
    "c_start": 0, 
    "end": 1, 
    "mention": "Ablation", 
    "pid": 1, 
    "senid": 31, 
    "sent": "Ablation at this site terminated the LAMRT. ", 
    "start": 0, 
    "type": "Therapeutic_or_Preventive_Procedure"
}
{
    "c_end": 21, 
    "c_start": 17, 
    "end": 4, 
    "mention": "site", 
    "pid": 1, 
    "senid": 31, 
    "sent": "Ablation at this site terminated the LAMRT. ", 
    "start": 3, 
    "type": "Spatial_Concept"
}
{
    "c_end": 32, 
    "c_start": 22, 
    "end": 5, 
    "mention": "terminated", 
    "pid": 1, 
    "senid": 31, 
    "sent": "Ablation at this site terminated the LAMRT. ", 
    "start": 4, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 15, 
    "c_start": 4, 
    "end": 3, 
    "mention": "chest X-ray", 
    "pid": 1, 
    "senid": 46, 
    "sent": "The chest X-ray (Fig. 1) showed a malposi-tioned catheter in the left lung. ", 
    "start": 1, 
    "type": "Diagnostic_Procedure"
}
{
    "c_end": 20, 
    "c_start": 17, 
    "end": 5, 
    "mention": "Fig", 
    "pid": 1, 
    "senid": 46, 
    "sent": "The chest X-ray (Fig. 1) showed a malposi-tioned catheter in the left lung. ", 
    "start": 4, 
    "type": "Food"
}
{
    "c_end": 31, 
    "c_start": 25, 
    "end": 9, 
    "mention": "showed", 
    "pid": 1, 
    "senid": 46, 
    "sent": "The chest X-ray (Fig. 1) showed a malposi-tioned catheter in the left lung. ", 
    "start": 8, 
    "type": "Animal"
}
{
    "c_end": 57, 
    "c_start": 49, 
    "end": 12, 
    "mention": "catheter", 
    "pid": 1, 
    "senid": 46, 
    "sent": "The chest X-ray (Fig. 1) showed a malposi-tioned catheter in the left lung. ", 
    "start": 11, 
    "type": "Medical_Device"
}
{
    "c_end": 74, 
    "c_start": 65, 
    "end": 16, 
    "mention": "left lung", 
    "pid": 1, 
    "senid": 46, 
    "sent": "The chest X-ray (Fig. 1) showed a malposi-tioned catheter in the left lung. ", 
    "start": 14, 
    "type": "Body_Part__Organ__or_Organ_Component"
}
{
    "c_end": 22, 
    "c_start": 10, 
    "end": 2, 
    "mention": "fractionated", 
    "pid": 1, 
    "senid": 16, 
    "sent": "Capturing fractionated bipolar electrograms at anterolateral left atrial (LA) wall demonstrated concealed entrainment with postpacing interval comparable with tachycardia cycle length. ", 
    "start": 1, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 30, 
    "c_start": 23, 
    "end": 3, 
    "mention": "bipolar", 
    "pid": 1, 
    "senid": 16, 
    "sent": "Capturing fractionated bipolar electrograms at anterolateral left atrial (LA) wall demonstrated concealed entrainment with postpacing interval comparable with tachycardia cycle length. ", 
    "start": 2, 
    "type": "Spatial_Concept"
}
{
    "c_end": 60, 
    "c_start": 47, 
    "end": 6, 
    "mention": "anterolateral", 
    "pid": 1, 
    "senid": 16, 
    "sent": "Capturing fractionated bipolar electrograms at anterolateral left atrial (LA) wall demonstrated concealed entrainment with postpacing interval comparable with tachycardia cycle length. ", 
    "start": 5, 
    "type": "Spatial_Concept"
}
{
    "c_end": 65, 
    "c_start": 61, 
    "end": 7, 
    "mention": "left", 
    "pid": 1, 
    "senid": 16, 
    "sent": "Capturing fractionated bipolar electrograms at anterolateral left atrial (LA) wall demonstrated concealed entrainment with postpacing interval comparable with tachycardia cycle length. ", 
    "start": 6, 
    "type": "Functional_Concept"
}
{
    "c_end": 72, 
    "c_start": 31, 
    "end": 8, 
    "mention": "electrograms at anterolateral left atrial", 
    "pid": 1, 
    "senid": 16, 
    "sent": "Capturing fractionated bipolar electrograms at anterolateral left atrial (LA) wall demonstrated concealed entrainment with postpacing interval comparable with tachycardia cycle length. ", 
    "start": 3, 
    "type": "Laboratory_or_Test_Result"
}
{
    "c_end": 82, 
    "c_start": 78, 
    "end": 12, 
    "mention": "wall", 
    "pid": 1, 
    "senid": 16, 
    "sent": "Capturing fractionated bipolar electrograms at anterolateral left atrial (LA) wall demonstrated concealed entrainment with postpacing interval comparable with tachycardia cycle length. ", 
    "start": 11, 
    "type": "Manufactured_Object"
}
{
    "c_end": 105, 
    "c_start": 96, 
    "end": 14, 
    "mention": "concealed", 
    "pid": 1, 
    "senid": 16, 
    "sent": "Capturing fractionated bipolar electrograms at anterolateral left atrial (LA) wall demonstrated concealed entrainment with postpacing interval comparable with tachycardia cycle length. ", 
    "start": 13, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 142, 
    "c_start": 134, 
    "end": 18, 
    "mention": "interval", 
    "pid": 1, 
    "senid": 16, 
    "sent": "Capturing fractionated bipolar electrograms at anterolateral left atrial (LA) wall demonstrated concealed entrainment with postpacing interval comparable with tachycardia cycle length. ", 
    "start": 17, 
    "type": "Intellectual_Product"
}
{
    "c_end": 170, 
    "c_start": 159, 
    "end": 21, 
    "mention": "tachycardia", 
    "pid": 1, 
    "senid": 16, 
    "sent": "Capturing fractionated bipolar electrograms at anterolateral left atrial (LA) wall demonstrated concealed entrainment with postpacing interval comparable with tachycardia cycle length. ", 
    "start": 20, 
    "type": "Pathologic_Function"
}
{
    "c_end": 176, 
    "c_start": 171, 
    "end": 22, 
    "mention": "cycle", 
    "pid": 1, 
    "senid": 16, 
    "sent": "Capturing fractionated bipolar electrograms at anterolateral left atrial (LA) wall demonstrated concealed entrainment with postpacing interval comparable with tachycardia cycle length. ", 
    "start": 21, 
    "type": "Temporal_Concept"
}
{
    "c_end": 183, 
    "c_start": 177, 
    "end": 23, 
    "mention": "length", 
    "pid": 1, 
    "senid": 16, 
    "sent": "Capturing fractionated bipolar electrograms at anterolateral left atrial (LA) wall demonstrated concealed entrainment with postpacing interval comparable with tachycardia cycle length. ", 
    "start": 22, 
    "type": "Research_Activity"
}
{
    "c_end": 23, 
    "c_start": 10, 
    "end": 4, 
    "mention": "ten-electrode", 
    "pid": 1, 
    "senid": 25, 
    "sent": "This is a ten-electrode steerable lasso-shaped cathe-ter that allows irrigated unipolar and bi-polar radiofrequency (RF) ablation (cool flow of 60 ml/min). ", 
    "start": 3, 
    "type": "Disease_or_Syndrome"
}
{
    "c_end": 46, 
    "c_start": 34, 
    "end": 6, 
    "mention": "lasso-shaped", 
    "pid": 1, 
    "senid": 25, 
    "sent": "This is a ten-electrode steerable lasso-shaped cathe-ter that allows irrigated unipolar and bi-polar radiofrequency (RF) ablation (cool flow of 60 ml/min). ", 
    "start": 5, 
    "type": "Organic_Chemical"
}
{
    "c_end": 56, 
    "c_start": 47, 
    "end": 7, 
    "mention": "cathe-ter", 
    "pid": 1, 
    "senid": 25, 
    "sent": "This is a ten-electrode steerable lasso-shaped cathe-ter that allows irrigated unipolar and bi-polar radiofrequency (RF) ablation (cool flow of 60 ml/min). ", 
    "start": 6, 
    "type": "Gene_or_Genome"
}
{
    "c_end": 68, 
    "c_start": 62, 
    "end": 9, 
    "mention": "allows", 
    "pid": 1, 
    "senid": 25, 
    "sent": "This is a ten-electrode steerable lasso-shaped cathe-ter that allows irrigated unipolar and bi-polar radiofrequency (RF) ablation (cool flow of 60 ml/min). ", 
    "start": 8, 
    "type": "Social_Behavior"
}
{
    "c_end": 78, 
    "c_start": 69, 
    "end": 10, 
    "mention": "irrigated", 
    "pid": 1, 
    "senid": 25, 
    "sent": "This is a ten-electrode steerable lasso-shaped cathe-ter that allows irrigated unipolar and bi-polar radiofrequency (RF) ablation (cool flow of 60 ml/min). ", 
    "start": 9, 
    "type": "Functional_Concept"
}
{
    "c_end": 87, 
    "c_start": 79, 
    "end": 11, 
    "mention": "unipolar", 
    "pid": 1, 
    "senid": 25, 
    "sent": "This is a ten-electrode steerable lasso-shaped cathe-ter that allows irrigated unipolar and bi-polar radiofrequency (RF) ablation (cool flow of 60 ml/min). ", 
    "start": 10, 
    "type": "Spatial_Concept"
}
{
    "c_end": 100, 
    "c_start": 92, 
    "end": 13, 
    "mention": "bi-polar", 
    "pid": 1, 
    "senid": 25, 
    "sent": "This is a ten-electrode steerable lasso-shaped cathe-ter that allows irrigated unipolar and bi-polar radiofrequency (RF) ablation (cool flow of 60 ml/min). ", 
    "start": 12, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 135, 
    "c_start": 131, 
    "end": 20, 
    "mention": "cool", 
    "pid": 1, 
    "senid": 25, 
    "sent": "This is a ten-electrode steerable lasso-shaped cathe-ter that allows irrigated unipolar and bi-polar radiofrequency (RF) ablation (cool flow of 60 ml/min). ", 
    "start": 19, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 140, 
    "c_start": 136, 
    "end": 21, 
    "mention": "flow", 
    "pid": 1, 
    "senid": 25, 
    "sent": "This is a ten-electrode steerable lasso-shaped cathe-ter that allows irrigated unipolar and bi-polar radiofrequency (RF) ablation (cool flow of 60 ml/min). ", 
    "start": 20, 
    "type": "Natural_Phenomenon_or_Process"
}
{
    "c_end": 146, 
    "c_start": 144, 
    "end": 23, 
    "mention": "60", 
    "pid": 1, 
    "senid": 25, 
    "sent": "This is a ten-electrode steerable lasso-shaped cathe-ter that allows irrigated unipolar and bi-polar radiofrequency (RF) ablation (cool flow of 60 ml/min). ", 
    "start": 22, 
    "type": "Finding"
}
{
    "c_end": 153, 
    "c_start": 147, 
    "end": 24, 
    "mention": "ml/min", 
    "pid": 1, 
    "senid": 25, 
    "sent": "This is a ten-electrode steerable lasso-shaped cathe-ter that allows irrigated unipolar and bi-polar radiofrequency (RF) ablation (cool flow of 60 ml/min). ", 
    "start": 23, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 11, 
    "c_start": 7, 
    "end": 3, 
    "mention": "felt", 
    "pid": 1, 
    "senid": 10, 
    "sent": "It was felt initially that the bradycardia was related to inferior rectus muscle entrapment. ", 
    "start": 2, 
    "type": "Mental_Process"
}
{
    "c_end": 21, 
    "c_start": 12, 
    "end": 4, 
    "mention": "initially", 
    "pid": 1, 
    "senid": 10, 
    "sent": "It was felt initially that the bradycardia was related to inferior rectus muscle entrapment. ", 
    "start": 3, 
    "type": "Temporal_Concept"
}
{
    "c_end": 42, 
    "c_start": 31, 
    "end": 7, 
    "mention": "bradycardia", 
    "pid": 1, 
    "senid": 10, 
    "sent": "It was felt initially that the bradycardia was related to inferior rectus muscle entrapment. ", 
    "start": 6, 
    "type": "Pathologic_Function"
}
{
    "c_end": 54, 
    "c_start": 47, 
    "end": 9, 
    "mention": "related", 
    "pid": 1, 
    "senid": 10, 
    "sent": "It was felt initially that the bradycardia was related to inferior rectus muscle entrapment. ", 
    "start": 8, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 80, 
    "c_start": 58, 
    "end": 13, 
    "mention": "inferior rectus muscle", 
    "pid": 1, 
    "senid": 10, 
    "sent": "It was felt initially that the bradycardia was related to inferior rectus muscle entrapment. ", 
    "start": 10, 
    "type": "Body_Part__Organ__or_Organ_Component"
}
{
    "c_end": 91, 
    "c_start": 81, 
    "end": 14, 
    "mention": "entrapment", 
    "pid": 1, 
    "senid": 10, 
    "sent": "It was felt initially that the bradycardia was related to inferior rectus muscle entrapment. ", 
    "start": 13, 
    "type": "Finding"
}
{
    "c_end": 8, 
    "c_start": 2, 
    "end": 2, 
    "mention": "review", 
    "pid": 1, 
    "senid": 19, 
    "sent": "A review of cardiac computed tomography (CT) before abla-tion revealed a small blood vessel originating from the left circumflex artery, running along the anterior LA wall to reach the cavoatrial junction of the right atrium, which was not seen in postablation CT. ", 
    "start": 1, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 39, 
    "c_start": 12, 
    "end": 6, 
    "mention": "cardiac computed tomography", 
    "pid": 1, 
    "senid": 19, 
    "sent": "A review of cardiac computed tomography (CT) before abla-tion revealed a small blood vessel originating from the left circumflex artery, running along the anterior LA wall to reach the cavoatrial junction of the right atrium, which was not seen in postablation CT. ", 
    "start": 3, 
    "type": "Diagnostic_Procedure"
}
{
    "c_end": 70, 
    "c_start": 62, 
    "end": 12, 
    "mention": "revealed", 
    "pid": 1, 
    "senid": 19, 
    "sent": "A review of cardiac computed tomography (CT) before abla-tion revealed a small blood vessel originating from the left circumflex artery, running along the anterior LA wall to reach the cavoatrial junction of the right atrium, which was not seen in postablation CT. ", 
    "start": 11, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 91, 
    "c_start": 73, 
    "end": 16, 
    "mention": "small blood vessel", 
    "pid": 1, 
    "senid": 19, 
    "sent": "A review of cardiac computed tomography (CT) before abla-tion revealed a small blood vessel originating from the left circumflex artery, running along the anterior LA wall to reach the cavoatrial junction of the right atrium, which was not seen in postablation CT. ", 
    "start": 13, 
    "type": "Body_Part__Organ__or_Organ_Component"
}
{
    "c_end": 135, 
    "c_start": 113, 
    "end": 22, 
    "mention": "left circumflex artery", 
    "pid": 1, 
    "senid": 19, 
    "sent": "A review of cardiac computed tomography (CT) before abla-tion revealed a small blood vessel originating from the left circumflex artery, running along the anterior LA wall to reach the cavoatrial junction of the right atrium, which was not seen in postablation CT. ", 
    "start": 19, 
    "type": "Body_Part__Organ__or_Organ_Component"
}
{
    "c_end": 144, 
    "c_start": 137, 
    "end": 24, 
    "mention": "running", 
    "pid": 1, 
    "senid": 19, 
    "sent": "A review of cardiac computed tomography (CT) before abla-tion revealed a small blood vessel originating from the left circumflex artery, running along the anterior LA wall to reach the cavoatrial junction of the right atrium, which was not seen in postablation CT. ", 
    "start": 23, 
    "type": "Daily_or_Recreational_Activity"
}
{
    "c_end": 171, 
    "c_start": 155, 
    "end": 29, 
    "mention": "anterior LA wall", 
    "pid": 1, 
    "senid": 19, 
    "sent": "A review of cardiac computed tomography (CT) before abla-tion revealed a small blood vessel originating from the left circumflex artery, running along the anterior LA wall to reach the cavoatrial junction of the right atrium, which was not seen in postablation CT. ", 
    "start": 26, 
    "type": "Body_Part__Organ__or_Organ_Component"
}
{
    "c_end": 174, 
    "c_start": 172, 
    "end": 30, 
    "mention": "to", 
    "pid": 1, 
    "senid": 19, 
    "sent": "A review of cardiac computed tomography (CT) before abla-tion revealed a small blood vessel originating from the left circumflex artery, running along the anterior LA wall to reach the cavoatrial junction of the right atrium, which was not seen in postablation CT. ", 
    "start": 29, 
    "type": "Amino_Acid__Peptide__or_Protein"
}
{
    "c_end": 180, 
    "c_start": 175, 
    "end": 31, 
    "mention": "reach", 
    "pid": 1, 
    "senid": 19, 
    "sent": "A review of cardiac computed tomography (CT) before abla-tion revealed a small blood vessel originating from the left circumflex artery, running along the anterior LA wall to reach the cavoatrial junction of the right atrium, which was not seen in postablation CT. ", 
    "start": 30, 
    "type": "Organism_Function"
}
{
    "c_end": 204, 
    "c_start": 196, 
    "end": 34, 
    "mention": "junction", 
    "pid": 1, 
    "senid": 19, 
    "sent": "A review of cardiac computed tomography (CT) before abla-tion revealed a small blood vessel originating from the left circumflex artery, running along the anterior LA wall to reach the cavoatrial junction of the right atrium, which was not seen in postablation CT. ", 
    "start": 33, 
    "type": "Manufactured_Object"
}
{
    "c_end": 224, 
    "c_start": 212, 
    "end": 38, 
    "mention": "right atrium", 
    "pid": 1, 
    "senid": 19, 
    "sent": "A review of cardiac computed tomography (CT) before abla-tion revealed a small blood vessel originating from the left circumflex artery, running along the anterior LA wall to reach the cavoatrial junction of the right atrium, which was not seen in postablation CT. ", 
    "start": 36, 
    "type": "Body_Part__Organ__or_Organ_Component"
}
{
    "c_end": 239, 
    "c_start": 236, 
    "end": 42, 
    "mention": "not", 
    "pid": 1, 
    "senid": 19, 
    "sent": "A review of cardiac computed tomography (CT) before abla-tion revealed a small blood vessel originating from the left circumflex artery, running along the anterior LA wall to reach the cavoatrial junction of the right atrium, which was not seen in postablation CT. ", 
    "start": 41, 
    "type": "Functional_Concept"
}
{
    "c_end": 244, 
    "c_start": 240, 
    "end": 43, 
    "mention": "seen", 
    "pid": 1, 
    "senid": 19, 
    "sent": "A review of cardiac computed tomography (CT) before abla-tion revealed a small blood vessel originating from the left circumflex artery, running along the anterior LA wall to reach the cavoatrial junction of the right atrium, which was not seen in postablation CT. ", 
    "start": 42, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 12, 
    "c_start": 6, 
    "end": 2, 
    "mention": "single", 
    "pid": 1, 
    "senid": 28, 
    "sent": "After single transseptal puncture , a CARTO 3 map of the left atrium was acquired using the nMarq catheter. ", 
    "start": 1, 
    "type": "Finding"
}
{
    "c_end": 24, 
    "c_start": 13, 
    "end": 3, 
    "mention": "transseptal", 
    "pid": 1, 
    "senid": 28, 
    "sent": "After single transseptal puncture , a CARTO 3 map of the left atrium was acquired using the nMarq catheter. ", 
    "start": 2, 
    "type": "Spatial_Concept"
}
{
    "c_end": 33, 
    "c_start": 25, 
    "end": 4, 
    "mention": "puncture", 
    "pid": 1, 
    "senid": 28, 
    "sent": "After single transseptal puncture , a CARTO 3 map of the left atrium was acquired using the nMarq catheter. ", 
    "start": 3, 
    "type": "Health_Care_Activity"
}
{
    "c_end": 49, 
    "c_start": 46, 
    "end": 9, 
    "mention": "map", 
    "pid": 1, 
    "senid": 28, 
    "sent": "After single transseptal puncture , a CARTO 3 map of the left atrium was acquired using the nMarq catheter. ", 
    "start": 8, 
    "type": "Laboratory_Procedure"
}
{
    "c_end": 68, 
    "c_start": 57, 
    "end": 13, 
    "mention": "left atrium", 
    "pid": 1, 
    "senid": 28, 
    "sent": "After single transseptal puncture , a CARTO 3 map of the left atrium was acquired using the nMarq catheter. ", 
    "start": 11, 
    "type": "Body_Part__Organ__or_Organ_Component"
}
{
    "c_end": 81, 
    "c_start": 73, 
    "end": 15, 
    "mention": "acquired", 
    "pid": 1, 
    "senid": 28, 
    "sent": "After single transseptal puncture , a CARTO 3 map of the left atrium was acquired using the nMarq catheter. ", 
    "start": 14, 
    "type": "Intellectual_Product"
}
{
    "c_end": 87, 
    "c_start": 82, 
    "end": 16, 
    "mention": "using", 
    "pid": 1, 
    "senid": 28, 
    "sent": "After single transseptal puncture , a CARTO 3 map of the left atrium was acquired using the nMarq catheter. ", 
    "start": 15, 
    "type": "Functional_Concept"
}
{
    "c_end": 106, 
    "c_start": 98, 
    "end": 19, 
    "mention": "catheter", 
    "pid": 1, 
    "senid": 28, 
    "sent": "After single transseptal puncture , a CARTO 3 map of the left atrium was acquired using the nMarq catheter. ", 
    "start": 18, 
    "type": "Medical_Device"
}
{
    "c_end": 14, 
    "c_start": 6, 
    "end": 3, 
    "mention": "3 months", 
    "pid": 1, 
    "senid": 22, 
    "sent": "After 3 months, he presented with a symptomatic LAMRT with a cycle length of 385 ms (. Fig. 1). ", 
    "start": 1, 
    "type": "Temporal_Concept"
}
{
    "c_end": 28, 
    "c_start": 19, 
    "end": 6, 
    "mention": "presented", 
    "pid": 1, 
    "senid": 22, 
    "sent": "After 3 months, he presented with a symptomatic LAMRT with a cycle length of 385 ms (. Fig. 1). ", 
    "start": 5, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 47, 
    "c_start": 36, 
    "end": 9, 
    "mention": "symptomatic", 
    "pid": 1, 
    "senid": 22, 
    "sent": "After 3 months, he presented with a symptomatic LAMRT with a cycle length of 385 ms (. Fig. 1). ", 
    "start": 8, 
    "type": "Functional_Concept"
}
{
    "c_end": 66, 
    "c_start": 61, 
    "end": 13, 
    "mention": "cycle", 
    "pid": 1, 
    "senid": 22, 
    "sent": "After 3 months, he presented with a symptomatic LAMRT with a cycle length of 385 ms (. Fig. 1). ", 
    "start": 12, 
    "type": "Temporal_Concept"
}
{
    "c_end": 73, 
    "c_start": 67, 
    "end": 14, 
    "mention": "length", 
    "pid": 1, 
    "senid": 22, 
    "sent": "After 3 months, he presented with a symptomatic LAMRT with a cycle length of 385 ms (. Fig. 1). ", 
    "start": 13, 
    "type": "Research_Activity"
}
{
    "c_end": 83, 
    "c_start": 81, 
    "end": 17, 
    "mention": "ms", 
    "pid": 1, 
    "senid": 22, 
    "sent": "After 3 months, he presented with a symptomatic LAMRT with a cycle length of 385 ms (. Fig. 1). ", 
    "start": 16, 
    "type": "Enzyme"
}
{
    "c_end": 90, 
    "c_start": 87, 
    "end": 20, 
    "mention": "Fig", 
    "pid": 1, 
    "senid": 22, 
    "sent": "After 3 months, he presented with a symptomatic LAMRT with a cycle length of 385 ms (. Fig. 1). ", 
    "start": 19, 
    "type": "Food"
}
{
    "c_end": 19, 
    "c_start": 4, 
    "end": 3, 
    "mention": "septal ablation", 
    "pid": 1, 
    "senid": 35, 
    "sent": "The septal ablation line showed gaps in the anteriorinferior part, which were successfully closed. ", 
    "start": 1, 
    "type": "Therapeutic_or_Preventive_Procedure"
}
{
    "c_end": 24, 
    "c_start": 20, 
    "end": 4, 
    "mention": "line", 
    "pid": 1, 
    "senid": 35, 
    "sent": "The septal ablation line showed gaps in the anteriorinferior part, which were successfully closed. ", 
    "start": 3, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 31, 
    "c_start": 25, 
    "end": 5, 
    "mention": "showed", 
    "pid": 1, 
    "senid": 35, 
    "sent": "The septal ablation line showed gaps in the anteriorinferior part, which were successfully closed. ", 
    "start": 4, 
    "type": "Animal"
}
{
    "c_end": 36, 
    "c_start": 32, 
    "end": 6, 
    "mention": "gaps", 
    "pid": 1, 
    "senid": 35, 
    "sent": "The septal ablation line showed gaps in the anteriorinferior part, which were successfully closed. ", 
    "start": 5, 
    "type": "Spatial_Concept"
}
{
    "c_end": 65, 
    "c_start": 61, 
    "end": 10, 
    "mention": "part", 
    "pid": 1, 
    "senid": 35, 
    "sent": "The septal ablation line showed gaps in the anteriorinferior part, which were successfully closed. ", 
    "start": 9, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 97, 
    "c_start": 91, 
    "end": 15, 
    "mention": "closed", 
    "pid": 1, 
    "senid": 35, 
    "sent": "The septal ablation line showed gaps in the anteriorinferior part, which were successfully closed. ", 
    "start": 14, 
    "type": "Functional_Concept"
}
{
    "c_end": 15, 
    "c_start": 4, 
    "end": 2, 
    "mention": "bradycardia", 
    "pid": 1, 
    "senid": 7, 
    "sent": "The bradycardia would promptly resolve after return to primary gaze, and the degree of bradycardia would also diminish with sustained upgaze to around 50 beats per minute after approximately 20 seconds. ", 
    "start": 1, 
    "type": "Pathologic_Function"
}
{
    "c_end": 38, 
    "c_start": 31, 
    "end": 5, 
    "mention": "resolve", 
    "pid": 1, 
    "senid": 7, 
    "sent": "The bradycardia would promptly resolve after return to primary gaze, and the degree of bradycardia would also diminish with sustained upgaze to around 50 beats per minute after approximately 20 seconds. ", 
    "start": 4, 
    "type": "Conceptual_Entity"
}
{
    "c_end": 51, 
    "c_start": 45, 
    "end": 7, 
    "mention": "return", 
    "pid": 1, 
    "senid": 7, 
    "sent": "The bradycardia would promptly resolve after return to primary gaze, and the degree of bradycardia would also diminish with sustained upgaze to around 50 beats per minute after approximately 20 seconds. ", 
    "start": 6, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 67, 
    "c_start": 55, 
    "end": 10, 
    "mention": "primary gaze", 
    "pid": 1, 
    "senid": 7, 
    "sent": "The bradycardia would promptly resolve after return to primary gaze, and the degree of bradycardia would also diminish with sustained upgaze to around 50 beats per minute after approximately 20 seconds. ", 
    "start": 8, 
    "type": "Spatial_Concept"
}
{
    "c_end": 83, 
    "c_start": 77, 
    "end": 14, 
    "mention": "degree", 
    "pid": 1, 
    "senid": 7, 
    "sent": "The bradycardia would promptly resolve after return to primary gaze, and the degree of bradycardia would also diminish with sustained upgaze to around 50 beats per minute after approximately 20 seconds. ", 
    "start": 13, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 118, 
    "c_start": 110, 
    "end": 19, 
    "mention": "diminish", 
    "pid": 1, 
    "senid": 7, 
    "sent": "The bradycardia would promptly resolve after return to primary gaze, and the degree of bradycardia would also diminish with sustained upgaze to around 50 beats per minute after approximately 20 seconds. ", 
    "start": 18, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 133, 
    "c_start": 124, 
    "end": 21, 
    "mention": "sustained", 
    "pid": 1, 
    "senid": 7, 
    "sent": "The bradycardia would promptly resolve after return to primary gaze, and the degree of bradycardia would also diminish with sustained upgaze to around 50 beats per minute after approximately 20 seconds. ", 
    "start": 20, 
    "type": "Functional_Concept"
}
{
    "c_end": 153, 
    "c_start": 151, 
    "end": 25, 
    "mention": "50", 
    "pid": 1, 
    "senid": 7, 
    "sent": "The bradycardia would promptly resolve after return to primary gaze, and the degree of bradycardia would also diminish with sustained upgaze to around 50 beats per minute after approximately 20 seconds. ", 
    "start": 24, 
    "type": "Finding"
}
{
    "c_end": 170, 
    "c_start": 164, 
    "end": 28, 
    "mention": "minute", 
    "pid": 1, 
    "senid": 7, 
    "sent": "The bradycardia would promptly resolve after return to primary gaze, and the degree of bradycardia would also diminish with sustained upgaze to around 50 beats per minute after approximately 20 seconds. ", 
    "start": 27, 
    "type": "Temporal_Concept"
}
{
    "c_end": 190, 
    "c_start": 177, 
    "end": 30, 
    "mention": "approximately", 
    "pid": 1, 
    "senid": 7, 
    "sent": "The bradycardia would promptly resolve after return to primary gaze, and the degree of bradycardia would also diminish with sustained upgaze to around 50 beats per minute after approximately 20 seconds. ", 
    "start": 29, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 193, 
    "c_start": 191, 
    "end": 31, 
    "mention": "20", 
    "pid": 1, 
    "senid": 7, 
    "sent": "The bradycardia would promptly resolve after return to primary gaze, and the degree of bradycardia would also diminish with sustained upgaze to around 50 beats per minute after approximately 20 seconds. ", 
    "start": 30, 
    "type": "Finding"
}
{
    "c_end": 201, 
    "c_start": 194, 
    "end": 32, 
    "mention": "seconds", 
    "pid": 1, 
    "senid": 7, 
    "sent": "The bradycardia would promptly resolve after return to primary gaze, and the degree of bradycardia would also diminish with sustained upgaze to around 50 beats per minute after approximately 20 seconds. ", 
    "start": 31, 
    "type": "Temporal_Concept"
}
{
    "c_end": 15, 
    "c_start": 7, 
    "end": 2, 
    "mention": "repeated", 
    "pid": 1, 
    "senid": 14, 
    "sent": "During repeated ablation, clinical arrhythmia was induced. ", 
    "start": 1, 
    "type": "Functional_Concept"
}
{
    "c_end": 24, 
    "c_start": 16, 
    "end": 3, 
    "mention": "ablation", 
    "pid": 1, 
    "senid": 14, 
    "sent": "During repeated ablation, clinical arrhythmia was induced. ", 
    "start": 2, 
    "type": "Therapeutic_or_Preventive_Procedure"
}
{
    "c_end": 34, 
    "c_start": 26, 
    "end": 5, 
    "mention": "clinical", 
    "pid": 1, 
    "senid": 14, 
    "sent": "During repeated ablation, clinical arrhythmia was induced. ", 
    "start": 4, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 45, 
    "c_start": 35, 
    "end": 6, 
    "mention": "arrhythmia", 
    "pid": 1, 
    "senid": 14, 
    "sent": "During repeated ablation, clinical arrhythmia was induced. ", 
    "start": 5, 
    "type": "Finding"
}
{
    "c_end": 57, 
    "c_start": 50, 
    "end": 8, 
    "mention": "induced", 
    "pid": 1, 
    "senid": 14, 
    "sent": "During repeated ablation, clinical arrhythmia was induced. ", 
    "start": 7, 
    "type": "Functional_Concept"
}
{
    "c_end": 13, 
    "c_start": 2, 
    "end": 2, 
    "mention": "57-year-old", 
    "pid": 1, 
    "senid": 1, 
    "sent": "A 57-year-old male hypertensive Caucasian patient who was on medical treatment for 1.5 months for non-organic AF was admitted to the ICU because of high-ventricular response AF (170 per minute), and sinus rhythm was maintained during the CV that was performed two times every second day. ", 
    "start": 1, 
    "type": "Temporal_Concept"
}
{
    "c_end": 49, 
    "c_start": 14, 
    "end": 6, 
    "mention": "male hypertensive Caucasian patient", 
    "pid": 1, 
    "senid": 1, 
    "sent": "A 57-year-old male hypertensive Caucasian patient who was on medical treatment for 1.5 months for non-organic AF was admitted to the ICU because of high-ventricular response AF (170 per minute), and sinus rhythm was maintained during the CV that was performed two times every second day. ", 
    "start": 2, 
    "type": "Organism_Attribute"
}
{
    "c_end": 31, 
    "c_start": 19, 
    "end": 4, 
    "mention": "hypertensive", 
    "pid": 1, 
    "senid": 1, 
    "sent": "A 57-year-old male hypertensive Caucasian patient who was on medical treatment for 1.5 months for non-organic AF was admitted to the ICU because of high-ventricular response AF (170 per minute), and sinus rhythm was maintained during the CV that was performed two times every second day. ", 
    "start": 3, 
    "type": "Finding"
}
{
    "c_end": 41, 
    "c_start": 32, 
    "end": 5, 
    "mention": "Caucasian", 
    "pid": 1, 
    "senid": 1, 
    "sent": "A 57-year-old male hypertensive Caucasian patient who was on medical treatment for 1.5 months for non-organic AF was admitted to the ICU because of high-ventricular response AF (170 per minute), and sinus rhythm was maintained during the CV that was performed two times every second day. ", 
    "start": 4, 
    "type": "Population_Group"
}
{
    "c_end": 78, 
    "c_start": 61, 
    "end": 11, 
    "mention": "medical treatment", 
    "pid": 1, 
    "senid": 1, 
    "sent": "A 57-year-old male hypertensive Caucasian patient who was on medical treatment for 1.5 months for non-organic AF was admitted to the ICU because of high-ventricular response AF (170 per minute), and sinus rhythm was maintained during the CV that was performed two times every second day. ", 
    "start": 9, 
    "type": "Therapeutic_or_Preventive_Procedure"
}
{
    "c_end": 86, 
    "c_start": 83, 
    "end": 13, 
    "mention": "1.5", 
    "pid": 1, 
    "senid": 1, 
    "sent": "A 57-year-old male hypertensive Caucasian patient who was on medical treatment for 1.5 months for non-organic AF was admitted to the ICU because of high-ventricular response AF (170 per minute), and sinus rhythm was maintained during the CV that was performed two times every second day. ", 
    "start": 12, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 93, 
    "c_start": 87, 
    "end": 14, 
    "mention": "months", 
    "pid": 1, 
    "senid": 1, 
    "sent": "A 57-year-old male hypertensive Caucasian patient who was on medical treatment for 1.5 months for non-organic AF was admitted to the ICU because of high-ventricular response AF (170 per minute), and sinus rhythm was maintained during the CV that was performed two times every second day. ", 
    "start": 13, 
    "type": "Temporal_Concept"
}
{
    "c_end": 109, 
    "c_start": 98, 
    "end": 16, 
    "mention": "non-organic", 
    "pid": 1, 
    "senid": 1, 
    "sent": "A 57-year-old male hypertensive Caucasian patient who was on medical treatment for 1.5 months for non-organic AF was admitted to the ICU because of high-ventricular response AF (170 per minute), and sinus rhythm was maintained during the CV that was performed two times every second day. ", 
    "start": 15, 
    "type": "Functional_Concept"
}
{
    "c_end": 176, 
    "c_start": 174, 
    "end": 27, 
    "mention": "AF", 
    "pid": 1, 
    "senid": 1, 
    "sent": "A 57-year-old male hypertensive Caucasian patient who was on medical treatment for 1.5 months for non-organic AF was admitted to the ICU because of high-ventricular response AF (170 per minute), and sinus rhythm was maintained during the CV that was performed two times every second day. ", 
    "start": 26, 
    "type": "Laboratory_or_Test_Result"
}
{
    "c_end": 125, 
    "c_start": 117, 
    "end": 19, 
    "mention": "admitted", 
    "pid": 1, 
    "senid": 1, 
    "sent": "A 57-year-old male hypertensive Caucasian patient who was on medical treatment for 1.5 months for non-organic AF was admitted to the ICU because of high-ventricular response AF (170 per minute), and sinus rhythm was maintained during the CV that was performed two times every second day. ", 
    "start": 18, 
    "type": "Health_Care_Activity"
}
{
    "c_end": 136, 
    "c_start": 133, 
    "end": 22, 
    "mention": "ICU", 
    "pid": 1, 
    "senid": 1, 
    "sent": "A 57-year-old male hypertensive Caucasian patient who was on medical treatment for 1.5 months for non-organic AF was admitted to the ICU because of high-ventricular response AF (170 per minute), and sinus rhythm was maintained during the CV that was performed two times every second day. ", 
    "start": 21, 
    "type": "Health_Care_Related_Organization"
}
{
    "c_end": 164, 
    "c_start": 148, 
    "end": 25, 
    "mention": "high-ventricular", 
    "pid": 1, 
    "senid": 1, 
    "sent": "A 57-year-old male hypertensive Caucasian patient who was on medical treatment for 1.5 months for non-organic AF was admitted to the ICU because of high-ventricular response AF (170 per minute), and sinus rhythm was maintained during the CV that was performed two times every second day. ", 
    "start": 24, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 173, 
    "c_start": 165, 
    "end": 26, 
    "mention": "response", 
    "pid": 1, 
    "senid": 1, 
    "sent": "A 57-year-old male hypertensive Caucasian patient who was on medical treatment for 1.5 months for non-organic AF was admitted to the ICU because of high-ventricular response AF (170 per minute), and sinus rhythm was maintained during the CV that was performed two times every second day. ", 
    "start": 25, 
    "type": "Finding"
}
{
    "c_end": 192, 
    "c_start": 186, 
    "end": 31, 
    "mention": "minute", 
    "pid": 1, 
    "senid": 1, 
    "sent": "A 57-year-old male hypertensive Caucasian patient who was on medical treatment for 1.5 months for non-organic AF was admitted to the ICU because of high-ventricular response AF (170 per minute), and sinus rhythm was maintained during the CV that was performed two times every second day. ", 
    "start": 30, 
    "type": "Temporal_Concept"
}
{
    "c_end": 211, 
    "c_start": 199, 
    "end": 36, 
    "mention": "sinus rhythm", 
    "pid": 1, 
    "senid": 1, 
    "sent": "A 57-year-old male hypertensive Caucasian patient who was on medical treatment for 1.5 months for non-organic AF was admitted to the ICU because of high-ventricular response AF (170 per minute), and sinus rhythm was maintained during the CV that was performed two times every second day. ", 
    "start": 34, 
    "type": "Finding"
}
{
    "c_end": 226, 
    "c_start": 216, 
    "end": 38, 
    "mention": "maintained", 
    "pid": 1, 
    "senid": 1, 
    "sent": "A 57-year-old male hypertensive Caucasian patient who was on medical treatment for 1.5 months for non-organic AF was admitted to the ICU because of high-ventricular response AF (170 per minute), and sinus rhythm was maintained during the CV that was performed two times every second day. ", 
    "start": 37, 
    "type": "Functional_Concept"
}
{
    "c_end": 240, 
    "c_start": 238, 
    "end": 41, 
    "mention": "CV", 
    "pid": 1, 
    "senid": 1, 
    "sent": "A 57-year-old male hypertensive Caucasian patient who was on medical treatment for 1.5 months for non-organic AF was admitted to the ICU because of high-ventricular response AF (170 per minute), and sinus rhythm was maintained during the CV that was performed two times every second day. ", 
    "start": 40, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 259, 
    "c_start": 250, 
    "end": 44, 
    "mention": "performed", 
    "pid": 1, 
    "senid": 1, 
    "sent": "A 57-year-old male hypertensive Caucasian patient who was on medical treatment for 1.5 months for non-organic AF was admitted to the ICU because of high-ventricular response AF (170 per minute), and sinus rhythm was maintained during the CV that was performed two times every second day. ", 
    "start": 43, 
    "type": "Functional_Concept"
}
{
    "c_end": 269, 
    "c_start": 260, 
    "end": 46, 
    "mention": "two times", 
    "pid": 1, 
    "senid": 1, 
    "sent": "A 57-year-old male hypertensive Caucasian patient who was on medical treatment for 1.5 months for non-organic AF was admitted to the ICU because of high-ventricular response AF (170 per minute), and sinus rhythm was maintained during the CV that was performed two times every second day. ", 
    "start": 44, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 282, 
    "c_start": 276, 
    "end": 48, 
    "mention": "second", 
    "pid": 1, 
    "senid": 1, 
    "sent": "A 57-year-old male hypertensive Caucasian patient who was on medical treatment for 1.5 months for non-organic AF was admitted to the ICU because of high-ventricular response AF (170 per minute), and sinus rhythm was maintained during the CV that was performed two times every second day. ", 
    "start": 47, 
    "type": "Temporal_Concept"
}
{
    "c_end": 286, 
    "c_start": 283, 
    "end": 49, 
    "mention": "day", 
    "pid": 1, 
    "senid": 1, 
    "sent": "A 57-year-old male hypertensive Caucasian patient who was on medical treatment for 1.5 months for non-organic AF was admitted to the ICU because of high-ventricular response AF (170 per minute), and sinus rhythm was maintained during the CV that was performed two times every second day. ", 
    "start": 48, 
    "type": "Temporal_Concept"
}
{
    "c_end": 8, 
    "c_start": 4, 
    "end": 2, 
    "mention": "exit", 
    "pid": 1, 
    "senid": 32, 
    "sent": "The exit to the LA was blocked. ", 
    "start": 1, 
    "type": "Functional_Concept"
}
{
    "c_end": 18, 
    "c_start": 16, 
    "end": 5, 
    "mention": "LA", 
    "pid": 1, 
    "senid": 32, 
    "sent": "The exit to the LA was blocked. ", 
    "start": 4, 
    "type": "Body_Part__Organ__or_Organ_Component"
}
{
    "c_end": 30, 
    "c_start": 23, 
    "end": 7, 
    "mention": "blocked", 
    "pid": 1, 
    "senid": 32, 
    "sent": "The exit to the LA was blocked. ", 
    "start": 6, 
    "type": "Pathologic_Function"
}
{
    "c_end": 4, 
    "c_start": 0, 
    "end": 1, 
    "mention": "Case", 
    "pid": 1, 
    "senid": 41, 
    "sent": "Case 5 A 39-year-old obese woman presented with influenza A (H1N1)-related acute respiratory distress syndrome (ARDS). ", 
    "start": 0, 
    "type": "Functional_Concept"
}
{
    "c_end": 20, 
    "c_start": 9, 
    "end": 4, 
    "mention": "39-year-old", 
    "pid": 1, 
    "senid": 41, 
    "sent": "Case 5 A 39-year-old obese woman presented with influenza A (H1N1)-related acute respiratory distress syndrome (ARDS). ", 
    "start": 3, 
    "type": "Temporal_Concept"
}
{
    "c_end": 26, 
    "c_start": 21, 
    "end": 5, 
    "mention": "obese", 
    "pid": 1, 
    "senid": 41, 
    "sent": "Case 5 A 39-year-old obese woman presented with influenza A (H1N1)-related acute respiratory distress syndrome (ARDS). ", 
    "start": 4, 
    "type": "Disease_or_Syndrome"
}
{
    "c_end": 32, 
    "c_start": 27, 
    "end": 6, 
    "mention": "woman", 
    "pid": 1, 
    "senid": 41, 
    "sent": "Case 5 A 39-year-old obese woman presented with influenza A (H1N1)-related acute respiratory distress syndrome (ARDS). ", 
    "start": 5, 
    "type": "Population_Group"
}
{
    "c_end": 42, 
    "c_start": 33, 
    "end": 7, 
    "mention": "presented", 
    "pid": 1, 
    "senid": 41, 
    "sent": "Case 5 A 39-year-old obese woman presented with influenza A (H1N1)-related acute respiratory distress syndrome (ARDS). ", 
    "start": 6, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 119, 
    "c_start": 81, 
    "end": 19, 
    "mention": "respiratory distress syndrome (ARDS). ", 
    "pid": 1, 
    "senid": 41, 
    "sent": "Case 5 A 39-year-old obese woman presented with influenza A (H1N1)-related acute respiratory distress syndrome (ARDS). ", 
    "start": 15, 
    "type": "Disease_or_Syndrome"
}
{
    "c_end": 10, 
    "c_start": 0, 
    "end": 1, 
    "mention": "Conclusion", 
    "pid": 1, 
    "senid": 39, 
    "sent": "Conclusion The reentrant circuit of this LAMRT could be nicely depicted using the nMarq catheter. ", 
    "start": 0, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 77, 
    "c_start": 72, 
    "end": 12, 
    "mention": "using", 
    "pid": 1, 
    "senid": 39, 
    "sent": "Conclusion The reentrant circuit of this LAMRT could be nicely depicted using the nMarq catheter. ", 
    "start": 11, 
    "type": "Functional_Concept"
}
{
    "c_end": 96, 
    "c_start": 88, 
    "end": 15, 
    "mention": "catheter", 
    "pid": 1, 
    "senid": 39, 
    "sent": "Conclusion The reentrant circuit of this LAMRT could be nicely depicted using the nMarq catheter. ", 
    "start": 14, 
    "type": "Medical_Device"
}
{
    "c_end": 11, 
    "c_start": 4, 
    "end": 2, 
    "mention": "patient", 
    "pid": 1, 
    "senid": 5, 
    "sent": "The patient was wearing a helmet but sustained unilateral lacerations and a zygomaticomaxillary complex fracture with an orbital floor fracture. ", 
    "start": 1, 
    "type": "Patient_or_Disabled_Group"
}
{
    "c_end": 32, 
    "c_start": 26, 
    "end": 6, 
    "mention": "helmet", 
    "pid": 1, 
    "senid": 5, 
    "sent": "The patient was wearing a helmet but sustained unilateral lacerations and a zygomaticomaxillary complex fracture with an orbital floor fracture. ", 
    "start": 5, 
    "type": "Manufactured_Object"
}
{
    "c_end": 46, 
    "c_start": 37, 
    "end": 8, 
    "mention": "sustained", 
    "pid": 1, 
    "senid": 5, 
    "sent": "The patient was wearing a helmet but sustained unilateral lacerations and a zygomaticomaxillary complex fracture with an orbital floor fracture. ", 
    "start": 7, 
    "type": "Functional_Concept"
}
{
    "c_end": 57, 
    "c_start": 47, 
    "end": 9, 
    "mention": "unilateral", 
    "pid": 1, 
    "senid": 5, 
    "sent": "The patient was wearing a helmet but sustained unilateral lacerations and a zygomaticomaxillary complex fracture with an orbital floor fracture. ", 
    "start": 8, 
    "type": "Spatial_Concept"
}
{
    "c_end": 69, 
    "c_start": 58, 
    "end": 10, 
    "mention": "lacerations", 
    "pid": 1, 
    "senid": 5, 
    "sent": "The patient was wearing a helmet but sustained unilateral lacerations and a zygomaticomaxillary complex fracture with an orbital floor fracture. ", 
    "start": 9, 
    "type": "Injury_or_Poisoning"
}
{
    "c_end": 103, 
    "c_start": 96, 
    "end": 14, 
    "mention": "complex", 
    "pid": 1, 
    "senid": 5, 
    "sent": "The patient was wearing a helmet but sustained unilateral lacerations and a zygomaticomaxillary complex fracture with an orbital floor fracture. ", 
    "start": 13, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 134, 
    "c_start": 104, 
    "end": 19, 
    "mention": "fracture with an orbital floor", 
    "pid": 1, 
    "senid": 5, 
    "sent": "The patient was wearing a helmet but sustained unilateral lacerations and a zygomaticomaxillary complex fracture with an orbital floor fracture. ", 
    "start": 14, 
    "type": "Injury_or_Poisoning"
}
{
    "c_end": 14, 
    "c_start": 5, 
    "end": 2, 
    "mention": "electrode", 
    "pid": 1, 
    "senid": 26, 
    "sent": "Each electrode can be switched on and off separately. ", 
    "start": 1, 
    "type": "Manufactured_Object"
}
{
    "c_end": 30, 
    "c_start": 22, 
    "end": 5, 
    "mention": "switched", 
    "pid": 1, 
    "senid": 26, 
    "sent": "Each electrode can be switched on and off separately. ", 
    "start": 4, 
    "type": "Manufactured_Object"
}
{
    "c_end": 14, 
    "c_start": 0, 
    "end": 2, 
    "mention": "Cardiac arrest", 
    "pid": 1, 
    "senid": 47, 
    "sent": "Cardiac arrest ensued and emergent sternotomy was performed under ECMO-assisted cardiopulmonary resuscitation after femoral artery cannu-lation (venous-venous-arterial ECMO). ", 
    "start": 0, 
    "type": "Disease_or_Syndrome"
}
{
    "c_end": 34, 
    "c_start": 26, 
    "end": 5, 
    "mention": "emergent", 
    "pid": 1, 
    "senid": 47, 
    "sent": "Cardiac arrest ensued and emergent sternotomy was performed under ECMO-assisted cardiopulmonary resuscitation after femoral artery cannu-lation (venous-venous-arterial ECMO). ", 
    "start": 4, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 45, 
    "c_start": 35, 
    "end": 6, 
    "mention": "sternotomy", 
    "pid": 1, 
    "senid": 47, 
    "sent": "Cardiac arrest ensued and emergent sternotomy was performed under ECMO-assisted cardiopulmonary resuscitation after femoral artery cannu-lation (venous-venous-arterial ECMO). ", 
    "start": 5, 
    "type": "Therapeutic_or_Preventive_Procedure"
}
{
    "c_end": 59, 
    "c_start": 50, 
    "end": 8, 
    "mention": "performed", 
    "pid": 1, 
    "senid": 47, 
    "sent": "Cardiac arrest ensued and emergent sternotomy was performed under ECMO-assisted cardiopulmonary resuscitation after femoral artery cannu-lation (venous-venous-arterial ECMO). ", 
    "start": 7, 
    "type": "Functional_Concept"
}
{
    "c_end": 79, 
    "c_start": 66, 
    "end": 10, 
    "mention": "ECMO-assisted", 
    "pid": 1, 
    "senid": 47, 
    "sent": "Cardiac arrest ensued and emergent sternotomy was performed under ECMO-assisted cardiopulmonary resuscitation after femoral artery cannu-lation (venous-venous-arterial ECMO). ", 
    "start": 9, 
    "type": "Therapeutic_or_Preventive_Procedure"
}
{
    "c_end": 109, 
    "c_start": 80, 
    "end": 12, 
    "mention": "cardiopulmonary resuscitation", 
    "pid": 1, 
    "senid": 47, 
    "sent": "Cardiac arrest ensued and emergent sternotomy was performed under ECMO-assisted cardiopulmonary resuscitation after femoral artery cannu-lation (venous-venous-arterial ECMO). ", 
    "start": 10, 
    "type": "Therapeutic_or_Preventive_Procedure"
}
{
    "c_end": 130, 
    "c_start": 116, 
    "end": 15, 
    "mention": "femoral artery", 
    "pid": 1, 
    "senid": 47, 
    "sent": "Cardiac arrest ensued and emergent sternotomy was performed under ECMO-assisted cardiopulmonary resuscitation after femoral artery cannu-lation (venous-venous-arterial ECMO). ", 
    "start": 13, 
    "type": "Body_Part__Organ__or_Organ_Component"
}
{
    "c_end": 143, 
    "c_start": 131, 
    "end": 16, 
    "mention": "cannu-lation", 
    "pid": 1, 
    "senid": 47, 
    "sent": "Cardiac arrest ensued and emergent sternotomy was performed under ECMO-assisted cardiopulmonary resuscitation after femoral artery cannu-lation (venous-venous-arterial ECMO). ", 
    "start": 15, 
    "type": "Eukaryote"
}
{
    "c_end": 167, 
    "c_start": 145, 
    "end": 18, 
    "mention": "venous-venous-arterial", 
    "pid": 1, 
    "senid": 47, 
    "sent": "Cardiac arrest ensued and emergent sternotomy was performed under ECMO-assisted cardiopulmonary resuscitation after femoral artery cannu-lation (venous-venous-arterial ECMO). ", 
    "start": 17, 
    "type": "Body_Part__Organ__or_Organ_Component"
}
{
    "c_end": 19, 
    "c_start": 4, 
    "end": 3, 
    "mention": "hospital course", 
    "pid": 1, 
    "senid": 49, 
    "sent": "Her hospital course was further complicated by severe ARDS secondary to Enterococcus faecalis bacteremia with redo veno-venous ECMO. ", 
    "start": 1, 
    "type": "Clinical_Attribute"
}
{
    "c_end": 31, 
    "c_start": 24, 
    "end": 5, 
    "mention": "further", 
    "pid": 1, 
    "senid": 49, 
    "sent": "Her hospital course was further complicated by severe ARDS secondary to Enterococcus faecalis bacteremia with redo veno-venous ECMO. ", 
    "start": 4, 
    "type": "Spatial_Concept"
}
{
    "c_end": 43, 
    "c_start": 32, 
    "end": 6, 
    "mention": "complicated", 
    "pid": 1, 
    "senid": 49, 
    "sent": "Her hospital course was further complicated by severe ARDS secondary to Enterococcus faecalis bacteremia with redo veno-venous ECMO. ", 
    "start": 5, 
    "type": "Functional_Concept"
}
{
    "c_end": 58, 
    "c_start": 47, 
    "end": 9, 
    "mention": "severe ARDS", 
    "pid": 1, 
    "senid": 49, 
    "sent": "Her hospital course was further complicated by severe ARDS secondary to Enterococcus faecalis bacteremia with redo veno-venous ECMO. ", 
    "start": 7, 
    "type": "Disease_or_Syndrome"
}
{
    "c_end": 58, 
    "c_start": 54, 
    "end": 9, 
    "mention": "ARDS", 
    "pid": 1, 
    "senid": 49, 
    "sent": "Her hospital course was further complicated by severe ARDS secondary to Enterococcus faecalis bacteremia with redo veno-venous ECMO. ", 
    "start": 8, 
    "type": "Mental_Process"
}
{
    "c_end": 53, 
    "c_start": 47, 
    "end": 8, 
    "mention": "severe", 
    "pid": 1, 
    "senid": 49, 
    "sent": "Her hospital course was further complicated by severe ARDS secondary to Enterococcus faecalis bacteremia with redo veno-venous ECMO. ", 
    "start": 7, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 71, 
    "c_start": 59, 
    "end": 11, 
    "mention": "secondary to", 
    "pid": 1, 
    "senid": 49, 
    "sent": "Her hospital course was further complicated by severe ARDS secondary to Enterococcus faecalis bacteremia with redo veno-venous ECMO. ", 
    "start": 9, 
    "type": "Temporal_Concept"
}
{
    "c_end": 93, 
    "c_start": 72, 
    "end": 13, 
    "mention": "Enterococcus faecalis", 
    "pid": 1, 
    "senid": 49, 
    "sent": "Her hospital course was further complicated by severe ARDS secondary to Enterococcus faecalis bacteremia with redo veno-venous ECMO. ", 
    "start": 11, 
    "type": "Bacterium"
}
{
    "c_end": 104, 
    "c_start": 94, 
    "end": 14, 
    "mention": "bacteremia", 
    "pid": 1, 
    "senid": 49, 
    "sent": "Her hospital course was further complicated by severe ARDS secondary to Enterococcus faecalis bacteremia with redo veno-venous ECMO. ", 
    "start": 13, 
    "type": "Disease_or_Syndrome"
}
{
    "c_end": 114, 
    "c_start": 110, 
    "end": 16, 
    "mention": "redo", 
    "pid": 1, 
    "senid": 49, 
    "sent": "Her hospital course was further complicated by severe ARDS secondary to Enterococcus faecalis bacteremia with redo veno-venous ECMO. ", 
    "start": 15, 
    "type": "Temporal_Concept"
}
{
    "c_end": 126, 
    "c_start": 115, 
    "end": 17, 
    "mention": "veno-venous", 
    "pid": 1, 
    "senid": 49, 
    "sent": "Her hospital course was further complicated by severe ARDS secondary to Enterococcus faecalis bacteremia with redo veno-venous ECMO. ", 
    "start": 16, 
    "type": "Spatial_Concept"
}
{
    "c_end": 131, 
    "c_start": 127, 
    "end": 18, 
    "mention": "ECMO", 
    "pid": 1, 
    "senid": 49, 
    "sent": "Her hospital course was further complicated by severe ARDS secondary to Enterococcus faecalis bacteremia with redo veno-venous ECMO. ", 
    "start": 17, 
    "type": "Therapeutic_or_Preventive_Procedure"
}
{
    "c_end": 36, 
    "c_start": 2, 
    "end": 4, 
    "mention": "3-dimensional reconstruction image", 
    "pid": 1, 
    "senid": 20, 
    "sent": "A 3-dimensional reconstruction image showed that this was a left-sided SN artery.  ", 
    "start": 1, 
    "type": "Manufactured_Object"
}
{
    "c_end": 30, 
    "c_start": 16, 
    "end": 3, 
    "mention": "reconstruction", 
    "pid": 1, 
    "senid": 20, 
    "sent": "A 3-dimensional reconstruction image showed that this was a left-sided SN artery.  ", 
    "start": 2, 
    "type": "Therapeutic_or_Preventive_Procedure"
}
{
    "c_end": 43, 
    "c_start": 37, 
    "end": 5, 
    "mention": "showed", 
    "pid": 1, 
    "senid": 20, 
    "sent": "A 3-dimensional reconstruction image showed that this was a left-sided SN artery.  ", 
    "start": 4, 
    "type": "Animal"
}
{
    "c_end": 70, 
    "c_start": 60, 
    "end": 10, 
    "mention": "left-sided", 
    "pid": 1, 
    "senid": 20, 
    "sent": "A 3-dimensional reconstruction image showed that this was a left-sided SN artery.  ", 
    "start": 9, 
    "type": "Spatial_Concept"
}
{
    "c_end": 80, 
    "c_start": 71, 
    "end": 12, 
    "mention": "SN artery", 
    "pid": 1, 
    "senid": 20, 
    "sent": "A 3-dimensional reconstruction image showed that this was a left-sided SN artery.  ", 
    "start": 10, 
    "type": "Body_Part__Organ__or_Organ_Component"
}
{
    "c_end": 13, 
    "c_start": 11, 
    "end": 4, 
    "mention": "CT", 
    "pid": 1, 
    "senid": 11, 
    "sent": "However, a CT of the head/orbits demonstrated no prolapse of the inferior rectus but instead evidence of a small amount of soft tissue, which likely represented adventitia surrounding the inferior rectus trapped in and below the orbital floor fracture. ", 
    "start": 3, 
    "type": "Spatial_Concept"
}
{
    "c_end": 32, 
    "c_start": 11, 
    "end": 7, 
    "mention": "CT of the head/orbits", 
    "pid": 1, 
    "senid": 11, 
    "sent": "However, a CT of the head/orbits demonstrated no prolapse of the inferior rectus but instead evidence of a small amount of soft tissue, which likely represented adventitia surrounding the inferior rectus trapped in and below the orbital floor fracture. ", 
    "start": 3, 
    "type": "Diagnostic_Procedure"
}
{
    "c_end": 32, 
    "c_start": 21, 
    "end": 7, 
    "mention": "head/orbits", 
    "pid": 1, 
    "senid": 11, 
    "sent": "However, a CT of the head/orbits demonstrated no prolapse of the inferior rectus but instead evidence of a small amount of soft tissue, which likely represented adventitia surrounding the inferior rectus trapped in and below the orbital floor fracture. ", 
    "start": 6, 
    "type": "Body_Space_or_Junction"
}
{
    "c_end": 57, 
    "c_start": 49, 
    "end": 10, 
    "mention": "prolapse", 
    "pid": 1, 
    "senid": 11, 
    "sent": "However, a CT of the head/orbits demonstrated no prolapse of the inferior rectus but instead evidence of a small amount of soft tissue, which likely represented adventitia surrounding the inferior rectus trapped in and below the orbital floor fracture. ", 
    "start": 9, 
    "type": "Disease_or_Syndrome"
}
{
    "c_end": 80, 
    "c_start": 65, 
    "end": 14, 
    "mention": "inferior rectus", 
    "pid": 1, 
    "senid": 11, 
    "sent": "However, a CT of the head/orbits demonstrated no prolapse of the inferior rectus but instead evidence of a small amount of soft tissue, which likely represented adventitia surrounding the inferior rectus trapped in and below the orbital floor fracture. ", 
    "start": 12, 
    "type": "Body_Part__Organ__or_Organ_Component"
}
{
    "c_end": 101, 
    "c_start": 93, 
    "end": 17, 
    "mention": "evidence", 
    "pid": 1, 
    "senid": 11, 
    "sent": "However, a CT of the head/orbits demonstrated no prolapse of the inferior rectus but instead evidence of a small amount of soft tissue, which likely represented adventitia surrounding the inferior rectus trapped in and below the orbital floor fracture. ", 
    "start": 16, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 119, 
    "c_start": 107, 
    "end": 21, 
    "mention": "small amount", 
    "pid": 1, 
    "senid": 11, 
    "sent": "However, a CT of the head/orbits demonstrated no prolapse of the inferior rectus but instead evidence of a small amount of soft tissue, which likely represented adventitia surrounding the inferior rectus trapped in and below the orbital floor fracture. ", 
    "start": 19, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 134, 
    "c_start": 123, 
    "end": 24, 
    "mention": "soft tissue", 
    "pid": 1, 
    "senid": 11, 
    "sent": "However, a CT of the head/orbits demonstrated no prolapse of the inferior rectus but instead evidence of a small amount of soft tissue, which likely represented adventitia surrounding the inferior rectus trapped in and below the orbital floor fracture. ", 
    "start": 22, 
    "type": "Functional_Concept"
}
{
    "c_end": 148, 
    "c_start": 142, 
    "end": 27, 
    "mention": "likely", 
    "pid": 1, 
    "senid": 11, 
    "sent": "However, a CT of the head/orbits demonstrated no prolapse of the inferior rectus but instead evidence of a small amount of soft tissue, which likely represented adventitia surrounding the inferior rectus trapped in and below the orbital floor fracture. ", 
    "start": 26, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 160, 
    "c_start": 149, 
    "end": 28, 
    "mention": "represented", 
    "pid": 1, 
    "senid": 11, 
    "sent": "However, a CT of the head/orbits demonstrated no prolapse of the inferior rectus but instead evidence of a small amount of soft tissue, which likely represented adventitia surrounding the inferior rectus trapped in and below the orbital floor fracture. ", 
    "start": 27, 
    "type": "Activity"
}
{
    "c_end": 171, 
    "c_start": 161, 
    "end": 29, 
    "mention": "adventitia", 
    "pid": 1, 
    "senid": 11, 
    "sent": "However, a CT of the head/orbits demonstrated no prolapse of the inferior rectus but instead evidence of a small amount of soft tissue, which likely represented adventitia surrounding the inferior rectus trapped in and below the orbital floor fracture. ", 
    "start": 28, 
    "type": "Tissue"
}
{
    "c_end": 183, 
    "c_start": 172, 
    "end": 30, 
    "mention": "surrounding", 
    "pid": 1, 
    "senid": 11, 
    "sent": "However, a CT of the head/orbits demonstrated no prolapse of the inferior rectus but instead evidence of a small amount of soft tissue, which likely represented adventitia surrounding the inferior rectus trapped in and below the orbital floor fracture. ", 
    "start": 29, 
    "type": "Spatial_Concept"
}
{
    "c_end": 211, 
    "c_start": 204, 
    "end": 34, 
    "mention": "trapped", 
    "pid": 1, 
    "senid": 11, 
    "sent": "However, a CT of the head/orbits demonstrated no prolapse of the inferior rectus but instead evidence of a small amount of soft tissue, which likely represented adventitia surrounding the inferior rectus trapped in and below the orbital floor fracture. ", 
    "start": 33, 
    "type": "Mental_Process"
}
{
    "c_end": 251, 
    "c_start": 229, 
    "end": 41, 
    "mention": "orbital floor fracture", 
    "pid": 1, 
    "senid": 11, 
    "sent": "However, a CT of the head/orbits demonstrated no prolapse of the inferior rectus but instead evidence of a small amount of soft tissue, which likely represented adventitia surrounding the inferior rectus trapped in and below the orbital floor fracture. ", 
    "start": 38, 
    "type": "Injury_or_Poisoning"
}
{
    "c_end": 6, 
    "c_start": 3, 
    "end": 2, 
    "mention": "day", 
    "pid": 1, 
    "senid": 43, 
    "sent": "At day 15, venous catheter-related infection was suspected and a left subclavian venous catheter was inserted using the Seldinger technique, with blood that was freely aspirated before and after insertion of the catheter. ", 
    "start": 1, 
    "type": "Temporal_Concept"
}
{
    "c_end": 17, 
    "c_start": 11, 
    "end": 5, 
    "mention": "venous", 
    "pid": 1, 
    "senid": 43, 
    "sent": "At day 15, venous catheter-related infection was suspected and a left subclavian venous catheter was inserted using the Seldinger technique, with blood that was freely aspirated before and after insertion of the catheter. ", 
    "start": 4, 
    "type": "Body_Part__Organ__or_Organ_Component"
}
{
    "c_end": 44, 
    "c_start": 18, 
    "end": 7, 
    "mention": "catheter-related infection", 
    "pid": 1, 
    "senid": 43, 
    "sent": "At day 15, venous catheter-related infection was suspected and a left subclavian venous catheter was inserted using the Seldinger technique, with blood that was freely aspirated before and after insertion of the catheter. ", 
    "start": 5, 
    "type": "Pathologic_Function"
}
{
    "c_end": 58, 
    "c_start": 49, 
    "end": 9, 
    "mention": "suspected", 
    "pid": 1, 
    "senid": 43, 
    "sent": "At day 15, venous catheter-related infection was suspected and a left subclavian venous catheter was inserted using the Seldinger technique, with blood that was freely aspirated before and after insertion of the catheter. ", 
    "start": 8, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 87, 
    "c_start": 65, 
    "end": 14, 
    "mention": "left subclavian venous", 
    "pid": 1, 
    "senid": 43, 
    "sent": "At day 15, venous catheter-related infection was suspected and a left subclavian venous catheter was inserted using the Seldinger technique, with blood that was freely aspirated before and after insertion of the catheter. ", 
    "start": 11, 
    "type": "Body_Part__Organ__or_Organ_Component"
}
{
    "c_end": 96, 
    "c_start": 88, 
    "end": 15, 
    "mention": "catheter", 
    "pid": 1, 
    "senid": 43, 
    "sent": "At day 15, venous catheter-related infection was suspected and a left subclavian venous catheter was inserted using the Seldinger technique, with blood that was freely aspirated before and after insertion of the catheter. ", 
    "start": 14, 
    "type": "Medical_Device"
}
{
    "c_end": 109, 
    "c_start": 101, 
    "end": 17, 
    "mention": "inserted", 
    "pid": 1, 
    "senid": 43, 
    "sent": "At day 15, venous catheter-related infection was suspected and a left subclavian venous catheter was inserted using the Seldinger technique, with blood that was freely aspirated before and after insertion of the catheter. ", 
    "start": 16, 
    "type": "Health_Care_Activity"
}
{
    "c_end": 115, 
    "c_start": 110, 
    "end": 18, 
    "mention": "using", 
    "pid": 1, 
    "senid": 43, 
    "sent": "At day 15, venous catheter-related infection was suspected and a left subclavian venous catheter was inserted using the Seldinger technique, with blood that was freely aspirated before and after insertion of the catheter. ", 
    "start": 17, 
    "type": "Functional_Concept"
}
{
    "c_end": 139, 
    "c_start": 120, 
    "end": 21, 
    "mention": "Seldinger technique", 
    "pid": 1, 
    "senid": 43, 
    "sent": "At day 15, venous catheter-related infection was suspected and a left subclavian venous catheter was inserted using the Seldinger technique, with blood that was freely aspirated before and after insertion of the catheter. ", 
    "start": 19, 
    "type": "Therapeutic_or_Preventive_Procedure"
}
{
    "c_end": 151, 
    "c_start": 146, 
    "end": 24, 
    "mention": "blood", 
    "pid": 1, 
    "senid": 43, 
    "sent": "At day 15, venous catheter-related infection was suspected and a left subclavian venous catheter was inserted using the Seldinger technique, with blood that was freely aspirated before and after insertion of the catheter. ", 
    "start": 23, 
    "type": "Body_Substance"
}
{
    "c_end": 167, 
    "c_start": 161, 
    "end": 27, 
    "mention": "freely", 
    "pid": 1, 
    "senid": 43, 
    "sent": "At day 15, venous catheter-related infection was suspected and a left subclavian venous catheter was inserted using the Seldinger technique, with blood that was freely aspirated before and after insertion of the catheter. ", 
    "start": 26, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 177, 
    "c_start": 168, 
    "end": 28, 
    "mention": "aspirated", 
    "pid": 1, 
    "senid": 43, 
    "sent": "At day 15, venous catheter-related infection was suspected and a left subclavian venous catheter was inserted using the Seldinger technique, with blood that was freely aspirated before and after insertion of the catheter. ", 
    "start": 27, 
    "type": "Pathologic_Function"
}
{
    "c_end": 220, 
    "c_start": 195, 
    "end": 35, 
    "mention": "insertion of the catheter", 
    "pid": 1, 
    "senid": 43, 
    "sent": "At day 15, venous catheter-related infection was suspected and a left subclavian venous catheter was inserted using the Seldinger technique, with blood that was freely aspirated before and after insertion of the catheter. ", 
    "start": 31, 
    "type": "Therapeutic_or_Preventive_Procedure"
}
{
    "c_end": 16, 
    "c_start": 0, 
    "end": 1, 
    "mention": "Echocardiography", 
    "pid": 1, 
    "senid": 55, 
    "sent": "Echocardiography revealed dilatation of the left ventricle, highly reduced systolic function and diffuse hypokinesia. ", 
    "start": 0, 
    "type": "Diagnostic_Procedure"
}
{
    "c_end": 25, 
    "c_start": 17, 
    "end": 2, 
    "mention": "revealed", 
    "pid": 1, 
    "senid": 55, 
    "sent": "Echocardiography revealed dilatation of the left ventricle, highly reduced systolic function and diffuse hypokinesia. ", 
    "start": 1, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 58, 
    "c_start": 26, 
    "end": 7, 
    "mention": "dilatation of the left ventricle", 
    "pid": 1, 
    "senid": 55, 
    "sent": "Echocardiography revealed dilatation of the left ventricle, highly reduced systolic function and diffuse hypokinesia. ", 
    "start": 2, 
    "type": "Congenital_Abnormality"
}
{
    "c_end": 66, 
    "c_start": 60, 
    "end": 9, 
    "mention": "highly", 
    "pid": 1, 
    "senid": 55, 
    "sent": "Echocardiography revealed dilatation of the left ventricle, highly reduced systolic function and diffuse hypokinesia. ", 
    "start": 8, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 74, 
    "c_start": 67, 
    "end": 10, 
    "mention": "reduced", 
    "pid": 1, 
    "senid": 55, 
    "sent": "Echocardiography revealed dilatation of the left ventricle, highly reduced systolic function and diffuse hypokinesia. ", 
    "start": 9, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 83, 
    "c_start": 75, 
    "end": 11, 
    "mention": "systolic", 
    "pid": 1, 
    "senid": 55, 
    "sent": "Echocardiography revealed dilatation of the left ventricle, highly reduced systolic function and diffuse hypokinesia. ", 
    "start": 10, 
    "type": "Temporal_Concept"
}
{
    "c_end": 92, 
    "c_start": 84, 
    "end": 12, 
    "mention": "function", 
    "pid": 1, 
    "senid": 55, 
    "sent": "Echocardiography revealed dilatation of the left ventricle, highly reduced systolic function and diffuse hypokinesia. ", 
    "start": 11, 
    "type": "Intellectual_Product"
}
{
    "c_end": 104, 
    "c_start": 97, 
    "end": 14, 
    "mention": "diffuse", 
    "pid": 1, 
    "senid": 55, 
    "sent": "Echocardiography revealed dilatation of the left ventricle, highly reduced systolic function and diffuse hypokinesia. ", 
    "start": 13, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 116, 
    "c_start": 105, 
    "end": 15, 
    "mention": "hypokinesia", 
    "pid": 1, 
    "senid": 55, 
    "sent": "Echocardiography revealed dilatation of the left ventricle, highly reduced systolic function and diffuse hypokinesia. ", 
    "start": 14, 
    "type": "Sign_or_Symptom"
}
{
    "c_end": 4, 
    "c_start": 0, 
    "end": 1, 
    "mention": "Case", 
    "pid": 1, 
    "senid": 58, 
    "sent": "Case 7 In the last decades, number of drugs were withdrawn due to cases of TdP, leading to intensify assessment of drug QT interval. ", 
    "start": 0, 
    "type": "Functional_Concept"
}
{
    "c_end": 26, 
    "c_start": 19, 
    "end": 6, 
    "mention": "decades", 
    "pid": 1, 
    "senid": 58, 
    "sent": "Case 7 In the last decades, number of drugs were withdrawn due to cases of TdP, leading to intensify assessment of drug QT interval. ", 
    "start": 5, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 34, 
    "c_start": 28, 
    "end": 8, 
    "mention": "number", 
    "pid": 1, 
    "senid": 58, 
    "sent": "Case 7 In the last decades, number of drugs were withdrawn due to cases of TdP, leading to intensify assessment of drug QT interval. ", 
    "start": 7, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 43, 
    "c_start": 38, 
    "end": 10, 
    "mention": "drugs", 
    "pid": 1, 
    "senid": 58, 
    "sent": "Case 7 In the last decades, number of drugs were withdrawn due to cases of TdP, leading to intensify assessment of drug QT interval. ", 
    "start": 9, 
    "type": "Pharmacologic_Substance"
}
{
    "c_end": 58, 
    "c_start": 49, 
    "end": 12, 
    "mention": "withdrawn", 
    "pid": 1, 
    "senid": 58, 
    "sent": "Case 7 In the last decades, number of drugs were withdrawn due to cases of TdP, leading to intensify assessment of drug QT interval. ", 
    "start": 11, 
    "type": "Intellectual_Product"
}
{
    "c_end": 65, 
    "c_start": 59, 
    "end": 14, 
    "mention": "due to", 
    "pid": 1, 
    "senid": 58, 
    "sent": "Case 7 In the last decades, number of drugs were withdrawn due to cases of TdP, leading to intensify assessment of drug QT interval. ", 
    "start": 12, 
    "type": "Functional_Concept"
}
{
    "c_end": 71, 
    "c_start": 66, 
    "end": 15, 
    "mention": "cases", 
    "pid": 1, 
    "senid": 58, 
    "sent": "Case 7 In the last decades, number of drugs were withdrawn due to cases of TdP, leading to intensify assessment of drug QT interval. ", 
    "start": 14, 
    "type": "Functional_Concept"
}
{
    "c_end": 87, 
    "c_start": 80, 
    "end": 19, 
    "mention": "leading", 
    "pid": 1, 
    "senid": 58, 
    "sent": "Case 7 In the last decades, number of drugs were withdrawn due to cases of TdP, leading to intensify assessment of drug QT interval. ", 
    "start": 18, 
    "type": "Temporal_Concept"
}
{
    "c_end": 90, 
    "c_start": 88, 
    "end": 20, 
    "mention": "to", 
    "pid": 1, 
    "senid": 58, 
    "sent": "Case 7 In the last decades, number of drugs were withdrawn due to cases of TdP, leading to intensify assessment of drug QT interval. ", 
    "start": 19, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 119, 
    "c_start": 101, 
    "end": 24, 
    "mention": "assessment of drug", 
    "pid": 1, 
    "senid": 58, 
    "sent": "Case 7 In the last decades, number of drugs were withdrawn due to cases of TdP, leading to intensify assessment of drug QT interval. ", 
    "start": 21, 
    "type": "Research_Activity"
}
{
    "c_end": 131, 
    "c_start": 120, 
    "end": 26, 
    "mention": "QT interval", 
    "pid": 1, 
    "senid": 58, 
    "sent": "Case 7 In the last decades, number of drugs were withdrawn due to cases of TdP, leading to intensify assessment of drug QT interval. ", 
    "start": 24, 
    "type": "Clinical_Attribute"
}
{
    "c_end": 13, 
    "c_start": 7, 
    "end": 2, 
    "mention": "linear", 
    "pid": 1, 
    "senid": 17, 
    "sent": "During linear ablation from mitral annulus along fractionated electrograms to the scar near left superior pulmonary vein using an irrigated tip catheter (power, 35 W; temperature, 40 oC), atrial flutter terminated, which was followed by sinus nodal (SN) arrest requiring urgent temporary pacing. ", 
    "start": 1, 
    "type": "Spatial_Concept"
}
{
    "c_end": 22, 
    "c_start": 14, 
    "end": 3, 
    "mention": "ablation", 
    "pid": 1, 
    "senid": 17, 
    "sent": "During linear ablation from mitral annulus along fractionated electrograms to the scar near left superior pulmonary vein using an irrigated tip catheter (power, 35 W; temperature, 40 oC), atrial flutter terminated, which was followed by sinus nodal (SN) arrest requiring urgent temporary pacing. ", 
    "start": 2, 
    "type": "Therapeutic_or_Preventive_Procedure"
}
{
    "c_end": 42, 
    "c_start": 28, 
    "end": 6, 
    "mention": "mitral annulus", 
    "pid": 1, 
    "senid": 17, 
    "sent": "During linear ablation from mitral annulus along fractionated electrograms to the scar near left superior pulmonary vein using an irrigated tip catheter (power, 35 W; temperature, 40 oC), atrial flutter terminated, which was followed by sinus nodal (SN) arrest requiring urgent temporary pacing. ", 
    "start": 4, 
    "type": "Body_Part__Organ__or_Organ_Component"
}
{
    "c_end": 61, 
    "c_start": 49, 
    "end": 8, 
    "mention": "fractionated", 
    "pid": 1, 
    "senid": 17, 
    "sent": "During linear ablation from mitral annulus along fractionated electrograms to the scar near left superior pulmonary vein using an irrigated tip catheter (power, 35 W; temperature, 40 oC), atrial flutter terminated, which was followed by sinus nodal (SN) arrest requiring urgent temporary pacing. ", 
    "start": 7, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 86, 
    "c_start": 82, 
    "end": 12, 
    "mention": "scar", 
    "pid": 1, 
    "senid": 17, 
    "sent": "During linear ablation from mitral annulus along fractionated electrograms to the scar near left superior pulmonary vein using an irrigated tip catheter (power, 35 W; temperature, 40 oC), atrial flutter terminated, which was followed by sinus nodal (SN) arrest requiring urgent temporary pacing. ", 
    "start": 11, 
    "type": "Finding"
}
{
    "c_end": 120, 
    "c_start": 92, 
    "end": 17, 
    "mention": "left superior pulmonary vein", 
    "pid": 1, 
    "senid": 17, 
    "sent": "During linear ablation from mitral annulus along fractionated electrograms to the scar near left superior pulmonary vein using an irrigated tip catheter (power, 35 W; temperature, 40 oC), atrial flutter terminated, which was followed by sinus nodal (SN) arrest requiring urgent temporary pacing. ", 
    "start": 13, 
    "type": "Body_Part__Organ__or_Organ_Component"
}
{
    "c_end": 126, 
    "c_start": 121, 
    "end": 18, 
    "mention": "using", 
    "pid": 1, 
    "senid": 17, 
    "sent": "During linear ablation from mitral annulus along fractionated electrograms to the scar near left superior pulmonary vein using an irrigated tip catheter (power, 35 W; temperature, 40 oC), atrial flutter terminated, which was followed by sinus nodal (SN) arrest requiring urgent temporary pacing. ", 
    "start": 17, 
    "type": "Functional_Concept"
}
{
    "c_end": 139, 
    "c_start": 130, 
    "end": 20, 
    "mention": "irrigated", 
    "pid": 1, 
    "senid": 17, 
    "sent": "During linear ablation from mitral annulus along fractionated electrograms to the scar near left superior pulmonary vein using an irrigated tip catheter (power, 35 W; temperature, 40 oC), atrial flutter terminated, which was followed by sinus nodal (SN) arrest requiring urgent temporary pacing. ", 
    "start": 19, 
    "type": "Functional_Concept"
}
{
    "c_end": 152, 
    "c_start": 140, 
    "end": 22, 
    "mention": "tip catheter", 
    "pid": 1, 
    "senid": 17, 
    "sent": "During linear ablation from mitral annulus along fractionated electrograms to the scar near left superior pulmonary vein using an irrigated tip catheter (power, 35 W; temperature, 40 oC), atrial flutter terminated, which was followed by sinus nodal (SN) arrest requiring urgent temporary pacing. ", 
    "start": 20, 
    "type": "Medical_Device"
}
{
    "c_end": 159, 
    "c_start": 154, 
    "end": 24, 
    "mention": "power", 
    "pid": 1, 
    "senid": 17, 
    "sent": "During linear ablation from mitral annulus along fractionated electrograms to the scar near left superior pulmonary vein using an irrigated tip catheter (power, 35 W; temperature, 40 oC), atrial flutter terminated, which was followed by sinus nodal (SN) arrest requiring urgent temporary pacing. ", 
    "start": 23, 
    "type": "Human-caused_Phenomenon_or_Process"
}
{
    "c_end": 178, 
    "c_start": 167, 
    "end": 29, 
    "mention": "temperature", 
    "pid": 1, 
    "senid": 17, 
    "sent": "During linear ablation from mitral annulus along fractionated electrograms to the scar near left superior pulmonary vein using an irrigated tip catheter (power, 35 W; temperature, 40 oC), atrial flutter terminated, which was followed by sinus nodal (SN) arrest requiring urgent temporary pacing. ", 
    "start": 28, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 182, 
    "c_start": 180, 
    "end": 31, 
    "mention": "40", 
    "pid": 1, 
    "senid": 17, 
    "sent": "During linear ablation from mitral annulus along fractionated electrograms to the scar near left superior pulmonary vein using an irrigated tip catheter (power, 35 W; temperature, 40 oC), atrial flutter terminated, which was followed by sinus nodal (SN) arrest requiring urgent temporary pacing. ", 
    "start": 30, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 185, 
    "c_start": 183, 
    "end": 32, 
    "mention": "oC", 
    "pid": 1, 
    "senid": 17, 
    "sent": "During linear ablation from mitral annulus along fractionated electrograms to the scar near left superior pulmonary vein using an irrigated tip catheter (power, 35 W; temperature, 40 oC), atrial flutter terminated, which was followed by sinus nodal (SN) arrest requiring urgent temporary pacing. ", 
    "start": 31, 
    "type": "Gene_or_Genome"
}
{
    "c_end": 202, 
    "c_start": 188, 
    "end": 36, 
    "mention": "atrial flutter", 
    "pid": 1, 
    "senid": 17, 
    "sent": "During linear ablation from mitral annulus along fractionated electrograms to the scar near left superior pulmonary vein using an irrigated tip catheter (power, 35 W; temperature, 40 oC), atrial flutter terminated, which was followed by sinus nodal (SN) arrest requiring urgent temporary pacing. ", 
    "start": 34, 
    "type": "Laboratory_or_Test_Result"
}
{
    "c_end": 213, 
    "c_start": 203, 
    "end": 37, 
    "mention": "terminated", 
    "pid": 1, 
    "senid": 17, 
    "sent": "During linear ablation from mitral annulus along fractionated electrograms to the scar near left superior pulmonary vein using an irrigated tip catheter (power, 35 W; temperature, 40 oC), atrial flutter terminated, which was followed by sinus nodal (SN) arrest requiring urgent temporary pacing. ", 
    "start": 36, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 236, 
    "c_start": 225, 
    "end": 42, 
    "mention": "followed by", 
    "pid": 1, 
    "senid": 17, 
    "sent": "During linear ablation from mitral annulus along fractionated electrograms to the scar near left superior pulmonary vein using an irrigated tip catheter (power, 35 W; temperature, 40 oC), atrial flutter terminated, which was followed by sinus nodal (SN) arrest requiring urgent temporary pacing. ", 
    "start": 40, 
    "type": "Temporal_Concept"
}
{
    "c_end": 248, 
    "c_start": 243, 
    "end": 44, 
    "mention": "nodal", 
    "pid": 1, 
    "senid": 17, 
    "sent": "During linear ablation from mitral annulus along fractionated electrograms to the scar near left superior pulmonary vein using an irrigated tip catheter (power, 35 W; temperature, 40 oC), atrial flutter terminated, which was followed by sinus nodal (SN) arrest requiring urgent temporary pacing. ", 
    "start": 43, 
    "type": "Spatial_Concept"
}
{
    "c_end": 277, 
    "c_start": 271, 
    "end": 50, 
    "mention": "urgent", 
    "pid": 1, 
    "senid": 17, 
    "sent": "During linear ablation from mitral annulus along fractionated electrograms to the scar near left superior pulmonary vein using an irrigated tip catheter (power, 35 W; temperature, 40 oC), atrial flutter terminated, which was followed by sinus nodal (SN) arrest requiring urgent temporary pacing. ", 
    "start": 49, 
    "type": "Temporal_Concept"
}
{
    "c_end": 287, 
    "c_start": 278, 
    "end": 51, 
    "mention": "temporary", 
    "pid": 1, 
    "senid": 17, 
    "sent": "During linear ablation from mitral annulus along fractionated electrograms to the scar near left superior pulmonary vein using an irrigated tip catheter (power, 35 W; temperature, 40 oC), atrial flutter terminated, which was followed by sinus nodal (SN) arrest requiring urgent temporary pacing. ", 
    "start": 50, 
    "type": "Temporal_Concept"
}
{
    "c_end": 294, 
    "c_start": 288, 
    "end": 52, 
    "mention": "pacing", 
    "pid": 1, 
    "senid": 17, 
    "sent": "During linear ablation from mitral annulus along fractionated electrograms to the scar near left superior pulmonary vein using an irrigated tip catheter (power, 35 W; temperature, 40 oC), atrial flutter terminated, which was followed by sinus nodal (SN) arrest requiring urgent temporary pacing. ", 
    "start": 51, 
    "type": "Individual_Behavior"
}
{
    "c_end": 1, 
    "c_start": 0, 
    "end": 1, 
    "mention": "1", 
    "pid": 1, 
    "senid": 52, 
    "sent": "1 Chest X-ray showing the malpositioned left subclavian central venous catheter Intensive . ", 
    "start": 0, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 13, 
    "c_start": 2, 
    "end": 3, 
    "mention": "Chest X-ray", 
    "pid": 1, 
    "senid": 52, 
    "sent": "1 Chest X-ray showing the malpositioned left subclavian central venous catheter Intensive . ", 
    "start": 1, 
    "type": "Diagnostic_Procedure"
}
{
    "c_end": 21, 
    "c_start": 14, 
    "end": 4, 
    "mention": "showing", 
    "pid": 1, 
    "senid": 52, 
    "sent": "1 Chest X-ray showing the malpositioned left subclavian central venous catheter Intensive . ", 
    "start": 3, 
    "type": "Animal"
}
{
    "c_end": 39, 
    "c_start": 26, 
    "end": 6, 
    "mention": "malpositioned", 
    "pid": 1, 
    "senid": 52, 
    "sent": "1 Chest X-ray showing the malpositioned left subclavian central venous catheter Intensive . ", 
    "start": 5, 
    "type": "Spatial_Concept"
}
{
    "c_end": 44, 
    "c_start": 40, 
    "end": 7, 
    "mention": "left", 
    "pid": 1, 
    "senid": 52, 
    "sent": "1 Chest X-ray showing the malpositioned left subclavian central venous catheter Intensive . ", 
    "start": 6, 
    "type": "Functional_Concept"
}
{
    "c_end": 79, 
    "c_start": 45, 
    "end": 11, 
    "mention": "subclavian central venous catheter", 
    "pid": 1, 
    "senid": 52, 
    "sent": "1 Chest X-ray showing the malpositioned left subclavian central venous catheter Intensive . ", 
    "start": 7, 
    "type": "Finding"
}
{
    "c_end": 89, 
    "c_start": 80, 
    "end": 12, 
    "mention": "Intensive", 
    "pid": 1, 
    "senid": 52, 
    "sent": "1 Chest X-ray showing the malpositioned left subclavian central venous catheter Intensive . ", 
    "start": 11, 
    "type": "Functional_Concept"
}
{
    "c_end": 11, 
    "c_start": 4, 
    "end": 2, 
    "mention": "patient", 
    "pid": 1, 
    "senid": 23, 
    "sent": "The patient was on amiodarone (200 mg daily). ", 
    "start": 1, 
    "type": "Patient_or_Disabled_Group"
}
{
    "c_end": 29, 
    "c_start": 19, 
    "end": 5, 
    "mention": "amiodarone", 
    "pid": 1, 
    "senid": 23, 
    "sent": "The patient was on amiodarone (200 mg daily). ", 
    "start": 4, 
    "type": "Organic_Chemical"
}
{
    "c_end": 37, 
    "c_start": 35, 
    "end": 8, 
    "mention": "mg", 
    "pid": 1, 
    "senid": 23, 
    "sent": "The patient was on amiodarone (200 mg daily). ", 
    "start": 7, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 43, 
    "c_start": 38, 
    "end": 9, 
    "mention": "daily", 
    "pid": 1, 
    "senid": 23, 
    "sent": "The patient was on amiodarone (200 mg daily). ", 
    "start": 8, 
    "type": "Temporal_Concept"
}
{
    "c_end": 10, 
    "c_start": 7, 
    "end": 3, 
    "mention": "end", 
    "pid": 1, 
    "senid": 36, 
    "sent": "At the end of the procedure there was no in-ducible tachycardia. ", 
    "start": 2, 
    "type": "Temporal_Concept"
}
{
    "c_end": 27, 
    "c_start": 18, 
    "end": 6, 
    "mention": "procedure", 
    "pid": 1, 
    "senid": 36, 
    "sent": "At the end of the procedure there was no in-ducible tachycardia. ", 
    "start": 5, 
    "type": "Activity"
}
{
    "c_end": 63, 
    "c_start": 52, 
    "end": 11, 
    "mention": "tachycardia", 
    "pid": 1, 
    "senid": 36, 
    "sent": "At the end of the procedure there was no in-ducible tachycardia. ", 
    "start": 10, 
    "type": "Finding"
}
{
    "c_end": 7, 
    "c_start": 0, 
    "end": 1, 
    "mention": "Mapping", 
    "pid": 1, 
    "senid": 15, 
    "sent": "Mapping of the left atrium revealed the entire tachycardia cycle length. ", 
    "start": 0, 
    "type": "Activity"
}
{
    "c_end": 26, 
    "c_start": 15, 
    "end": 5, 
    "mention": "left atrium", 
    "pid": 1, 
    "senid": 15, 
    "sent": "Mapping of the left atrium revealed the entire tachycardia cycle length. ", 
    "start": 3, 
    "type": "Body_Part__Organ__or_Organ_Component"
}
{
    "c_end": 35, 
    "c_start": 27, 
    "end": 6, 
    "mention": "revealed", 
    "pid": 1, 
    "senid": 15, 
    "sent": "Mapping of the left atrium revealed the entire tachycardia cycle length. ", 
    "start": 5, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 46, 
    "c_start": 40, 
    "end": 8, 
    "mention": "entire", 
    "pid": 1, 
    "senid": 15, 
    "sent": "Mapping of the left atrium revealed the entire tachycardia cycle length. ", 
    "start": 7, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 58, 
    "c_start": 47, 
    "end": 9, 
    "mention": "tachycardia", 
    "pid": 1, 
    "senid": 15, 
    "sent": "Mapping of the left atrium revealed the entire tachycardia cycle length. ", 
    "start": 8, 
    "type": "Pathologic_Function"
}
{
    "c_end": 64, 
    "c_start": 59, 
    "end": 10, 
    "mention": "cycle", 
    "pid": 1, 
    "senid": 15, 
    "sent": "Mapping of the left atrium revealed the entire tachycardia cycle length. ", 
    "start": 9, 
    "type": "Temporal_Concept"
}
{
    "c_end": 71, 
    "c_start": 65, 
    "end": 11, 
    "mention": "length", 
    "pid": 1, 
    "senid": 15, 
    "sent": "Mapping of the left atrium revealed the entire tachycardia cycle length. ", 
    "start": 10, 
    "type": "Research_Activity"
}
{
    "c_end": 11, 
    "c_start": 4, 
    "end": 2, 
    "mention": "patient", 
    "pid": 1, 
    "senid": 8, 
    "sent": "The patient did not endorse syncopal symptoms during the bradycardia, but he did have 3 witnessed episodes of vomiting, while in the emergency department. ", 
    "start": 1, 
    "type": "Patient_or_Disabled_Group"
}
{
    "c_end": 19, 
    "c_start": 16, 
    "end": 4, 
    "mention": "not", 
    "pid": 1, 
    "senid": 8, 
    "sent": "The patient did not endorse syncopal symptoms during the bradycardia, but he did have 3 witnessed episodes of vomiting, while in the emergency department. ", 
    "start": 3, 
    "type": "Functional_Concept"
}
{
    "c_end": 45, 
    "c_start": 28, 
    "end": 7, 
    "mention": "syncopal symptoms", 
    "pid": 1, 
    "senid": 8, 
    "sent": "The patient did not endorse syncopal symptoms during the bradycardia, but he did have 3 witnessed episodes of vomiting, while in the emergency department. ", 
    "start": 5, 
    "type": "Sign_or_Symptom"
}
{
    "c_end": 68, 
    "c_start": 57, 
    "end": 10, 
    "mention": "bradycardia", 
    "pid": 1, 
    "senid": 8, 
    "sent": "The patient did not endorse syncopal symptoms during the bradycardia, but he did have 3 witnessed episodes of vomiting, while in the emergency department. ", 
    "start": 9, 
    "type": "Pathologic_Function"
}
{
    "c_end": 87, 
    "c_start": 86, 
    "end": 16, 
    "mention": "3", 
    "pid": 1, 
    "senid": 8, 
    "sent": "The patient did not endorse syncopal symptoms during the bradycardia, but he did have 3 witnessed episodes of vomiting, while in the emergency department. ", 
    "start": 15, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 97, 
    "c_start": 88, 
    "end": 17, 
    "mention": "witnessed", 
    "pid": 1, 
    "senid": 8, 
    "sent": "The patient did not endorse syncopal symptoms during the bradycardia, but he did have 3 witnessed episodes of vomiting, while in the emergency department. ", 
    "start": 16, 
    "type": "Population_Group"
}
{
    "c_end": 109, 
    "c_start": 98, 
    "end": 19, 
    "mention": "episodes of", 
    "pid": 1, 
    "senid": 8, 
    "sent": "The patient did not endorse syncopal symptoms during the bradycardia, but he did have 3 witnessed episodes of vomiting, while in the emergency department. ", 
    "start": 17, 
    "type": "Temporal_Concept"
}
{
    "c_end": 118, 
    "c_start": 110, 
    "end": 20, 
    "mention": "vomiting", 
    "pid": 1, 
    "senid": 8, 
    "sent": "The patient did not endorse syncopal symptoms during the bradycardia, but he did have 3 witnessed episodes of vomiting, while in the emergency department. ", 
    "start": 19, 
    "type": "Pathologic_Function"
}
{
    "c_end": 153, 
    "c_start": 133, 
    "end": 26, 
    "mention": "emergency department", 
    "pid": 1, 
    "senid": 8, 
    "sent": "The patient did not endorse syncopal symptoms during the bradycardia, but he did have 3 witnessed episodes of vomiting, while in the emergency department. ", 
    "start": 24, 
    "type": "Health_Care_Related_Organization"
}
{
    "c_end": 10, 
    "c_start": 0, 
    "end": 1, 
    "mention": "Conduction", 
    "pid": 1, 
    "senid": 33, 
    "sent": "Conduction into the left pulmonary veins was still present because of the gap at the bottom of the LIPV (. Fig. 3). ", 
    "start": 0, 
    "type": "Natural_Phenomenon_or_Process"
}
{
    "c_end": 40, 
    "c_start": 20, 
    "end": 6, 
    "mention": "left pulmonary veins", 
    "pid": 1, 
    "senid": 33, 
    "sent": "Conduction into the left pulmonary veins was still present because of the gap at the bottom of the LIPV (. Fig. 3). ", 
    "start": 3, 
    "type": "Body_Part__Organ__or_Organ_Component"
}
{
    "c_end": 58, 
    "c_start": 51, 
    "end": 9, 
    "mention": "present", 
    "pid": 1, 
    "senid": 33, 
    "sent": "Conduction into the left pulmonary veins was still present because of the gap at the bottom of the LIPV (. Fig. 3). ", 
    "start": 8, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 77, 
    "c_start": 74, 
    "end": 13, 
    "mention": "gap", 
    "pid": 1, 
    "senid": 33, 
    "sent": "Conduction into the left pulmonary veins was still present because of the gap at the bottom of the LIPV (. Fig. 3). ", 
    "start": 12, 
    "type": "Spatial_Concept"
}
{
    "c_end": 91, 
    "c_start": 85, 
    "end": 16, 
    "mention": "bottom", 
    "pid": 1, 
    "senid": 33, 
    "sent": "Conduction into the left pulmonary veins was still present because of the gap at the bottom of the LIPV (. Fig. 3). ", 
    "start": 15, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 110, 
    "c_start": 107, 
    "end": 22, 
    "mention": "Fig", 
    "pid": 1, 
    "senid": 33, 
    "sent": "Conduction into the left pulmonary veins was still present because of the gap at the bottom of the LIPV (. Fig. 3). ", 
    "start": 21, 
    "type": "Food"
}
{
    "c_end": 8, 
    "c_start": 3, 
    "end": 3, 
    "mention": "day 2", 
    "pid": 1, 
    "senid": 42, 
    "sent": "At day 2, refractory hypoxemia ensued and veno-venous extracorporeal membrane oxygenation (ECMO) was initiated. ", 
    "start": 1, 
    "type": "Finding"
}
{
    "c_end": 20, 
    "c_start": 10, 
    "end": 5, 
    "mention": "refractory", 
    "pid": 1, 
    "senid": 42, 
    "sent": "At day 2, refractory hypoxemia ensued and veno-venous extracorporeal membrane oxygenation (ECMO) was initiated. ", 
    "start": 4, 
    "type": "Functional_Concept"
}
{
    "c_end": 30, 
    "c_start": 21, 
    "end": 6, 
    "mention": "hypoxemia", 
    "pid": 1, 
    "senid": 42, 
    "sent": "At day 2, refractory hypoxemia ensued and veno-venous extracorporeal membrane oxygenation (ECMO) was initiated. ", 
    "start": 5, 
    "type": "Finding"
}
{
    "c_end": 53, 
    "c_start": 42, 
    "end": 9, 
    "mention": "veno-venous", 
    "pid": 1, 
    "senid": 42, 
    "sent": "At day 2, refractory hypoxemia ensued and veno-venous extracorporeal membrane oxygenation (ECMO) was initiated. ", 
    "start": 8, 
    "type": "Spatial_Concept"
}
{
    "c_end": 89, 
    "c_start": 54, 
    "end": 12, 
    "mention": "extracorporeal membrane oxygenation", 
    "pid": 1, 
    "senid": 42, 
    "sent": "At day 2, refractory hypoxemia ensued and veno-venous extracorporeal membrane oxygenation (ECMO) was initiated. ", 
    "start": 9, 
    "type": "Therapeutic_or_Preventive_Procedure"
}
{
    "c_end": 110, 
    "c_start": 101, 
    "end": 17, 
    "mention": "initiated", 
    "pid": 1, 
    "senid": 42, 
    "sent": "At day 2, refractory hypoxemia ensued and veno-venous extracorporeal membrane oxygenation (ECMO) was initiated. ", 
    "start": 16, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 7, 
    "c_start": 4, 
    "end": 2, 
    "mention": "PVI", 
    "pid": 1, 
    "senid": 27, 
    "sent": "For PVI, an antral ablation (outside the PV) was performed. ", 
    "start": 1, 
    "type": "Body_Part__Organ__or_Organ_Component"
}
{
    "c_end": 18, 
    "c_start": 12, 
    "end": 5, 
    "mention": "antral", 
    "pid": 1, 
    "senid": 27, 
    "sent": "For PVI, an antral ablation (outside the PV) was performed. ", 
    "start": 4, 
    "type": "Organic_Chemical"
}
{
    "c_end": 27, 
    "c_start": 19, 
    "end": 6, 
    "mention": "ablation", 
    "pid": 1, 
    "senid": 27, 
    "sent": "For PVI, an antral ablation (outside the PV) was performed. ", 
    "start": 5, 
    "type": "Therapeutic_or_Preventive_Procedure"
}
{
    "c_end": 36, 
    "c_start": 29, 
    "end": 8, 
    "mention": "outside", 
    "pid": 1, 
    "senid": 27, 
    "sent": "For PVI, an antral ablation (outside the PV) was performed. ", 
    "start": 7, 
    "type": "Spatial_Concept"
}
{
    "c_end": 43, 
    "c_start": 41, 
    "end": 10, 
    "mention": "PV", 
    "pid": 1, 
    "senid": 27, 
    "sent": "For PVI, an antral ablation (outside the PV) was performed. ", 
    "start": 9, 
    "type": "Neoplastic_Process"
}
{
    "c_end": 58, 
    "c_start": 49, 
    "end": 13, 
    "mention": "performed", 
    "pid": 1, 
    "senid": 27, 
    "sent": "For PVI, an antral ablation (outside the PV) was performed. ", 
    "start": 12, 
    "type": "Functional_Concept"
}
{
    "c_end": 24, 
    "c_start": 19, 
    "end": 5, 
    "mention": "apnea", 
    "pid": 1, 
    "senid": 2, 
    "sent": "The results of the apnea test performed in the ICU on the same night after the second CV were as follows: apnea-hypopnea index (AHI) of 71 per hour, minimum peripheral oxygen saturation (SpO2) of 67%, and desaturation period (SpO2 of less than 90%) of 28 minutes. ", 
    "start": 4, 
    "type": "Pathologic_Function"
}
{
    "c_end": 29, 
    "c_start": 4, 
    "end": 6, 
    "mention": "results of the apnea test", 
    "pid": 1, 
    "senid": 2, 
    "sent": "The results of the apnea test performed in the ICU on the same night after the second CV were as follows: apnea-hypopnea index (AHI) of 71 per hour, minimum peripheral oxygen saturation (SpO2) of 67%, and desaturation period (SpO2 of less than 90%) of 28 minutes. ", 
    "start": 1, 
    "type": "Finding"
}
{
    "c_end": 39, 
    "c_start": 30, 
    "end": 7, 
    "mention": "performed", 
    "pid": 1, 
    "senid": 2, 
    "sent": "The results of the apnea test performed in the ICU on the same night after the second CV were as follows: apnea-hypopnea index (AHI) of 71 per hour, minimum peripheral oxygen saturation (SpO2) of 67%, and desaturation period (SpO2 of less than 90%) of 28 minutes. ", 
    "start": 6, 
    "type": "Functional_Concept"
}
{
    "c_end": 50, 
    "c_start": 47, 
    "end": 10, 
    "mention": "ICU", 
    "pid": 1, 
    "senid": 2, 
    "sent": "The results of the apnea test performed in the ICU on the same night after the second CV were as follows: apnea-hypopnea index (AHI) of 71 per hour, minimum peripheral oxygen saturation (SpO2) of 67%, and desaturation period (SpO2 of less than 90%) of 28 minutes. ", 
    "start": 9, 
    "type": "Health_Care_Related_Organization"
}
{
    "c_end": 62, 
    "c_start": 58, 
    "end": 13, 
    "mention": "same", 
    "pid": 1, 
    "senid": 2, 
    "sent": "The results of the apnea test performed in the ICU on the same night after the second CV were as follows: apnea-hypopnea index (AHI) of 71 per hour, minimum peripheral oxygen saturation (SpO2) of 67%, and desaturation period (SpO2 of less than 90%) of 28 minutes. ", 
    "start": 12, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 68, 
    "c_start": 63, 
    "end": 14, 
    "mention": "night", 
    "pid": 1, 
    "senid": 2, 
    "sent": "The results of the apnea test performed in the ICU on the same night after the second CV were as follows: apnea-hypopnea index (AHI) of 71 per hour, minimum peripheral oxygen saturation (SpO2) of 67%, and desaturation period (SpO2 of less than 90%) of 28 minutes. ", 
    "start": 13, 
    "type": "Temporal_Concept"
}
{
    "c_end": 85, 
    "c_start": 79, 
    "end": 17, 
    "mention": "second", 
    "pid": 1, 
    "senid": 2, 
    "sent": "The results of the apnea test performed in the ICU on the same night after the second CV were as follows: apnea-hypopnea index (AHI) of 71 per hour, minimum peripheral oxygen saturation (SpO2) of 67%, and desaturation period (SpO2 of less than 90%) of 28 minutes. ", 
    "start": 16, 
    "type": "Temporal_Concept"
}
{
    "c_end": 88, 
    "c_start": 86, 
    "end": 18, 
    "mention": "CV", 
    "pid": 1, 
    "senid": 2, 
    "sent": "The results of the apnea test performed in the ICU on the same night after the second CV were as follows: apnea-hypopnea index (AHI) of 71 per hour, minimum peripheral oxygen saturation (SpO2) of 67%, and desaturation period (SpO2 of less than 90%) of 28 minutes. ", 
    "start": 17, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 105, 
    "c_start": 97, 
    "end": 22, 
    "mention": "follows:", 
    "pid": 1, 
    "senid": 2, 
    "sent": "The results of the apnea test performed in the ICU on the same night after the second CV were as follows: apnea-hypopnea index (AHI) of 71 per hour, minimum peripheral oxygen saturation (SpO2) of 67%, and desaturation period (SpO2 of less than 90%) of 28 minutes. ", 
    "start": 20, 
    "type": "Temporal_Concept"
}
{
    "c_end": 126, 
    "c_start": 106, 
    "end": 24, 
    "mention": "apnea-hypopnea index", 
    "pid": 1, 
    "senid": 2, 
    "sent": "The results of the apnea test performed in the ICU on the same night after the second CV were as follows: apnea-hypopnea index (AHI) of 71 per hour, minimum peripheral oxygen saturation (SpO2) of 67%, and desaturation period (SpO2 of less than 90%) of 28 minutes. ", 
    "start": 22, 
    "type": "Diagnostic_Procedure"
}
{
    "c_end": 138, 
    "c_start": 136, 
    "end": 29, 
    "mention": "71", 
    "pid": 1, 
    "senid": 2, 
    "sent": "The results of the apnea test performed in the ICU on the same night after the second CV were as follows: apnea-hypopnea index (AHI) of 71 per hour, minimum peripheral oxygen saturation (SpO2) of 67%, and desaturation period (SpO2 of less than 90%) of 28 minutes. ", 
    "start": 28, 
    "type": "Intellectual_Product"
}
{
    "c_end": 147, 
    "c_start": 143, 
    "end": 31, 
    "mention": "hour", 
    "pid": 1, 
    "senid": 2, 
    "sent": "The results of the apnea test performed in the ICU on the same night after the second CV were as follows: apnea-hypopnea index (AHI) of 71 per hour, minimum peripheral oxygen saturation (SpO2) of 67%, and desaturation period (SpO2 of less than 90%) of 28 minutes. ", 
    "start": 30, 
    "type": "Temporal_Concept"
}
{
    "c_end": 156, 
    "c_start": 149, 
    "end": 33, 
    "mention": "minimum", 
    "pid": 1, 
    "senid": 2, 
    "sent": "The results of the apnea test performed in the ICU on the same night after the second CV were as follows: apnea-hypopnea index (AHI) of 71 per hour, minimum peripheral oxygen saturation (SpO2) of 67%, and desaturation period (SpO2 of less than 90%) of 28 minutes. ", 
    "start": 32, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 185, 
    "c_start": 157, 
    "end": 36, 
    "mention": "peripheral oxygen saturation", 
    "pid": 1, 
    "senid": 2, 
    "sent": "The results of the apnea test performed in the ICU on the same night after the second CV were as follows: apnea-hypopnea index (AHI) of 71 per hour, minimum peripheral oxygen saturation (SpO2) of 67%, and desaturation period (SpO2 of less than 90%) of 28 minutes. ", 
    "start": 33, 
    "type": "Organ_or_Tissue_Function"
}
{
    "c_end": 217, 
    "c_start": 205, 
    "end": 45, 
    "mention": "desaturation", 
    "pid": 1, 
    "senid": 2, 
    "sent": "The results of the apnea test performed in the ICU on the same night after the second CV were as follows: apnea-hypopnea index (AHI) of 71 per hour, minimum peripheral oxygen saturation (SpO2) of 67%, and desaturation period (SpO2 of less than 90%) of 28 minutes. ", 
    "start": 44, 
    "type": "Finding"
}
{
    "c_end": 224, 
    "c_start": 218, 
    "end": 46, 
    "mention": "period", 
    "pid": 1, 
    "senid": 2, 
    "sent": "The results of the apnea test performed in the ICU on the same night after the second CV were as follows: apnea-hypopnea index (AHI) of 71 per hour, minimum peripheral oxygen saturation (SpO2) of 67%, and desaturation period (SpO2 of less than 90%) of 28 minutes. ", 
    "start": 45, 
    "type": "Temporal_Concept"
}
{
    "c_end": 247, 
    "c_start": 244, 
    "end": 53, 
    "mention": "90%", 
    "pid": 1, 
    "senid": 2, 
    "sent": "The results of the apnea test performed in the ICU on the same night after the second CV were as follows: apnea-hypopnea index (AHI) of 71 per hour, minimum peripheral oxygen saturation (SpO2) of 67%, and desaturation period (SpO2 of less than 90%) of 28 minutes. ", 
    "start": 51, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 262, 
    "c_start": 255, 
    "end": 57, 
    "mention": "minutes", 
    "pid": 1, 
    "senid": 2, 
    "sent": "The results of the apnea test performed in the ICU on the same night after the second CV were as follows: apnea-hypopnea index (AHI) of 71 per hour, minimum peripheral oxygen saturation (SpO2) of 67%, and desaturation period (SpO2 of less than 90%) of 28 minutes. ", 
    "start": 56, 
    "type": "Temporal_Concept"
}
{
    "c_end": 284, 
    "c_start": 274, 
    "end": 62, 
    "mention": "activation", 
    "pid": 1, 
    "senid": 29, 
    "sent": "The activation map revealed an LAMRT with its exit to the left atrium (LA) at the roof of the left superior pulmonary vein (LSPV) and its entrance at the bottom of the left inferior pulmonary vein (LIPV;. Fig. 2) By placing the nMarq catheter at the ostium of the LSPV, the activation sequence could be nicely depicted. ", 
    "start": 61, 
    "type": "Activity"
}
{
    "c_end": 18, 
    "c_start": 15, 
    "end": 3, 
    "mention": "map", 
    "pid": 1, 
    "senid": 29, 
    "sent": "The activation map revealed an LAMRT with its exit to the left atrium (LA) at the roof of the left superior pulmonary vein (LSPV) and its entrance at the bottom of the left inferior pulmonary vein (LIPV;. Fig. 2) By placing the nMarq catheter at the ostium of the LSPV, the activation sequence could be nicely depicted. ", 
    "start": 2, 
    "type": "Laboratory_Procedure"
}
{
    "c_end": 27, 
    "c_start": 19, 
    "end": 4, 
    "mention": "revealed", 
    "pid": 1, 
    "senid": 29, 
    "sent": "The activation map revealed an LAMRT with its exit to the left atrium (LA) at the roof of the left superior pulmonary vein (LSPV) and its entrance at the bottom of the left inferior pulmonary vein (LIPV;. Fig. 2) By placing the nMarq catheter at the ostium of the LSPV, the activation sequence could be nicely depicted. ", 
    "start": 3, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 50, 
    "c_start": 46, 
    "end": 9, 
    "mention": "exit", 
    "pid": 1, 
    "senid": 29, 
    "sent": "The activation map revealed an LAMRT with its exit to the left atrium (LA) at the roof of the left superior pulmonary vein (LSPV) and its entrance at the bottom of the left inferior pulmonary vein (LIPV;. Fig. 2) By placing the nMarq catheter at the ostium of the LSPV, the activation sequence could be nicely depicted. ", 
    "start": 8, 
    "type": "Functional_Concept"
}
{
    "c_end": 69, 
    "c_start": 58, 
    "end": 13, 
    "mention": "left atrium", 
    "pid": 1, 
    "senid": 29, 
    "sent": "The activation map revealed an LAMRT with its exit to the left atrium (LA) at the roof of the left superior pulmonary vein (LSPV) and its entrance at the bottom of the left inferior pulmonary vein (LIPV;. Fig. 2) By placing the nMarq catheter at the ostium of the LSPV, the activation sequence could be nicely depicted. ", 
    "start": 11, 
    "type": "Body_Part__Organ__or_Organ_Component"
}
{
    "c_end": 73, 
    "c_start": 71, 
    "end": 15, 
    "mention": "LA", 
    "pid": 1, 
    "senid": 29, 
    "sent": "The activation map revealed an LAMRT with its exit to the left atrium (LA) at the roof of the left superior pulmonary vein (LSPV) and its entrance at the bottom of the left inferior pulmonary vein (LIPV;. Fig. 2) By placing the nMarq catheter at the ostium of the LSPV, the activation sequence could be nicely depicted. ", 
    "start": 14, 
    "type": "Body_Part__Organ__or_Organ_Component"
}
{
    "c_end": 86, 
    "c_start": 82, 
    "end": 19, 
    "mention": "roof", 
    "pid": 1, 
    "senid": 29, 
    "sent": "The activation map revealed an LAMRT with its exit to the left atrium (LA) at the roof of the left superior pulmonary vein (LSPV) and its entrance at the bottom of the left inferior pulmonary vein (LIPV;. Fig. 2) By placing the nMarq catheter at the ostium of the LSPV, the activation sequence could be nicely depicted. ", 
    "start": 18, 
    "type": "Manufactured_Object"
}
{
    "c_end": 122, 
    "c_start": 94, 
    "end": 25, 
    "mention": "left superior pulmonary vein", 
    "pid": 1, 
    "senid": 29, 
    "sent": "The activation map revealed an LAMRT with its exit to the left atrium (LA) at the roof of the left superior pulmonary vein (LSPV) and its entrance at the bottom of the left inferior pulmonary vein (LIPV;. Fig. 2) By placing the nMarq catheter at the ostium of the LSPV, the activation sequence could be nicely depicted. ", 
    "start": 21, 
    "type": "Body_Part__Organ__or_Organ_Component"
}
{
    "c_end": 146, 
    "c_start": 138, 
    "end": 31, 
    "mention": "entrance", 
    "pid": 1, 
    "senid": 29, 
    "sent": "The activation map revealed an LAMRT with its exit to the left atrium (LA) at the roof of the left superior pulmonary vein (LSPV) and its entrance at the bottom of the left inferior pulmonary vein (LIPV;. Fig. 2) By placing the nMarq catheter at the ostium of the LSPV, the activation sequence could be nicely depicted. ", 
    "start": 30, 
    "type": "Spatial_Concept"
}
{
    "c_end": 160, 
    "c_start": 154, 
    "end": 34, 
    "mention": "bottom", 
    "pid": 1, 
    "senid": 29, 
    "sent": "The activation map revealed an LAMRT with its exit to the left atrium (LA) at the roof of the left superior pulmonary vein (LSPV) and its entrance at the bottom of the left inferior pulmonary vein (LIPV;. Fig. 2) By placing the nMarq catheter at the ostium of the LSPV, the activation sequence could be nicely depicted. ", 
    "start": 33, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 196, 
    "c_start": 168, 
    "end": 40, 
    "mention": "left inferior pulmonary vein", 
    "pid": 1, 
    "senid": 29, 
    "sent": "The activation map revealed an LAMRT with its exit to the left atrium (LA) at the roof of the left superior pulmonary vein (LSPV) and its entrance at the bottom of the left inferior pulmonary vein (LIPV;. Fig. 2) By placing the nMarq catheter at the ostium of the LSPV, the activation sequence could be nicely depicted. ", 
    "start": 36, 
    "type": "Body_Part__Organ__or_Organ_Component"
}
{
    "c_end": 208, 
    "c_start": 205, 
    "end": 45, 
    "mention": "Fig", 
    "pid": 1, 
    "senid": 29, 
    "sent": "The activation map revealed an LAMRT with its exit to the left atrium (LA) at the roof of the left superior pulmonary vein (LSPV) and its entrance at the bottom of the left inferior pulmonary vein (LIPV;. Fig. 2) By placing the nMarq catheter at the ostium of the LSPV, the activation sequence could be nicely depicted. ", 
    "start": 44, 
    "type": "Food"
}
{
    "c_end": 223, 
    "c_start": 216, 
    "end": 50, 
    "mention": "placing", 
    "pid": 1, 
    "senid": 29, 
    "sent": "The activation map revealed an LAMRT with its exit to the left atrium (LA) at the roof of the left superior pulmonary vein (LSPV) and its entrance at the bottom of the left inferior pulmonary vein (LIPV;. Fig. 2) By placing the nMarq catheter at the ostium of the LSPV, the activation sequence could be nicely depicted. ", 
    "start": 49, 
    "type": "Spatial_Concept"
}
{
    "c_end": 242, 
    "c_start": 234, 
    "end": 53, 
    "mention": "catheter", 
    "pid": 1, 
    "senid": 29, 
    "sent": "The activation map revealed an LAMRT with its exit to the left atrium (LA) at the roof of the left superior pulmonary vein (LSPV) and its entrance at the bottom of the left inferior pulmonary vein (LIPV;. Fig. 2) By placing the nMarq catheter at the ostium of the LSPV, the activation sequence could be nicely depicted. ", 
    "start": 52, 
    "type": "Medical_Device"
}
{
    "c_end": 268, 
    "c_start": 250, 
    "end": 59, 
    "mention": "ostium of the LSPV", 
    "pid": 1, 
    "senid": 29, 
    "sent": "The activation map revealed an LAMRT with its exit to the left atrium (LA) at the roof of the left superior pulmonary vein (LSPV) and its entrance at the bottom of the left inferior pulmonary vein (LIPV;. Fig. 2) By placing the nMarq catheter at the ostium of the LSPV, the activation sequence could be nicely depicted. ", 
    "start": 55, 
    "type": "Body_Space_or_Junction"
}
{
    "c_end": 293, 
    "c_start": 285, 
    "end": 63, 
    "mention": "sequence", 
    "pid": 1, 
    "senid": 29, 
    "sent": "The activation map revealed an LAMRT with its exit to the left atrium (LA) at the roof of the left superior pulmonary vein (LSPV) and its entrance at the bottom of the left inferior pulmonary vein (LIPV;. Fig. 2) By placing the nMarq catheter at the ostium of the LSPV, the activation sequence could be nicely depicted. ", 
    "start": 62, 
    "type": "Nucleotide_Sequence"
}
{
    "c_end": 11, 
    "c_start": 4, 
    "end": 2, 
    "mention": "patient", 
    "pid": 1, 
    "senid": 50, 
    "sent": "The patient made a full recovery and was discharged home 2.5 months after hospital admission with no neuro-logic or cardiopulmonary sequelae. ", 
    "start": 1, 
    "type": "Patient_or_Disabled_Group"
}
{
    "c_end": 16, 
    "c_start": 12, 
    "end": 3, 
    "mention": "made", 
    "pid": 1, 
    "senid": 50, 
    "sent": "The patient made a full recovery and was discharged home 2.5 months after hospital admission with no neuro-logic or cardiopulmonary sequelae. ", 
    "start": 2, 
    "type": "Functional_Concept"
}
{
    "c_end": 23, 
    "c_start": 19, 
    "end": 5, 
    "mention": "full", 
    "pid": 1, 
    "senid": 50, 
    "sent": "The patient made a full recovery and was discharged home 2.5 months after hospital admission with no neuro-logic or cardiopulmonary sequelae. ", 
    "start": 4, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 32, 
    "c_start": 24, 
    "end": 6, 
    "mention": "recovery", 
    "pid": 1, 
    "senid": 50, 
    "sent": "The patient made a full recovery and was discharged home 2.5 months after hospital admission with no neuro-logic or cardiopulmonary sequelae. ", 
    "start": 5, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 51, 
    "c_start": 41, 
    "end": 9, 
    "mention": "discharged", 
    "pid": 1, 
    "senid": 50, 
    "sent": "The patient made a full recovery and was discharged home 2.5 months after hospital admission with no neuro-logic or cardiopulmonary sequelae. ", 
    "start": 8, 
    "type": "Health_Care_Activity"
}
{
    "c_end": 56, 
    "c_start": 52, 
    "end": 10, 
    "mention": "home", 
    "pid": 1, 
    "senid": 50, 
    "sent": "The patient made a full recovery and was discharged home 2.5 months after hospital admission with no neuro-logic or cardiopulmonary sequelae. ", 
    "start": 9, 
    "type": "Conceptual_Entity"
}
{
    "c_end": 67, 
    "c_start": 61, 
    "end": 12, 
    "mention": "months", 
    "pid": 1, 
    "senid": 50, 
    "sent": "The patient made a full recovery and was discharged home 2.5 months after hospital admission with no neuro-logic or cardiopulmonary sequelae. ", 
    "start": 11, 
    "type": "Temporal_Concept"
}
{
    "c_end": 92, 
    "c_start": 74, 
    "end": 15, 
    "mention": "hospital admission", 
    "pid": 1, 
    "senid": 50, 
    "sent": "The patient made a full recovery and was discharged home 2.5 months after hospital admission with no neuro-logic or cardiopulmonary sequelae. ", 
    "start": 13, 
    "type": "Health_Care_Activity"
}
{
    "c_end": 112, 
    "c_start": 101, 
    "end": 18, 
    "mention": "neuro-logic", 
    "pid": 1, 
    "senid": 50, 
    "sent": "The patient made a full recovery and was discharged home 2.5 months after hospital admission with no neuro-logic or cardiopulmonary sequelae. ", 
    "start": 17, 
    "type": "Biomedical_Occupation_or_Discipline"
}
{
    "c_end": 131, 
    "c_start": 116, 
    "end": 20, 
    "mention": "cardiopulmonary", 
    "pid": 1, 
    "senid": 50, 
    "sent": "The patient made a full recovery and was discharged home 2.5 months after hospital admission with no neuro-logic or cardiopulmonary sequelae. ", 
    "start": 19, 
    "type": "Body_Location_or_Region"
}
{
    "c_end": 140, 
    "c_start": 132, 
    "end": 21, 
    "mention": "sequelae", 
    "pid": 1, 
    "senid": 50, 
    "sent": "The patient made a full recovery and was discharged home 2.5 months after hospital admission with no neuro-logic or cardiopulmonary sequelae. ", 
    "start": 20, 
    "type": "Finding"
}
{
    "c_end": 16, 
    "c_start": 0, 
    "end": 2, 
    "mention": "Pulmonary artery", 
    "pid": 1, 
    "senid": 48, 
    "sent": "Pulmonary artery perforation (Fig. 2) and hemopericardium were then surgically repaired after catheter withdrawal. ", 
    "start": 0, 
    "type": "Body_Part__Organ__or_Organ_Component"
}
{
    "c_end": 28, 
    "c_start": 17, 
    "end": 3, 
    "mention": "perforation", 
    "pid": 1, 
    "senid": 48, 
    "sent": "Pulmonary artery perforation (Fig. 2) and hemopericardium were then surgically repaired after catheter withdrawal. ", 
    "start": 2, 
    "type": "Pathologic_Function"
}
{
    "c_end": 33, 
    "c_start": 30, 
    "end": 5, 
    "mention": "Fig", 
    "pid": 1, 
    "senid": 48, 
    "sent": "Pulmonary artery perforation (Fig. 2) and hemopericardium were then surgically repaired after catheter withdrawal. ", 
    "start": 4, 
    "type": "Food"
}
{
    "c_end": 57, 
    "c_start": 42, 
    "end": 10, 
    "mention": "hemopericardium", 
    "pid": 1, 
    "senid": 48, 
    "sent": "Pulmonary artery perforation (Fig. 2) and hemopericardium were then surgically repaired after catheter withdrawal. ", 
    "start": 9, 
    "type": "Pathologic_Function"
}
{
    "c_end": 67, 
    "c_start": 63, 
    "end": 12, 
    "mention": "then", 
    "pid": 1, 
    "senid": 48, 
    "sent": "Pulmonary artery perforation (Fig. 2) and hemopericardium were then surgically repaired after catheter withdrawal. ", 
    "start": 11, 
    "type": "Temporal_Concept"
}
{
    "c_end": 78, 
    "c_start": 68, 
    "end": 13, 
    "mention": "surgically", 
    "pid": 1, 
    "senid": 48, 
    "sent": "Pulmonary artery perforation (Fig. 2) and hemopericardium were then surgically repaired after catheter withdrawal. ", 
    "start": 12, 
    "type": "Health_Care_Activity"
}
{
    "c_end": 87, 
    "c_start": 79, 
    "end": 14, 
    "mention": "repaired", 
    "pid": 1, 
    "senid": 48, 
    "sent": "Pulmonary artery perforation (Fig. 2) and hemopericardium were then surgically repaired after catheter withdrawal. ", 
    "start": 13, 
    "type": "Functional_Concept"
}
{
    "c_end": 102, 
    "c_start": 94, 
    "end": 16, 
    "mention": "catheter", 
    "pid": 1, 
    "senid": 48, 
    "sent": "Pulmonary artery perforation (Fig. 2) and hemopericardium were then surgically repaired after catheter withdrawal. ", 
    "start": 15, 
    "type": "Medical_Device"
}
{
    "c_end": 113, 
    "c_start": 103, 
    "end": 17, 
    "mention": "withdrawal", 
    "pid": 1, 
    "senid": 48, 
    "sent": "Pulmonary artery perforation (Fig. 2) and hemopericardium were then surgically repaired after catheter withdrawal. ", 
    "start": 16, 
    "type": "Intellectual_Product"
}
{
    "c_end": 32, 
    "c_start": 9, 
    "end": 5, 
    "mention": "acute circulatory shock", 
    "pid": 1, 
    "senid": 44, 
    "sent": "However, acute circulatory shock was observed shortly afterwards. ", 
    "start": 2, 
    "type": "Pathologic_Function"
}
{
    "c_end": 45, 
    "c_start": 37, 
    "end": 7, 
    "mention": "observed", 
    "pid": 1, 
    "senid": 44, 
    "sent": "However, acute circulatory shock was observed shortly afterwards. ", 
    "start": 6, 
    "type": "Functional_Concept"
}
{
    "c_end": 4, 
    "c_start": 0, 
    "end": 1, 
    "mention": "Case", 
    "pid": 1, 
    "senid": 21, 
    "sent": "Case 4 A 58-year-old patient with a 3-year history of paroxysmal atrial fibrillation underwent circumferential pulmonary vein isolation (PVI) in 2012. ", 
    "start": 0, 
    "type": "Functional_Concept"
}
{
    "c_end": 20, 
    "c_start": 9, 
    "end": 4, 
    "mention": "58-year-old", 
    "pid": 1, 
    "senid": 21, 
    "sent": "Case 4 A 58-year-old patient with a 3-year history of paroxysmal atrial fibrillation underwent circumferential pulmonary vein isolation (PVI) in 2012. ", 
    "start": 3, 
    "type": "Temporal_Concept"
}
{
    "c_end": 28, 
    "c_start": 21, 
    "end": 5, 
    "mention": "patient", 
    "pid": 1, 
    "senid": 21, 
    "sent": "Case 4 A 58-year-old patient with a 3-year history of paroxysmal atrial fibrillation underwent circumferential pulmonary vein isolation (PVI) in 2012. ", 
    "start": 4, 
    "type": "Patient_or_Disabled_Group"
}
{
    "c_end": 84, 
    "c_start": 43, 
    "end": 13, 
    "mention": "history of paroxysmal atrial fibrillation", 
    "pid": 1, 
    "senid": 21, 
    "sent": "Case 4 A 58-year-old patient with a 3-year history of paroxysmal atrial fibrillation underwent circumferential pulmonary vein isolation (PVI) in 2012. ", 
    "start": 8, 
    "type": "Finding"
}
{
    "c_end": 64, 
    "c_start": 54, 
    "end": 11, 
    "mention": "paroxysmal", 
    "pid": 1, 
    "senid": 21, 
    "sent": "Case 4 A 58-year-old patient with a 3-year history of paroxysmal atrial fibrillation underwent circumferential pulmonary vein isolation (PVI) in 2012. ", 
    "start": 10, 
    "type": "Temporal_Concept"
}
{
    "c_end": 110, 
    "c_start": 95, 
    "end": 15, 
    "mention": "circumferential", 
    "pid": 1, 
    "senid": 21, 
    "sent": "Case 4 A 58-year-old patient with a 3-year history of paroxysmal atrial fibrillation underwent circumferential pulmonary vein isolation (PVI) in 2012. ", 
    "start": 14, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 125, 
    "c_start": 111, 
    "end": 17, 
    "mention": "pulmonary vein", 
    "pid": 1, 
    "senid": 21, 
    "sent": "Case 4 A 58-year-old patient with a 3-year history of paroxysmal atrial fibrillation underwent circumferential pulmonary vein isolation (PVI) in 2012. ", 
    "start": 15, 
    "type": "Body_Part__Organ__or_Organ_Component"
}
{
    "c_end": 135, 
    "c_start": 126, 
    "end": 18, 
    "mention": "isolation", 
    "pid": 1, 
    "senid": 21, 
    "sent": "Case 4 A 58-year-old patient with a 3-year history of paroxysmal atrial fibrillation underwent circumferential pulmonary vein isolation (PVI) in 2012. ", 
    "start": 17, 
    "type": "Therapeutic_or_Preventive_Procedure"
}
{
    "c_end": 26, 
    "c_start": 15, 
    "end": 3, 
    "mention": "extraocular", 
    "pid": 1, 
    "senid": 6, 
    "sent": "Examination of extraocular motility revealed a-2 restriction in upgaze in the affected eye, and a continuous cardiac monitor revealed a reproducible decrease in heart rate from a baseline pulse of 65-70 to a pulse as low as 42-45 with attempted upgaze. ", 
    "start": 2, 
    "type": "Functional_Concept"
}
{
    "c_end": 35, 
    "c_start": 27, 
    "end": 4, 
    "mention": "motility", 
    "pid": 1, 
    "senid": 6, 
    "sent": "Examination of extraocular motility revealed a-2 restriction in upgaze in the affected eye, and a continuous cardiac monitor revealed a reproducible decrease in heart rate from a baseline pulse of 65-70 to a pulse as low as 42-45 with attempted upgaze. ", 
    "start": 3, 
    "type": "Organism_Function"
}
{
    "c_end": 44, 
    "c_start": 36, 
    "end": 5, 
    "mention": "revealed", 
    "pid": 1, 
    "senid": 6, 
    "sent": "Examination of extraocular motility revealed a-2 restriction in upgaze in the affected eye, and a continuous cardiac monitor revealed a reproducible decrease in heart rate from a baseline pulse of 65-70 to a pulse as low as 42-45 with attempted upgaze. ", 
    "start": 4, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 48, 
    "c_start": 45, 
    "end": 6, 
    "mention": "a-2", 
    "pid": 1, 
    "senid": 6, 
    "sent": "Examination of extraocular motility revealed a-2 restriction in upgaze in the affected eye, and a continuous cardiac monitor revealed a reproducible decrease in heart rate from a baseline pulse of 65-70 to a pulse as low as 42-45 with attempted upgaze. ", 
    "start": 5, 
    "type": "Classification"
}
{
    "c_end": 60, 
    "c_start": 49, 
    "end": 7, 
    "mention": "restriction", 
    "pid": 1, 
    "senid": 6, 
    "sent": "Examination of extraocular motility revealed a-2 restriction in upgaze in the affected eye, and a continuous cardiac monitor revealed a reproducible decrease in heart rate from a baseline pulse of 65-70 to a pulse as low as 42-45 with attempted upgaze. ", 
    "start": 6, 
    "type": "Functional_Concept"
}
{
    "c_end": 86, 
    "c_start": 78, 
    "end": 12, 
    "mention": "affected", 
    "pid": 1, 
    "senid": 6, 
    "sent": "Examination of extraocular motility revealed a-2 restriction in upgaze in the affected eye, and a continuous cardiac monitor revealed a reproducible decrease in heart rate from a baseline pulse of 65-70 to a pulse as low as 42-45 with attempted upgaze. ", 
    "start": 11, 
    "type": "Functional_Concept"
}
{
    "c_end": 90, 
    "c_start": 87, 
    "end": 13, 
    "mention": "eye", 
    "pid": 1, 
    "senid": 6, 
    "sent": "Examination of extraocular motility revealed a-2 restriction in upgaze in the affected eye, and a continuous cardiac monitor revealed a reproducible decrease in heart rate from a baseline pulse of 65-70 to a pulse as low as 42-45 with attempted upgaze. ", 
    "start": 12, 
    "type": "Body_Part__Organ__or_Organ_Component"
}
{
    "c_end": 108, 
    "c_start": 98, 
    "end": 17, 
    "mention": "continuous", 
    "pid": 1, 
    "senid": 6, 
    "sent": "Examination of extraocular motility revealed a-2 restriction in upgaze in the affected eye, and a continuous cardiac monitor revealed a reproducible decrease in heart rate from a baseline pulse of 65-70 to a pulse as low as 42-45 with attempted upgaze. ", 
    "start": 16, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 124, 
    "c_start": 109, 
    "end": 19, 
    "mention": "cardiac monitor", 
    "pid": 1, 
    "senid": 6, 
    "sent": "Examination of extraocular motility revealed a-2 restriction in upgaze in the affected eye, and a continuous cardiac monitor revealed a reproducible decrease in heart rate from a baseline pulse of 65-70 to a pulse as low as 42-45 with attempted upgaze. ", 
    "start": 17, 
    "type": "Diagnostic_Procedure"
}
{
    "c_end": 148, 
    "c_start": 136, 
    "end": 22, 
    "mention": "reproducible", 
    "pid": 1, 
    "senid": 6, 
    "sent": "Examination of extraocular motility revealed a-2 restriction in upgaze in the affected eye, and a continuous cardiac monitor revealed a reproducible decrease in heart rate from a baseline pulse of 65-70 to a pulse as low as 42-45 with attempted upgaze. ", 
    "start": 21, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 157, 
    "c_start": 149, 
    "end": 23, 
    "mention": "decrease", 
    "pid": 1, 
    "senid": 6, 
    "sent": "Examination of extraocular motility revealed a-2 restriction in upgaze in the affected eye, and a continuous cardiac monitor revealed a reproducible decrease in heart rate from a baseline pulse of 65-70 to a pulse as low as 42-45 with attempted upgaze. ", 
    "start": 22, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 171, 
    "c_start": 161, 
    "end": 26, 
    "mention": "heart rate", 
    "pid": 1, 
    "senid": 6, 
    "sent": "Examination of extraocular motility revealed a-2 restriction in upgaze in the affected eye, and a continuous cardiac monitor revealed a reproducible decrease in heart rate from a baseline pulse of 65-70 to a pulse as low as 42-45 with attempted upgaze. ", 
    "start": 24, 
    "type": "Clinical_Attribute"
}
{
    "c_end": 187, 
    "c_start": 179, 
    "end": 29, 
    "mention": "baseline", 
    "pid": 1, 
    "senid": 6, 
    "sent": "Examination of extraocular motility revealed a-2 restriction in upgaze in the affected eye, and a continuous cardiac monitor revealed a reproducible decrease in heart rate from a baseline pulse of 65-70 to a pulse as low as 42-45 with attempted upgaze. ", 
    "start": 28, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 193, 
    "c_start": 188, 
    "end": 30, 
    "mention": "pulse", 
    "pid": 1, 
    "senid": 6, 
    "sent": "Examination of extraocular motility revealed a-2 restriction in upgaze in the affected eye, and a continuous cardiac monitor revealed a reproducible decrease in heart rate from a baseline pulse of 65-70 to a pulse as low as 42-45 with attempted upgaze. ", 
    "start": 29, 
    "type": "Clinical_Attribute"
}
{
    "c_end": 202, 
    "c_start": 197, 
    "end": 32, 
    "mention": "65-70", 
    "pid": 1, 
    "senid": 6, 
    "sent": "Examination of extraocular motility revealed a-2 restriction in upgaze in the affected eye, and a continuous cardiac monitor revealed a reproducible decrease in heart rate from a baseline pulse of 65-70 to a pulse as low as 42-45 with attempted upgaze. ", 
    "start": 31, 
    "type": "Finding"
}
{
    "c_end": 220, 
    "c_start": 208, 
    "end": 37, 
    "mention": "pulse as low", 
    "pid": 1, 
    "senid": 6, 
    "sent": "Examination of extraocular motility revealed a-2 restriction in upgaze in the affected eye, and a continuous cardiac monitor revealed a reproducible decrease in heart rate from a baseline pulse of 65-70 to a pulse as low as 42-45 with attempted upgaze. ", 
    "start": 34, 
    "type": "Finding"
}
{
    "c_end": 244, 
    "c_start": 235, 
    "end": 41, 
    "mention": "attempted", 
    "pid": 1, 
    "senid": 6, 
    "sent": "Examination of extraocular motility revealed a-2 restriction in upgaze in the affected eye, and a continuous cardiac monitor revealed a reproducible decrease in heart rate from a baseline pulse of 65-70 to a pulse as low as 42-45 with attempted upgaze. ", 
    "start": 40, 
    "type": "Event"
}
{
    "c_end": 17, 
    "c_start": 4, 
    "end": 3, 
    "mention": "orbital floor", 
    "pid": 1, 
    "senid": 12, 
    "sent": "The orbital floor bones were also non-displaced with only a linear fracture, consistent with a trapdoor fracture.  ", 
    "start": 1, 
    "type": "Body_Location_or_Region"
}
{
    "c_end": 23, 
    "c_start": 18, 
    "end": 4, 
    "mention": "bones", 
    "pid": 1, 
    "senid": 12, 
    "sent": "The orbital floor bones were also non-displaced with only a linear fracture, consistent with a trapdoor fracture.  ", 
    "start": 3, 
    "type": "Body_System"
}
{
    "c_end": 47, 
    "c_start": 34, 
    "end": 7, 
    "mention": "non-displaced", 
    "pid": 1, 
    "senid": 12, 
    "sent": "The orbital floor bones were also non-displaced with only a linear fracture, consistent with a trapdoor fracture.  ", 
    "start": 6, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 57, 
    "c_start": 53, 
    "end": 9, 
    "mention": "only", 
    "pid": 1, 
    "senid": 12, 
    "sent": "The orbital floor bones were also non-displaced with only a linear fracture, consistent with a trapdoor fracture.  ", 
    "start": 8, 
    "type": "Intellectual_Product"
}
{
    "c_end": 75, 
    "c_start": 60, 
    "end": 12, 
    "mention": "linear fracture", 
    "pid": 1, 
    "senid": 12, 
    "sent": "The orbital floor bones were also non-displaced with only a linear fracture, consistent with a trapdoor fracture.  ", 
    "start": 10, 
    "type": "Injury_or_Poisoning"
}
{
    "c_end": 92, 
    "c_start": 77, 
    "end": 15, 
    "mention": "consistent with", 
    "pid": 1, 
    "senid": 12, 
    "sent": "The orbital floor bones were also non-displaced with only a linear fracture, consistent with a trapdoor fracture.  ", 
    "start": 13, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 112, 
    "c_start": 104, 
    "end": 18, 
    "mention": "fracture", 
    "pid": 1, 
    "senid": 12, 
    "sent": "The orbital floor bones were also non-displaced with only a linear fracture, consistent with a trapdoor fracture.  ", 
    "start": 17, 
    "type": "Injury_or_Poisoning"
}
{
    "c_end": 11, 
    "c_start": 7, 
    "end": 3, 
    "mention": "case", 
    "pid": 1, 
    "senid": 59, 
    "sent": "In our case, hydroxyzine was identified as the only drug able to induce QTc interval prolongation in the patients active medication. ", 
    "start": 2, 
    "type": "Conceptual_Entity"
}
{
    "c_end": 24, 
    "c_start": 13, 
    "end": 5, 
    "mention": "hydroxyzine", 
    "pid": 1, 
    "senid": 59, 
    "sent": "In our case, hydroxyzine was identified as the only drug able to induce QTc interval prolongation in the patients active medication. ", 
    "start": 4, 
    "type": "Organic_Chemical"
}
{
    "c_end": 51, 
    "c_start": 47, 
    "end": 10, 
    "mention": "only", 
    "pid": 1, 
    "senid": 59, 
    "sent": "In our case, hydroxyzine was identified as the only drug able to induce QTc interval prolongation in the patients active medication. ", 
    "start": 9, 
    "type": "Intellectual_Product"
}
{
    "c_end": 56, 
    "c_start": 29, 
    "end": 11, 
    "mention": "identified as the only drug", 
    "pid": 1, 
    "senid": 59, 
    "sent": "In our case, hydroxyzine was identified as the only drug able to induce QTc interval prolongation in the patients active medication. ", 
    "start": 6, 
    "type": "Laboratory_or_Test_Result"
}
{
    "c_end": 61, 
    "c_start": 57, 
    "end": 12, 
    "mention": "able", 
    "pid": 1, 
    "senid": 59, 
    "sent": "In our case, hydroxyzine was identified as the only drug able to induce QTc interval prolongation in the patients active medication. ", 
    "start": 11, 
    "type": "Finding"
}
{
    "c_end": 64, 
    "c_start": 62, 
    "end": 13, 
    "mention": "to", 
    "pid": 1, 
    "senid": 59, 
    "sent": "In our case, hydroxyzine was identified as the only drug able to induce QTc interval prolongation in the patients active medication. ", 
    "start": 12, 
    "type": "Amino_Acid__Peptide__or_Protein"
}
{
    "c_end": 71, 
    "c_start": 65, 
    "end": 14, 
    "mention": "induce", 
    "pid": 1, 
    "senid": 59, 
    "sent": "In our case, hydroxyzine was identified as the only drug able to induce QTc interval prolongation in the patients active medication. ", 
    "start": 13, 
    "type": "Functional_Concept"
}
{
    "c_end": 97, 
    "c_start": 72, 
    "end": 17, 
    "mention": "QTc interval prolongation", 
    "pid": 1, 
    "senid": 59, 
    "sent": "In our case, hydroxyzine was identified as the only drug able to induce QTc interval prolongation in the patients active medication. ", 
    "start": 14, 
    "type": "Finding"
}
{
    "c_end": 113, 
    "c_start": 105, 
    "end": 20, 
    "mention": "patients", 
    "pid": 1, 
    "senid": 59, 
    "sent": "In our case, hydroxyzine was identified as the only drug able to induce QTc interval prolongation in the patients active medication. ", 
    "start": 19, 
    "type": "Patient_or_Disabled_Group"
}
{
    "c_end": 120, 
    "c_start": 114, 
    "end": 21, 
    "mention": "active", 
    "pid": 1, 
    "senid": 59, 
    "sent": "In our case, hydroxyzine was identified as the only drug able to induce QTc interval prolongation in the patients active medication. ", 
    "start": 20, 
    "type": "Functional_Concept"
}
{
    "c_end": 131, 
    "c_start": 121, 
    "end": 22, 
    "mention": "medication", 
    "pid": 1, 
    "senid": 59, 
    "sent": "In our case, hydroxyzine was identified as the only drug able to induce QTc interval prolongation in the patients active medication. ", 
    "start": 21, 
    "type": "Functional_Concept"
}
{
    "c_end": 36, 
    "c_start": 13, 
    "end": 7, 
    "mention": "recovery of SN function", 
    "pid": 1, 
    "senid": 18, 
    "sent": "There was no recovery of SN function after 3 days, and a permanent pacemaker was implanted. ", 
    "start": 3, 
    "type": "Sign_or_Symptom"
}
{
    "c_end": 27, 
    "c_start": 25, 
    "end": 6, 
    "mention": "SN", 
    "pid": 1, 
    "senid": 18, 
    "sent": "There was no recovery of SN function after 3 days, and a permanent pacemaker was implanted. ", 
    "start": 5, 
    "type": "Body_Part__Organ__or_Organ_Component"
}
{
    "c_end": 49, 
    "c_start": 43, 
    "end": 10, 
    "mention": "3 days", 
    "pid": 1, 
    "senid": 18, 
    "sent": "There was no recovery of SN function after 3 days, and a permanent pacemaker was implanted. ", 
    "start": 8, 
    "type": "Temporal_Concept"
}
{
    "c_end": 76, 
    "c_start": 57, 
    "end": 15, 
    "mention": "permanent pacemaker", 
    "pid": 1, 
    "senid": 18, 
    "sent": "There was no recovery of SN function after 3 days, and a permanent pacemaker was implanted. ", 
    "start": 13, 
    "type": "Medical_Device"
}
{
    "c_end": 90, 
    "c_start": 81, 
    "end": 17, 
    "mention": "implanted", 
    "pid": 1, 
    "senid": 18, 
    "sent": "There was no recovery of SN function after 3 days, and a permanent pacemaker was implanted. ", 
    "start": 16, 
    "type": "Medical_Device"
}
{
    "c_end": 8, 
    "c_start": 4, 
    "end": 2, 
    "mention": "rest", 
    "pid": 1, 
    "senid": 9, 
    "sent": "The rest of the eye exam was unremarkable. ", 
    "start": 1, 
    "type": "Daily_or_Recreational_Activity"
}
{
    "c_end": 24, 
    "c_start": 16, 
    "end": 6, 
    "mention": "eye exam", 
    "pid": 1, 
    "senid": 9, 
    "sent": "The rest of the eye exam was unremarkable. ", 
    "start": 4, 
    "type": "Therapeutic_or_Preventive_Procedure"
}
{
    "c_end": 41, 
    "c_start": 29, 
    "end": 8, 
    "mention": "unremarkable", 
    "pid": 1, 
    "senid": 9, 
    "sent": "The rest of the eye exam was unremarkable. ", 
    "start": 7, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 4, 
    "c_start": 0, 
    "end": 1, 
    "mention": "Case", 
    "pid": 1, 
    "senid": 53, 
    "sent": "Case 6 A 54-year-old woman presented with giant struma, hyperthyroidism of unknown duration, palpitations and dyspnoea. ", 
    "start": 0, 
    "type": "Functional_Concept"
}
{
    "c_end": 20, 
    "c_start": 9, 
    "end": 4, 
    "mention": "54-year-old", 
    "pid": 1, 
    "senid": 53, 
    "sent": "Case 6 A 54-year-old woman presented with giant struma, hyperthyroidism of unknown duration, palpitations and dyspnoea. ", 
    "start": 3, 
    "type": "Temporal_Concept"
}
{
    "c_end": 26, 
    "c_start": 21, 
    "end": 5, 
    "mention": "woman", 
    "pid": 1, 
    "senid": 53, 
    "sent": "Case 6 A 54-year-old woman presented with giant struma, hyperthyroidism of unknown duration, palpitations and dyspnoea. ", 
    "start": 4, 
    "type": "Population_Group"
}
{
    "c_end": 36, 
    "c_start": 27, 
    "end": 6, 
    "mention": "presented", 
    "pid": 1, 
    "senid": 53, 
    "sent": "Case 6 A 54-year-old woman presented with giant struma, hyperthyroidism of unknown duration, palpitations and dyspnoea. ", 
    "start": 5, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 47, 
    "c_start": 42, 
    "end": 8, 
    "mention": "giant", 
    "pid": 1, 
    "senid": 53, 
    "sent": "Case 6 A 54-year-old woman presented with giant struma, hyperthyroidism of unknown duration, palpitations and dyspnoea. ", 
    "start": 7, 
    "type": "Disease_or_Syndrome"
}
{
    "c_end": 54, 
    "c_start": 48, 
    "end": 9, 
    "mention": "struma", 
    "pid": 1, 
    "senid": 53, 
    "sent": "Case 6 A 54-year-old woman presented with giant struma, hyperthyroidism of unknown duration, palpitations and dyspnoea. ", 
    "start": 8, 
    "type": "Pathologic_Function"
}
{
    "c_end": 71, 
    "c_start": 56, 
    "end": 11, 
    "mention": "hyperthyroidism", 
    "pid": 1, 
    "senid": 53, 
    "sent": "Case 6 A 54-year-old woman presented with giant struma, hyperthyroidism of unknown duration, palpitations and dyspnoea. ", 
    "start": 10, 
    "type": "Disease_or_Syndrome"
}
{
    "c_end": 82, 
    "c_start": 75, 
    "end": 13, 
    "mention": "unknown", 
    "pid": 1, 
    "senid": 53, 
    "sent": "Case 6 A 54-year-old woman presented with giant struma, hyperthyroidism of unknown duration, palpitations and dyspnoea. ", 
    "start": 12, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 91, 
    "c_start": 83, 
    "end": 14, 
    "mention": "duration", 
    "pid": 1, 
    "senid": 53, 
    "sent": "Case 6 A 54-year-old woman presented with giant struma, hyperthyroidism of unknown duration, palpitations and dyspnoea. ", 
    "start": 13, 
    "type": "Pharmacologic_Substance"
}
{
    "c_end": 105, 
    "c_start": 93, 
    "end": 16, 
    "mention": "palpitations", 
    "pid": 1, 
    "senid": 53, 
    "sent": "Case 6 A 54-year-old woman presented with giant struma, hyperthyroidism of unknown duration, palpitations and dyspnoea. ", 
    "start": 15, 
    "type": "Finding"
}
{
    "c_end": 118, 
    "c_start": 110, 
    "end": 18, 
    "mention": "dyspnoea", 
    "pid": 1, 
    "senid": 53, 
    "sent": "Case 6 A 54-year-old woman presented with giant struma, hyperthyroidism of unknown duration, palpitations and dyspnoea. ", 
    "start": 17, 
    "type": "Sign_or_Symptom"
}
{
    "c_end": 11, 
    "c_start": 4, 
    "end": 2, 
    "mention": "patient", 
    "pid": 1, 
    "senid": 3, 
    "sent": "The patient was discharged with medical treatment and nocturnal BiPAP treatment.  ", 
    "start": 1, 
    "type": "Patient_or_Disabled_Group"
}
{
    "c_end": 26, 
    "c_start": 16, 
    "end": 4, 
    "mention": "discharged", 
    "pid": 1, 
    "senid": 3, 
    "sent": "The patient was discharged with medical treatment and nocturnal BiPAP treatment.  ", 
    "start": 3, 
    "type": "Health_Care_Activity"
}
{
    "c_end": 49, 
    "c_start": 32, 
    "end": 7, 
    "mention": "medical treatment", 
    "pid": 1, 
    "senid": 3, 
    "sent": "The patient was discharged with medical treatment and nocturnal BiPAP treatment.  ", 
    "start": 5, 
    "type": "Therapeutic_or_Preventive_Procedure"
}
{
    "c_end": 63, 
    "c_start": 54, 
    "end": 9, 
    "mention": "nocturnal", 
    "pid": 1, 
    "senid": 3, 
    "sent": "The patient was discharged with medical treatment and nocturnal BiPAP treatment.  ", 
    "start": 8, 
    "type": "Temporal_Concept"
}
{
    "c_end": 79, 
    "c_start": 70, 
    "end": 11, 
    "mention": "treatment", 
    "pid": 1, 
    "senid": 3, 
    "sent": "The patient was discharged with medical treatment and nocturnal BiPAP treatment.  ", 
    "start": 10, 
    "type": "Functional_Concept"
}
{
    "c_end": 3, 
    "c_start": 0, 
    "end": 1, 
    "mention": "Fig", 
    "pid": 1, 
    "senid": 51, 
    "sent": "Fig. ", 
    "start": 0, 
    "type": "Food"
}
{
    "c_end": 10, 
    "c_start": 2, 
    "end": 2, 
    "mention": "PVI-redo", 
    "pid": 1, 
    "senid": 24, 
    "sent": "A PVI-redo was performed using a novel circular mapping and abla-tion catheter (nMarq, Biosense Webster, Diamond Bar, Calif., USA). ", 
    "start": 1, 
    "type": "Body_Part__Organ__or_Organ_Component"
}
{
    "c_end": 24, 
    "c_start": 15, 
    "end": 4, 
    "mention": "performed", 
    "pid": 1, 
    "senid": 24, 
    "sent": "A PVI-redo was performed using a novel circular mapping and abla-tion catheter (nMarq, Biosense Webster, Diamond Bar, Calif., USA). ", 
    "start": 3, 
    "type": "Functional_Concept"
}
{
    "c_end": 30, 
    "c_start": 25, 
    "end": 5, 
    "mention": "using", 
    "pid": 1, 
    "senid": 24, 
    "sent": "A PVI-redo was performed using a novel circular mapping and abla-tion catheter (nMarq, Biosense Webster, Diamond Bar, Calif., USA). ", 
    "start": 4, 
    "type": "Functional_Concept"
}
{
    "c_end": 38, 
    "c_start": 33, 
    "end": 7, 
    "mention": "novel", 
    "pid": 1, 
    "senid": 24, 
    "sent": "A PVI-redo was performed using a novel circular mapping and abla-tion catheter (nMarq, Biosense Webster, Diamond Bar, Calif., USA). ", 
    "start": 6, 
    "type": "Intellectual_Product"
}
{
    "c_end": 47, 
    "c_start": 39, 
    "end": 8, 
    "mention": "circular", 
    "pid": 1, 
    "senid": 24, 
    "sent": "A PVI-redo was performed using a novel circular mapping and abla-tion catheter (nMarq, Biosense Webster, Diamond Bar, Calif., USA). ", 
    "start": 7, 
    "type": "Spatial_Concept"
}
{
    "c_end": 55, 
    "c_start": 48, 
    "end": 9, 
    "mention": "mapping", 
    "pid": 1, 
    "senid": 24, 
    "sent": "A PVI-redo was performed using a novel circular mapping and abla-tion catheter (nMarq, Biosense Webster, Diamond Bar, Calif., USA). ", 
    "start": 8, 
    "type": "Activity"
}
{
    "c_end": 78, 
    "c_start": 70, 
    "end": 12, 
    "mention": "catheter", 
    "pid": 1, 
    "senid": 24, 
    "sent": "A PVI-redo was performed using a novel circular mapping and abla-tion catheter (nMarq, Biosense Webster, Diamond Bar, Calif., USA). ", 
    "start": 11, 
    "type": "Medical_Device"
}
{
    "c_end": 112, 
    "c_start": 105, 
    "end": 19, 
    "mention": "Diamond", 
    "pid": 1, 
    "senid": 24, 
    "sent": "A PVI-redo was performed using a novel circular mapping and abla-tion catheter (nMarq, Biosense Webster, Diamond Bar, Calif., USA). ", 
    "start": 18, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 124, 
    "c_start": 118, 
    "end": 22, 
    "mention": "Calif.", 
    "pid": 1, 
    "senid": 24, 
    "sent": "A PVI-redo was performed using a novel circular mapping and abla-tion catheter (nMarq, Biosense Webster, Diamond Bar, Calif., USA). ", 
    "start": 21, 
    "type": "Gene_or_Genome"
}
{
    "c_end": 129, 
    "c_start": 126, 
    "end": 24, 
    "mention": "USA", 
    "pid": 1, 
    "senid": 24, 
    "sent": "A PVI-redo was performed using a novel circular mapping and abla-tion catheter (nMarq, Biosense Webster, Diamond Bar, Calif., USA). ", 
    "start": 23, 
    "type": "Geographic_Area"
}
{
    "c_end": 7, 
    "c_start": 4, 
    "end": 2, 
    "mention": "ECG", 
    "pid": 1, 
    "senid": 54, 
    "sent": "The ECG showed tachycardia atrial fibrillation. ", 
    "start": 1, 
    "type": "Diagnostic_Procedure"
}
{
    "c_end": 14, 
    "c_start": 8, 
    "end": 3, 
    "mention": "showed", 
    "pid": 1, 
    "senid": 54, 
    "sent": "The ECG showed tachycardia atrial fibrillation. ", 
    "start": 2, 
    "type": "Animal"
}
{
    "c_end": 26, 
    "c_start": 15, 
    "end": 4, 
    "mention": "tachycardia", 
    "pid": 1, 
    "senid": 54, 
    "sent": "The ECG showed tachycardia atrial fibrillation. ", 
    "start": 3, 
    "type": "Finding"
}
{
    "c_end": 46, 
    "c_start": 27, 
    "end": 6, 
    "mention": "atrial fibrillation", 
    "pid": 1, 
    "senid": 54, 
    "sent": "The ECG showed tachycardia atrial fibrillation. ", 
    "start": 4, 
    "type": "Finding"
}
{
    "c_end": 6, 
    "c_start": 0, 
    "end": 1, 
    "mention": "Pacing", 
    "pid": 1, 
    "senid": 30, 
    "sent": "Pacing from the roof of the LSPV showed perfect entrainment (PPI +8 ms) and a similar p-wave morphology compared to the tachy-cardia. ", 
    "start": 0, 
    "type": "Individual_Behavior"
}
{
    "c_end": 20, 
    "c_start": 16, 
    "end": 4, 
    "mention": "roof", 
    "pid": 1, 
    "senid": 30, 
    "sent": "Pacing from the roof of the LSPV showed perfect entrainment (PPI +8 ms) and a similar p-wave morphology compared to the tachy-cardia. ", 
    "start": 3, 
    "type": "Manufactured_Object"
}
{
    "c_end": 32, 
    "c_start": 28, 
    "end": 7, 
    "mention": "LSPV", 
    "pid": 1, 
    "senid": 30, 
    "sent": "Pacing from the roof of the LSPV showed perfect entrainment (PPI +8 ms) and a similar p-wave morphology compared to the tachy-cardia. ", 
    "start": 6, 
    "type": "Body_Part__Organ__or_Organ_Component"
}
{
    "c_end": 39, 
    "c_start": 33, 
    "end": 8, 
    "mention": "showed", 
    "pid": 1, 
    "senid": 30, 
    "sent": "Pacing from the roof of the LSPV showed perfect entrainment (PPI +8 ms) and a similar p-wave morphology compared to the tachy-cardia. ", 
    "start": 7, 
    "type": "Animal"
}
{
    "c_end": 64, 
    "c_start": 61, 
    "end": 12, 
    "mention": "PPI", 
    "pid": 1, 
    "senid": 30, 
    "sent": "Pacing from the roof of the LSPV showed perfect entrainment (PPI +8 ms) and a similar p-wave morphology compared to the tachy-cardia. ", 
    "start": 11, 
    "type": "Pharmacologic_Substance"
}
{
    "c_end": 70, 
    "c_start": 68, 
    "end": 14, 
    "mention": "ms", 
    "pid": 1, 
    "senid": 30, 
    "sent": "Pacing from the roof of the LSPV showed perfect entrainment (PPI +8 ms) and a similar p-wave morphology compared to the tachy-cardia. ", 
    "start": 13, 
    "type": "Enzyme"
}
{
    "c_end": 85, 
    "c_start": 78, 
    "end": 18, 
    "mention": "similar", 
    "pid": 1, 
    "senid": 30, 
    "sent": "Pacing from the roof of the LSPV showed perfect entrainment (PPI +8 ms) and a similar p-wave morphology compared to the tachy-cardia. ", 
    "start": 17, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 92, 
    "c_start": 86, 
    "end": 19, 
    "mention": "p-wave", 
    "pid": 1, 
    "senid": 30, 
    "sent": "Pacing from the roof of the LSPV showed perfect entrainment (PPI +8 ms) and a similar p-wave morphology compared to the tachy-cardia. ", 
    "start": 18, 
    "type": "Organism_Attribute"
}
{
    "c_end": 103, 
    "c_start": 93, 
    "end": 20, 
    "mention": "morphology", 
    "pid": 1, 
    "senid": 30, 
    "sent": "Pacing from the roof of the LSPV showed perfect entrainment (PPI +8 ms) and a similar p-wave morphology compared to the tachy-cardia. ", 
    "start": 19, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 112, 
    "c_start": 104, 
    "end": 21, 
    "mention": "compared", 
    "pid": 1, 
    "senid": 30, 
    "sent": "Pacing from the roof of the LSPV showed perfect entrainment (PPI +8 ms) and a similar p-wave morphology compared to the tachy-cardia. ", 
    "start": 20, 
    "type": "Activity"
}
{
    "c_end": 132, 
    "c_start": 120, 
    "end": 24, 
    "mention": "tachy-cardia", 
    "pid": 1, 
    "senid": 30, 
    "sent": "Pacing from the roof of the LSPV showed perfect entrainment (PPI +8 ms) and a similar p-wave morphology compared to the tachy-cardia. ", 
    "start": 23, 
    "type": "Body_Location_or_Region"
}
{
    "c_end": 61, 
    "c_start": 52, 
    "end": 11, 
    "mention": "less than", 
    "pid": 1, 
    "senid": 56, 
    "sent": "Serum thyroid stimulating hormone (TSH) levels were less than 0.03 lU/ml (physiological range 0.554.78 lU/ ml), free triiodothyronine (fT3) was 7.32 pg/ml (2.304.20 pg/ml) and free thyroxine (fT4) amounted to Fig. ", 
    "start": 9, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 66, 
    "c_start": 62, 
    "end": 12, 
    "mention": "0.03", 
    "pid": 1, 
    "senid": 56, 
    "sent": "Serum thyroid stimulating hormone (TSH) levels were less than 0.03 lU/ml (physiological range 0.554.78 lU/ ml), free triiodothyronine (fT3) was 7.32 pg/ml (2.304.20 pg/ml) and free thyroxine (fT4) amounted to Fig. ", 
    "start": 11, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 72, 
    "c_start": 67, 
    "end": 13, 
    "mention": "lU/ml", 
    "pid": 1, 
    "senid": 56, 
    "sent": "Serum thyroid stimulating hormone (TSH) levels were less than 0.03 lU/ml (physiological range 0.554.78 lU/ ml), free triiodothyronine (fT3) was 7.32 pg/ml (2.304.20 pg/ml) and free thyroxine (fT4) amounted to Fig. ", 
    "start": 12, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 87, 
    "c_start": 74, 
    "end": 15, 
    "mention": "physiological", 
    "pid": 1, 
    "senid": 56, 
    "sent": "Serum thyroid stimulating hormone (TSH) levels were less than 0.03 lU/ml (physiological range 0.554.78 lU/ ml), free triiodothyronine (fT3) was 7.32 pg/ml (2.304.20 pg/ml) and free thyroxine (fT4) amounted to Fig. ", 
    "start": 14, 
    "type": "Functional_Concept"
}
{
    "c_end": 93, 
    "c_start": 88, 
    "end": 16, 
    "mention": "range", 
    "pid": 1, 
    "senid": 56, 
    "sent": "Serum thyroid stimulating hormone (TSH) levels were less than 0.03 lU/ml (physiological range 0.554.78 lU/ ml), free triiodothyronine (fT3) was 7.32 pg/ml (2.304.20 pg/ml) and free thyroxine (fT4) amounted to Fig. ", 
    "start": 15, 
    "type": "Intellectual_Product"
}
{
    "c_end": 150, 
    "c_start": 117, 
    "end": 24, 
    "mention": "triiodothyronine (fT3) was 7.32 p", 
    "pid": 1, 
    "senid": 56, 
    "sent": "Serum thyroid stimulating hormone (TSH) levels were less than 0.03 lU/ml (physiological range 0.554.78 lU/ ml), free triiodothyronine (fT3) was 7.32 pg/ml (2.304.20 pg/ml) and free thyroxine (fT4) amounted to Fig. ", 
    "start": 22, 
    "type": "Hormone"
}
{
    "c_end": 141, 
    "c_start": 138, 
    "end": 26, 
    "mention": ") w", 
    "pid": 1, 
    "senid": 56, 
    "sent": "Serum thyroid stimulating hormone (TSH) levels were less than 0.03 lU/ml (physiological range 0.554.78 lU/ ml), free triiodothyronine (fT3) was 7.32 pg/ml (2.304.20 pg/ml) and free thyroxine (fT4) amounted to Fig. ", 
    "start": 25, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 175, 
    "c_start": 170, 
    "end": 33, 
    "mention": ") and", 
    "pid": 1, 
    "senid": 56, 
    "sent": "Serum thyroid stimulating hormone (TSH) levels were less than 0.03 lU/ml (physiological range 0.554.78 lU/ ml), free triiodothyronine (fT3) was 7.32 pg/ml (2.304.20 pg/ml) and free thyroxine (fT4) amounted to Fig. ", 
    "start": 32, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 173, 
    "c_start": 165, 
    "end": 32, 
    "mention": "pg/ml) a", 
    "pid": 1, 
    "senid": 56, 
    "sent": "Serum thyroid stimulating hormone (TSH) levels were less than 0.03 lU/ml (physiological range 0.554.78 lU/ ml), free triiodothyronine (fT3) was 7.32 pg/ml (2.304.20 pg/ml) and free thyroxine (fT4) amounted to Fig. ", 
    "start": 31, 
    "type": "Finding"
}
{
    "c_end": 200, 
    "c_start": 181, 
    "end": 37, 
    "mention": "thyroxine (fT4) amo", 
    "pid": 1, 
    "senid": 56, 
    "sent": "Serum thyroid stimulating hormone (TSH) levels were less than 0.03 lU/ml (physiological range 0.554.78 lU/ ml), free triiodothyronine (fT3) was 7.32 pg/ml (2.304.20 pg/ml) and free thyroxine (fT4) amounted to Fig. ", 
    "start": 35, 
    "type": "Laboratory_Procedure"
}
{
    "c_end": 214, 
    "c_start": 206, 
    "end": 41, 
    "mention": "to Fig. ", 
    "pid": 1, 
    "senid": 56, 
    "sent": "Serum thyroid stimulating hormone (TSH) levels were less than 0.03 lU/ml (physiological range 0.554.78 lU/ ml), free triiodothyronine (fT3) was 7.32 pg/ml (2.304.20 pg/ml) and free thyroxine (fT4) amounted to Fig. ", 
    "start": 40, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 215, 
    "c_start": 212, 
    "end": 43, 
    "mention": ". ", 
    "pid": 1, 
    "senid": 56, 
    "sent": "Serum thyroid stimulating hormone (TSH) levels were less than 0.03 lU/ml (physiological range 0.554.78 lU/ ml), free triiodothyronine (fT3) was 7.32 pg/ml (2.304.20 pg/ml) and free thyroxine (fT4) amounted to Fig. ", 
    "start": 42, 
    "type": "Food"
}
{
    "c_end": 32, 
    "c_start": 4, 
    "end": 3, 
    "mention": "transthoracic echocardiogram", 
    "pid": 1, 
    "senid": 45, 
    "sent": "The transthoracic echocardiogram revealed pericardial effusion with collapsed right chambers, suggesting cardiac tamponade. ", 
    "start": 1, 
    "type": "Diagnostic_Procedure"
}
{
    "c_end": 41, 
    "c_start": 33, 
    "end": 4, 
    "mention": "revealed", 
    "pid": 1, 
    "senid": 45, 
    "sent": "The transthoracic echocardiogram revealed pericardial effusion with collapsed right chambers, suggesting cardiac tamponade. ", 
    "start": 3, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 62, 
    "c_start": 42, 
    "end": 6, 
    "mention": "pericardial effusion", 
    "pid": 1, 
    "senid": 45, 
    "sent": "The transthoracic echocardiogram revealed pericardial effusion with collapsed right chambers, suggesting cardiac tamponade. ", 
    "start": 4, 
    "type": "Body_Substance"
}
{
    "c_end": 77, 
    "c_start": 68, 
    "end": 8, 
    "mention": "collapsed", 
    "pid": 1, 
    "senid": 45, 
    "sent": "The transthoracic echocardiogram revealed pericardial effusion with collapsed right chambers, suggesting cardiac tamponade. ", 
    "start": 7, 
    "type": "Functional_Concept"
}
{
    "c_end": 83, 
    "c_start": 78, 
    "end": 9, 
    "mention": "right", 
    "pid": 1, 
    "senid": 45, 
    "sent": "The transthoracic echocardiogram revealed pericardial effusion with collapsed right chambers, suggesting cardiac tamponade. ", 
    "start": 8, 
    "type": "Spatial_Concept"
}
{
    "c_end": 92, 
    "c_start": 84, 
    "end": 10, 
    "mention": "chambers", 
    "pid": 1, 
    "senid": 45, 
    "sent": "The transthoracic echocardiogram revealed pericardial effusion with collapsed right chambers, suggesting cardiac tamponade. ", 
    "start": 9, 
    "type": "Manufactured_Object"
}
{
    "c_end": 104, 
    "c_start": 94, 
    "end": 12, 
    "mention": "suggesting", 
    "pid": 1, 
    "senid": 45, 
    "sent": "The transthoracic echocardiogram revealed pericardial effusion with collapsed right chambers, suggesting cardiac tamponade. ", 
    "start": 11, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 122, 
    "c_start": 105, 
    "end": 14, 
    "mention": "cardiac tamponade", 
    "pid": 1, 
    "senid": 45, 
    "sent": "The transthoracic echocardiogram revealed pericardial effusion with collapsed right chambers, suggesting cardiac tamponade. ", 
    "start": 12, 
    "type": "Disease_or_Syndrome"
}
{
    "c_end": 32, 
    "c_start": 12, 
    "end": 5, 
    "mention": "hydroxyzine overdose", 
    "pid": 1, 
    "senid": 60, 
    "sent": "Moreover, a hydroxyzine overdose was detected probably due to high posology, bile ducts obstruction, and liver impairment (rise in GPT). ", 
    "start": 3, 
    "type": "Injury_or_Poisoning"
}
{
    "c_end": 45, 
    "c_start": 37, 
    "end": 7, 
    "mention": "detected", 
    "pid": 1, 
    "senid": 60, 
    "sent": "Moreover, a hydroxyzine overdose was detected probably due to high posology, bile ducts obstruction, and liver impairment (rise in GPT). ", 
    "start": 6, 
    "type": "Therapeutic_or_Preventive_Procedure"
}
{
    "c_end": 54, 
    "c_start": 46, 
    "end": 8, 
    "mention": "probably", 
    "pid": 1, 
    "senid": 60, 
    "sent": "Moreover, a hydroxyzine overdose was detected probably due to high posology, bile ducts obstruction, and liver impairment (rise in GPT). ", 
    "start": 7, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 61, 
    "c_start": 55, 
    "end": 10, 
    "mention": "due to", 
    "pid": 1, 
    "senid": 60, 
    "sent": "Moreover, a hydroxyzine overdose was detected probably due to high posology, bile ducts obstruction, and liver impairment (rise in GPT). ", 
    "start": 8, 
    "type": "Functional_Concept"
}
{
    "c_end": 75, 
    "c_start": 62, 
    "end": 12, 
    "mention": "high posology", 
    "pid": 1, 
    "senid": 60, 
    "sent": "Moreover, a hydroxyzine overdose was detected probably due to high posology, bile ducts obstruction, and liver impairment (rise in GPT). ", 
    "start": 10, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 99, 
    "c_start": 77, 
    "end": 16, 
    "mention": "bile ducts obstruction", 
    "pid": 1, 
    "senid": 60, 
    "sent": "Moreover, a hydroxyzine overdose was detected probably due to high posology, bile ducts obstruction, and liver impairment (rise in GPT). ", 
    "start": 13, 
    "type": "Disease_or_Syndrome"
}
{
    "c_end": 121, 
    "c_start": 105, 
    "end": 20, 
    "mention": "liver impairment", 
    "pid": 1, 
    "senid": 60, 
    "sent": "Moreover, a hydroxyzine overdose was detected probably due to high posology, bile ducts obstruction, and liver impairment (rise in GPT). ", 
    "start": 18, 
    "type": "Disease_or_Syndrome"
}
{
    "c_end": 134, 
    "c_start": 131, 
    "end": 24, 
    "mention": "GPT", 
    "pid": 1, 
    "senid": 60, 
    "sent": "Moreover, a hydroxyzine overdose was detected probably due to high posology, bile ducts obstruction, and liver impairment (rise in GPT). ", 
    "start": 23, 
    "type": "Enzyme"
}
{
    "c_end": 10, 
    "c_start": 0, 
    "end": 1, 
    "mention": "Cetirizine", 
    "pid": 1, 
    "senid": 61, 
    "sent": "Cetirizine is the hydroxyzines major active metabolite; unfortunately, its blood level dosage was not performed. ", 
    "start": 0, 
    "type": "Pharmacologic_Substance"
}
{
    "c_end": 30, 
    "c_start": 18, 
    "end": 4, 
    "mention": "hydroxyzines", 
    "pid": 1, 
    "senid": 61, 
    "sent": "Cetirizine is the hydroxyzines major active metabolite; unfortunately, its blood level dosage was not performed. ", 
    "start": 3, 
    "type": "Organic_Chemical"
}
{
    "c_end": 36, 
    "c_start": 31, 
    "end": 5, 
    "mention": "major", 
    "pid": 1, 
    "senid": 61, 
    "sent": "Cetirizine is the hydroxyzines major active metabolite; unfortunately, its blood level dosage was not performed. ", 
    "start": 4, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 43, 
    "c_start": 37, 
    "end": 6, 
    "mention": "active", 
    "pid": 1, 
    "senid": 61, 
    "sent": "Cetirizine is the hydroxyzines major active metabolite; unfortunately, its blood level dosage was not performed. ", 
    "start": 5, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 55, 
    "c_start": 44, 
    "end": 8, 
    "mention": "metabolite;", 
    "pid": 1, 
    "senid": 61, 
    "sent": "Cetirizine is the hydroxyzines major active metabolite; unfortunately, its blood level dosage was not performed. ", 
    "start": 6, 
    "type": "Biologically_Active_Substance"
}
{
    "c_end": 80, 
    "c_start": 75, 
    "end": 12, 
    "mention": "blood", 
    "pid": 1, 
    "senid": 61, 
    "sent": "Cetirizine is the hydroxyzines major active metabolite; unfortunately, its blood level dosage was not performed. ", 
    "start": 11, 
    "type": "Body_Substance"
}
{
    "c_end": 86, 
    "c_start": 81, 
    "end": 13, 
    "mention": "level", 
    "pid": 1, 
    "senid": 61, 
    "sent": "Cetirizine is the hydroxyzines major active metabolite; unfortunately, its blood level dosage was not performed. ", 
    "start": 12, 
    "type": "Geographic_Area"
}
{
    "c_end": 93, 
    "c_start": 87, 
    "end": 14, 
    "mention": "dosage", 
    "pid": 1, 
    "senid": 61, 
    "sent": "Cetirizine is the hydroxyzines major active metabolite; unfortunately, its blood level dosage was not performed. ", 
    "start": 13, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 101, 
    "c_start": 98, 
    "end": 16, 
    "mention": "not", 
    "pid": 1, 
    "senid": 61, 
    "sent": "Cetirizine is the hydroxyzines major active metabolite; unfortunately, its blood level dosage was not performed. ", 
    "start": 15, 
    "type": "Functional_Concept"
}
{
    "c_end": 111, 
    "c_start": 102, 
    "end": 17, 
    "mention": "performed", 
    "pid": 1, 
    "senid": 61, 
    "sent": "Cetirizine is the hydroxyzines major active metabolite; unfortunately, its blood level dosage was not performed. ", 
    "start": 16, 
    "type": "Functional_Concept"
}
{
    "c_end": 27, 
    "c_start": 16, 
    "end": 4, 
    "mention": "combination", 
    "pid": 1, 
    "senid": 62, 
    "sent": "We suppose that combination of hydroxyzine overdose and transient renal failure could have lead to cetirizine accumulation. ", 
    "start": 3, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 51, 
    "c_start": 31, 
    "end": 7, 
    "mention": "hydroxyzine overdose", 
    "pid": 1, 
    "senid": 62, 
    "sent": "We suppose that combination of hydroxyzine overdose and transient renal failure could have lead to cetirizine accumulation. ", 
    "start": 5, 
    "type": "Injury_or_Poisoning"
}
{
    "c_end": 65, 
    "c_start": 56, 
    "end": 9, 
    "mention": "transient", 
    "pid": 1, 
    "senid": 62, 
    "sent": "We suppose that combination of hydroxyzine overdose and transient renal failure could have lead to cetirizine accumulation. ", 
    "start": 8, 
    "type": "Population_Group"
}
{
    "c_end": 79, 
    "c_start": 66, 
    "end": 11, 
    "mention": "renal failure", 
    "pid": 1, 
    "senid": 62, 
    "sent": "We suppose that combination of hydroxyzine overdose and transient renal failure could have lead to cetirizine accumulation. ", 
    "start": 9, 
    "type": "Disease_or_Syndrome"
}
{
    "c_end": 95, 
    "c_start": 91, 
    "end": 14, 
    "mention": "lead", 
    "pid": 1, 
    "senid": 62, 
    "sent": "We suppose that combination of hydroxyzine overdose and transient renal failure could have lead to cetirizine accumulation. ", 
    "start": 13, 
    "type": "Functional_Concept"
}
{
    "c_end": 98, 
    "c_start": 96, 
    "end": 15, 
    "mention": "to", 
    "pid": 1, 
    "senid": 62, 
    "sent": "We suppose that combination of hydroxyzine overdose and transient renal failure could have lead to cetirizine accumulation. ", 
    "start": 14, 
    "type": "Amino_Acid__Peptide__or_Protein"
}
{
    "c_end": 109, 
    "c_start": 99, 
    "end": 16, 
    "mention": "cetirizine", 
    "pid": 1, 
    "senid": 62, 
    "sent": "We suppose that combination of hydroxyzine overdose and transient renal failure could have lead to cetirizine accumulation. ", 
    "start": 15, 
    "type": "Pharmacologic_Substance"
}
{
    "c_end": 122, 
    "c_start": 110, 
    "end": 17, 
    "mention": "accumulation", 
    "pid": 1, 
    "senid": 62, 
    "sent": "We suppose that combination of hydroxyzine overdose and transient renal failure could have lead to cetirizine accumulation. ", 
    "start": 16, 
    "type": "Finding"
}
{
    "c_end": 19, 
    "c_start": 9, 
    "end": 3, 
    "mention": "cetirizine", 
    "pid": 1, 
    "senid": 63, 
    "sent": "However, cetirizine seems to be safe regarding ventricular repolarization, even at supratherapeutic dose. ", 
    "start": 2, 
    "type": "Pharmacologic_Substance"
}
{
    "c_end": 28, 
    "c_start": 26, 
    "end": 5, 
    "mention": "to", 
    "pid": 1, 
    "senid": 63, 
    "sent": "However, cetirizine seems to be safe regarding ventricular repolarization, even at supratherapeutic dose. ", 
    "start": 4, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 73, 
    "c_start": 47, 
    "end": 10, 
    "mention": "ventricular repolarization", 
    "pid": 1, 
    "senid": 63, 
    "sent": "However, cetirizine seems to be safe regarding ventricular repolarization, even at supratherapeutic dose. ", 
    "start": 8, 
    "type": "Organ_or_Tissue_Function"
}
{
    "c_end": 104, 
    "c_start": 100, 
    "end": 15, 
    "mention": "dose", 
    "pid": 1, 
    "senid": 63, 
    "sent": "However, cetirizine seems to be safe regarding ventricular repolarization, even at supratherapeutic dose. ", 
    "start": 14, 
    "type": "Clinical_Attribute"
}
{
    "c_end": 11, 
    "c_start": 7, 
    "end": 2, 
    "mention": "only", 
    "pid": 1, 
    "senid": 64, 
    "sent": "Theres only one published clinical case of hydroxyzine-induced QT prolongation. ", 
    "start": 1, 
    "type": "Intellectual_Product"
}
{
    "c_end": 15, 
    "c_start": 12, 
    "end": 3, 
    "mention": "one", 
    "pid": 1, 
    "senid": 64, 
    "sent": "Theres only one published clinical case of hydroxyzine-induced QT prolongation. ", 
    "start": 2, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 25, 
    "c_start": 16, 
    "end": 4, 
    "mention": "published", 
    "pid": 1, 
    "senid": 64, 
    "sent": "Theres only one published clinical case of hydroxyzine-induced QT prolongation. ", 
    "start": 3, 
    "type": "Intellectual_Product"
}
{
    "c_end": 34, 
    "c_start": 26, 
    "end": 5, 
    "mention": "clinical", 
    "pid": 1, 
    "senid": 64, 
    "sent": "Theres only one published clinical case of hydroxyzine-induced QT prolongation. ", 
    "start": 4, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 39, 
    "c_start": 35, 
    "end": 6, 
    "mention": "case", 
    "pid": 1, 
    "senid": 64, 
    "sent": "Theres only one published clinical case of hydroxyzine-induced QT prolongation. ", 
    "start": 5, 
    "type": "Conceptual_Entity"
}
{
    "c_end": 62, 
    "c_start": 43, 
    "end": 8, 
    "mention": "hydroxyzine-induced", 
    "pid": 1, 
    "senid": 64, 
    "sent": "Theres only one published clinical case of hydroxyzine-induced QT prolongation. ", 
    "start": 7, 
    "type": "Pharmacologic_Substance"
}
{
    "c_end": 78, 
    "c_start": 63, 
    "end": 10, 
    "mention": "QT prolongation", 
    "pid": 1, 
    "senid": 64, 
    "sent": "Theres only one published clinical case of hydroxyzine-induced QT prolongation. ", 
    "start": 8, 
    "type": "Finding"
}
{
    "c_end": 1, 
    "c_start": 0, 
    "end": 1, 
    "mention": "1", 
    "pid": 1, 
    "senid": 57, 
    "sent": "1 Turbo field-echo (TFE) inversion recovery (IR) sequences in vertical (a) and horizontal (b) long axis 10 min after intravenous gadolinium-based contrast agent administration: the healthy basal and midventricular myocardium shows no prolonged gadolinium retention and is depicted in black (arrowheads), whereas the transmural scar in the apical segments retains the gadolinium and has a bright appearance (arrows).  ", 
    "start": 0, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 18, 
    "c_start": 2, 
    "end": 3, 
    "mention": "Turbo field-echo", 
    "pid": 1, 
    "senid": 57, 
    "sent": "1 Turbo field-echo (TFE) inversion recovery (IR) sequences in vertical (a) and horizontal (b) long axis 10 min after intravenous gadolinium-based contrast agent administration: the healthy basal and midventricular myocardium shows no prolonged gadolinium retention and is depicted in black (arrowheads), whereas the transmural scar in the apical segments retains the gadolinium and has a bright appearance (arrows).  ", 
    "start": 1, 
    "type": "Diagnostic_Procedure"
}
{
    "c_end": 34, 
    "c_start": 25, 
    "end": 7, 
    "mention": "inversion", 
    "pid": 1, 
    "senid": 57, 
    "sent": "1 Turbo field-echo (TFE) inversion recovery (IR) sequences in vertical (a) and horizontal (b) long axis 10 min after intravenous gadolinium-based contrast agent administration: the healthy basal and midventricular myocardium shows no prolonged gadolinium retention and is depicted in black (arrowheads), whereas the transmural scar in the apical segments retains the gadolinium and has a bright appearance (arrows).  ", 
    "start": 6, 
    "type": "Anatomical_Abnormality"
}
{
    "c_end": 43, 
    "c_start": 35, 
    "end": 8, 
    "mention": "recovery", 
    "pid": 1, 
    "senid": 57, 
    "sent": "1 Turbo field-echo (TFE) inversion recovery (IR) sequences in vertical (a) and horizontal (b) long axis 10 min after intravenous gadolinium-based contrast agent administration: the healthy basal and midventricular myocardium shows no prolonged gadolinium retention and is depicted in black (arrowheads), whereas the transmural scar in the apical segments retains the gadolinium and has a bright appearance (arrows).  ", 
    "start": 7, 
    "type": "Organism_Function"
}
{
    "c_end": 58, 
    "c_start": 49, 
    "end": 12, 
    "mention": "sequences", 
    "pid": 1, 
    "senid": 57, 
    "sent": "1 Turbo field-echo (TFE) inversion recovery (IR) sequences in vertical (a) and horizontal (b) long axis 10 min after intravenous gadolinium-based contrast agent administration: the healthy basal and midventricular myocardium shows no prolonged gadolinium retention and is depicted in black (arrowheads), whereas the transmural scar in the apical segments retains the gadolinium and has a bright appearance (arrows).  ", 
    "start": 11, 
    "type": "Nucleotide_Sequence"
}
{
    "c_end": 70, 
    "c_start": 62, 
    "end": 14, 
    "mention": "vertical", 
    "pid": 1, 
    "senid": 57, 
    "sent": "1 Turbo field-echo (TFE) inversion recovery (IR) sequences in vertical (a) and horizontal (b) long axis 10 min after intravenous gadolinium-based contrast agent administration: the healthy basal and midventricular myocardium shows no prolonged gadolinium retention and is depicted in black (arrowheads), whereas the transmural scar in the apical segments retains the gadolinium and has a bright appearance (arrows).  ", 
    "start": 13, 
    "type": "Spatial_Concept"
}
{
    "c_end": 89, 
    "c_start": 79, 
    "end": 19, 
    "mention": "horizontal", 
    "pid": 1, 
    "senid": 57, 
    "sent": "1 Turbo field-echo (TFE) inversion recovery (IR) sequences in vertical (a) and horizontal (b) long axis 10 min after intravenous gadolinium-based contrast agent administration: the healthy basal and midventricular myocardium shows no prolonged gadolinium retention and is depicted in black (arrowheads), whereas the transmural scar in the apical segments retains the gadolinium and has a bright appearance (arrows).  ", 
    "start": 18, 
    "type": "Spatial_Concept"
}
{
    "c_end": 103, 
    "c_start": 94, 
    "end": 24, 
    "mention": "long axis", 
    "pid": 1, 
    "senid": 57, 
    "sent": "1 Turbo field-echo (TFE) inversion recovery (IR) sequences in vertical (a) and horizontal (b) long axis 10 min after intravenous gadolinium-based contrast agent administration: the healthy basal and midventricular myocardium shows no prolonged gadolinium retention and is depicted in black (arrowheads), whereas the transmural scar in the apical segments retains the gadolinium and has a bright appearance (arrows).  ", 
    "start": 22, 
    "type": "Spatial_Concept"
}
{
    "c_end": 110, 
    "c_start": 104, 
    "end": 26, 
    "mention": "10 min", 
    "pid": 1, 
    "senid": 57, 
    "sent": "1 Turbo field-echo (TFE) inversion recovery (IR) sequences in vertical (a) and horizontal (b) long axis 10 min after intravenous gadolinium-based contrast agent administration: the healthy basal and midventricular myocardium shows no prolonged gadolinium retention and is depicted in black (arrowheads), whereas the transmural scar in the apical segments retains the gadolinium and has a bright appearance (arrows).  ", 
    "start": 24, 
    "type": "Temporal_Concept"
}
{
    "c_end": 176, 
    "c_start": 117, 
    "end": 33, 
    "mention": "intravenous gadolinium-based contrast agent administration:", 
    "pid": 1, 
    "senid": 57, 
    "sent": "1 Turbo field-echo (TFE) inversion recovery (IR) sequences in vertical (a) and horizontal (b) long axis 10 min after intravenous gadolinium-based contrast agent administration: the healthy basal and midventricular myocardium shows no prolonged gadolinium retention and is depicted in black (arrowheads), whereas the transmural scar in the apical segments retains the gadolinium and has a bright appearance (arrows).  ", 
    "start": 27, 
    "type": "Therapeutic_or_Preventive_Procedure"
}
{
    "c_end": 160, 
    "c_start": 129, 
    "end": 31, 
    "mention": "gadolinium-based contrast agent", 
    "pid": 1, 
    "senid": 57, 
    "sent": "1 Turbo field-echo (TFE) inversion recovery (IR) sequences in vertical (a) and horizontal (b) long axis 10 min after intravenous gadolinium-based contrast agent administration: the healthy basal and midventricular myocardium shows no prolonged gadolinium retention and is depicted in black (arrowheads), whereas the transmural scar in the apical segments retains the gadolinium and has a bright appearance (arrows).  ", 
    "start": 28, 
    "type": "Indicator__Reagent__or_Diagnostic_Aid"
}
{
    "c_end": 188, 
    "c_start": 181, 
    "end": 35, 
    "mention": "healthy", 
    "pid": 1, 
    "senid": 57, 
    "sent": "1 Turbo field-echo (TFE) inversion recovery (IR) sequences in vertical (a) and horizontal (b) long axis 10 min after intravenous gadolinium-based contrast agent administration: the healthy basal and midventricular myocardium shows no prolonged gadolinium retention and is depicted in black (arrowheads), whereas the transmural scar in the apical segments retains the gadolinium and has a bright appearance (arrows).  ", 
    "start": 34, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 194, 
    "c_start": 189, 
    "end": 36, 
    "mention": "basal", 
    "pid": 1, 
    "senid": 57, 
    "sent": "1 Turbo field-echo (TFE) inversion recovery (IR) sequences in vertical (a) and horizontal (b) long axis 10 min after intravenous gadolinium-based contrast agent administration: the healthy basal and midventricular myocardium shows no prolonged gadolinium retention and is depicted in black (arrowheads), whereas the transmural scar in the apical segments retains the gadolinium and has a bright appearance (arrows).  ", 
    "start": 35, 
    "type": "Spatial_Concept"
}
{
    "c_end": 224, 
    "c_start": 214, 
    "end": 39, 
    "mention": "myocardium", 
    "pid": 1, 
    "senid": 57, 
    "sent": "1 Turbo field-echo (TFE) inversion recovery (IR) sequences in vertical (a) and horizontal (b) long axis 10 min after intravenous gadolinium-based contrast agent administration: the healthy basal and midventricular myocardium shows no prolonged gadolinium retention and is depicted in black (arrowheads), whereas the transmural scar in the apical segments retains the gadolinium and has a bright appearance (arrows).  ", 
    "start": 38, 
    "type": "Tissue"
}
{
    "c_end": 230, 
    "c_start": 225, 
    "end": 40, 
    "mention": "shows", 
    "pid": 1, 
    "senid": 57, 
    "sent": "1 Turbo field-echo (TFE) inversion recovery (IR) sequences in vertical (a) and horizontal (b) long axis 10 min after intravenous gadolinium-based contrast agent administration: the healthy basal and midventricular myocardium shows no prolonged gadolinium retention and is depicted in black (arrowheads), whereas the transmural scar in the apical segments retains the gadolinium and has a bright appearance (arrows).  ", 
    "start": 39, 
    "type": "Animal"
}
{
    "c_end": 243, 
    "c_start": 234, 
    "end": 42, 
    "mention": "prolonged", 
    "pid": 1, 
    "senid": 57, 
    "sent": "1 Turbo field-echo (TFE) inversion recovery (IR) sequences in vertical (a) and horizontal (b) long axis 10 min after intravenous gadolinium-based contrast agent administration: the healthy basal and midventricular myocardium shows no prolonged gadolinium retention and is depicted in black (arrowheads), whereas the transmural scar in the apical segments retains the gadolinium and has a bright appearance (arrows).  ", 
    "start": 41, 
    "type": "Temporal_Concept"
}
{
    "c_end": 377, 
    "c_start": 367, 
    "end": 64, 
    "mention": "gadolinium", 
    "pid": 1, 
    "senid": 57, 
    "sent": "1 Turbo field-echo (TFE) inversion recovery (IR) sequences in vertical (a) and horizontal (b) long axis 10 min after intravenous gadolinium-based contrast agent administration: the healthy basal and midventricular myocardium shows no prolonged gadolinium retention and is depicted in black (arrowheads), whereas the transmural scar in the apical segments retains the gadolinium and has a bright appearance (arrows).  ", 
    "start": 63, 
    "type": "Indicator__Reagent__or_Diagnostic_Aid"
}
{
    "c_end": 264, 
    "c_start": 255, 
    "end": 44, 
    "mention": "retention", 
    "pid": 1, 
    "senid": 57, 
    "sent": "1 Turbo field-echo (TFE) inversion recovery (IR) sequences in vertical (a) and horizontal (b) long axis 10 min after intravenous gadolinium-based contrast agent administration: the healthy basal and midventricular myocardium shows no prolonged gadolinium retention and is depicted in black (arrowheads), whereas the transmural scar in the apical segments retains the gadolinium and has a bright appearance (arrows).  ", 
    "start": 43, 
    "type": "Functional_Concept"
}
{
    "c_end": 289, 
    "c_start": 284, 
    "end": 49, 
    "mention": "black", 
    "pid": 1, 
    "senid": 57, 
    "sent": "1 Turbo field-echo (TFE) inversion recovery (IR) sequences in vertical (a) and horizontal (b) long axis 10 min after intravenous gadolinium-based contrast agent administration: the healthy basal and midventricular myocardium shows no prolonged gadolinium retention and is depicted in black (arrowheads), whereas the transmural scar in the apical segments retains the gadolinium and has a bright appearance (arrows).  ", 
    "start": 48, 
    "type": "Population_Group"
}
{
    "c_end": 301, 
    "c_start": 291, 
    "end": 51, 
    "mention": "arrowheads", 
    "pid": 1, 
    "senid": 57, 
    "sent": "1 Turbo field-echo (TFE) inversion recovery (IR) sequences in vertical (a) and horizontal (b) long axis 10 min after intravenous gadolinium-based contrast agent administration: the healthy basal and midventricular myocardium shows no prolonged gadolinium retention and is depicted in black (arrowheads), whereas the transmural scar in the apical segments retains the gadolinium and has a bright appearance (arrows).  ", 
    "start": 50, 
    "type": "Plant"
}
{
    "c_end": 326, 
    "c_start": 316, 
    "end": 56, 
    "mention": "transmural", 
    "pid": 1, 
    "senid": 57, 
    "sent": "1 Turbo field-echo (TFE) inversion recovery (IR) sequences in vertical (a) and horizontal (b) long axis 10 min after intravenous gadolinium-based contrast agent administration: the healthy basal and midventricular myocardium shows no prolonged gadolinium retention and is depicted in black (arrowheads), whereas the transmural scar in the apical segments retains the gadolinium and has a bright appearance (arrows).  ", 
    "start": 55, 
    "type": "Functional_Concept"
}
{
    "c_end": 331, 
    "c_start": 327, 
    "end": 57, 
    "mention": "scar", 
    "pid": 1, 
    "senid": 57, 
    "sent": "1 Turbo field-echo (TFE) inversion recovery (IR) sequences in vertical (a) and horizontal (b) long axis 10 min after intravenous gadolinium-based contrast agent administration: the healthy basal and midventricular myocardium shows no prolonged gadolinium retention and is depicted in black (arrowheads), whereas the transmural scar in the apical segments retains the gadolinium and has a bright appearance (arrows).  ", 
    "start": 56, 
    "type": "Finding"
}
{
    "c_end": 345, 
    "c_start": 339, 
    "end": 60, 
    "mention": "apical", 
    "pid": 1, 
    "senid": 57, 
    "sent": "1 Turbo field-echo (TFE) inversion recovery (IR) sequences in vertical (a) and horizontal (b) long axis 10 min after intravenous gadolinium-based contrast agent administration: the healthy basal and midventricular myocardium shows no prolonged gadolinium retention and is depicted in black (arrowheads), whereas the transmural scar in the apical segments retains the gadolinium and has a bright appearance (arrows).  ", 
    "start": 59, 
    "type": "Spatial_Concept"
}
{
    "c_end": 354, 
    "c_start": 346, 
    "end": 61, 
    "mention": "segments", 
    "pid": 1, 
    "senid": 57, 
    "sent": "1 Turbo field-echo (TFE) inversion recovery (IR) sequences in vertical (a) and horizontal (b) long axis 10 min after intravenous gadolinium-based contrast agent administration: the healthy basal and midventricular myocardium shows no prolonged gadolinium retention and is depicted in black (arrowheads), whereas the transmural scar in the apical segments retains the gadolinium and has a bright appearance (arrows).  ", 
    "start": 60, 
    "type": "Spatial_Concept"
}
{
    "c_end": 362, 
    "c_start": 355, 
    "end": 62, 
    "mention": "retains", 
    "pid": 1, 
    "senid": 57, 
    "sent": "1 Turbo field-echo (TFE) inversion recovery (IR) sequences in vertical (a) and horizontal (b) long axis 10 min after intravenous gadolinium-based contrast agent administration: the healthy basal and midventricular myocardium shows no prolonged gadolinium retention and is depicted in black (arrowheads), whereas the transmural scar in the apical segments retains the gadolinium and has a bright appearance (arrows).  ", 
    "start": 61, 
    "type": "Functional_Concept"
}
{
    "c_end": 394, 
    "c_start": 388, 
    "end": 68, 
    "mention": "bright", 
    "pid": 1, 
    "senid": 57, 
    "sent": "1 Turbo field-echo (TFE) inversion recovery (IR) sequences in vertical (a) and horizontal (b) long axis 10 min after intravenous gadolinium-based contrast agent administration: the healthy basal and midventricular myocardium shows no prolonged gadolinium retention and is depicted in black (arrowheads), whereas the transmural scar in the apical segments retains the gadolinium and has a bright appearance (arrows).  ", 
    "start": 67, 
    "type": "Finding"
}
{
    "c_end": 405, 
    "c_start": 395, 
    "end": 69, 
    "mention": "appearance", 
    "pid": 1, 
    "senid": 57, 
    "sent": "1 Turbo field-echo (TFE) inversion recovery (IR) sequences in vertical (a) and horizontal (b) long axis 10 min after intravenous gadolinium-based contrast agent administration: the healthy basal and midventricular myocardium shows no prolonged gadolinium retention and is depicted in black (arrowheads), whereas the transmural scar in the apical segments retains the gadolinium and has a bright appearance (arrows).  ", 
    "start": 68, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 413, 
    "c_start": 407, 
    "end": 71, 
    "mention": "arrows", 
    "pid": 1, 
    "senid": 57, 
    "sent": "1 Turbo field-echo (TFE) inversion recovery (IR) sequences in vertical (a) and horizontal (b) long axis 10 min after intravenous gadolinium-based contrast agent administration: the healthy basal and midventricular myocardium shows no prolonged gadolinium retention and is depicted in black (arrowheads), whereas the transmural scar in the apical segments retains the gadolinium and has a bright appearance (arrows).  ", 
    "start": 70, 
    "type": "Manufactured_Object"
}
{
    "c_end": 9, 
    "c_start": 5, 
    "end": 2, 
    "mention": "case", 
    "pid": 1, 
    "senid": 65, 
    "sent": "This case describes recurrent syncope during hydroxyzine treatment at usual posology in a 34-year-old woman presenting a hERG mutation. ", 
    "start": 1, 
    "type": "Conceptual_Entity"
}
{
    "c_end": 29, 
    "c_start": 20, 
    "end": 4, 
    "mention": "recurrent", 
    "pid": 1, 
    "senid": 65, 
    "sent": "This case describes recurrent syncope during hydroxyzine treatment at usual posology in a 34-year-old woman presenting a hERG mutation. ", 
    "start": 3, 
    "type": "Temporal_Concept"
}
{
    "c_end": 37, 
    "c_start": 30, 
    "end": 5, 
    "mention": "syncope", 
    "pid": 1, 
    "senid": 65, 
    "sent": "This case describes recurrent syncope during hydroxyzine treatment at usual posology in a 34-year-old woman presenting a hERG mutation. ", 
    "start": 4, 
    "type": "Sign_or_Symptom"
}
{
    "c_end": 56, 
    "c_start": 45, 
    "end": 7, 
    "mention": "hydroxyzine", 
    "pid": 1, 
    "senid": 65, 
    "sent": "This case describes recurrent syncope during hydroxyzine treatment at usual posology in a 34-year-old woman presenting a hERG mutation. ", 
    "start": 6, 
    "type": "Organic_Chemical"
}
{
    "c_end": 66, 
    "c_start": 57, 
    "end": 8, 
    "mention": "treatment", 
    "pid": 1, 
    "senid": 65, 
    "sent": "This case describes recurrent syncope during hydroxyzine treatment at usual posology in a 34-year-old woman presenting a hERG mutation. ", 
    "start": 7, 
    "type": "Health_Care_Activity"
}
{
    "c_end": 75, 
    "c_start": 70, 
    "end": 10, 
    "mention": "usual", 
    "pid": 1, 
    "senid": 65, 
    "sent": "This case describes recurrent syncope during hydroxyzine treatment at usual posology in a 34-year-old woman presenting a hERG mutation. ", 
    "start": 9, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 84, 
    "c_start": 76, 
    "end": 11, 
    "mention": "posology", 
    "pid": 1, 
    "senid": 65, 
    "sent": "This case describes recurrent syncope during hydroxyzine treatment at usual posology in a 34-year-old woman presenting a hERG mutation. ", 
    "start": 10, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 101, 
    "c_start": 90, 
    "end": 14, 
    "mention": "34-year-old", 
    "pid": 1, 
    "senid": 65, 
    "sent": "This case describes recurrent syncope during hydroxyzine treatment at usual posology in a 34-year-old woman presenting a hERG mutation. ", 
    "start": 13, 
    "type": "Temporal_Concept"
}
{
    "c_end": 107, 
    "c_start": 102, 
    "end": 15, 
    "mention": "woman", 
    "pid": 1, 
    "senid": 65, 
    "sent": "This case describes recurrent syncope during hydroxyzine treatment at usual posology in a 34-year-old woman presenting a hERG mutation. ", 
    "start": 14, 
    "type": "Population_Group"
}
{
    "c_end": 118, 
    "c_start": 108, 
    "end": 16, 
    "mention": "presenting", 
    "pid": 1, 
    "senid": 65, 
    "sent": "This case describes recurrent syncope during hydroxyzine treatment at usual posology in a 34-year-old woman presenting a hERG mutation. ", 
    "start": 15, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 125, 
    "c_start": 121, 
    "end": 18, 
    "mention": "hERG", 
    "pid": 1, 
    "senid": 65, 
    "sent": "This case describes recurrent syncope during hydroxyzine treatment at usual posology in a 34-year-old woman presenting a hERG mutation. ", 
    "start": 17, 
    "type": "Gene_or_Genome"
}
{
    "c_end": 134, 
    "c_start": 126, 
    "end": 19, 
    "mention": "mutation", 
    "pid": 1, 
    "senid": 65, 
    "sent": "This case describes recurrent syncope during hydroxyzine treatment at usual posology in a 34-year-old woman presenting a hERG mutation. ", 
    "start": 18, 
    "type": "Cell_or_Molecular_Dysfunction"
}
{
    "c_end": 4, 
    "c_start": 0, 
    "end": 1, 
    "mention": "hERG", 
    "pid": 1, 
    "senid": 66, 
    "sent": "hERG gene codes for the subunit of a potassium channel (I Kr ) implicated in the ventricular repolarization. ", 
    "start": 0, 
    "type": "Gene_or_Genome"
}
{
    "c_end": 9, 
    "c_start": 5, 
    "end": 2, 
    "mention": "gene", 
    "pid": 1, 
    "senid": 66, 
    "sent": "hERG gene codes for the subunit of a potassium channel (I Kr ) implicated in the ventricular repolarization. ", 
    "start": 1, 
    "type": "Gene_or_Genome"
}
{
    "c_end": 15, 
    "c_start": 10, 
    "end": 3, 
    "mention": "codes", 
    "pid": 1, 
    "senid": 66, 
    "sent": "hERG gene codes for the subunit of a potassium channel (I Kr ) implicated in the ventricular repolarization. ", 
    "start": 2, 
    "type": "Occupational_Activity"
}
{
    "c_end": 31, 
    "c_start": 24, 
    "end": 6, 
    "mention": "subunit", 
    "pid": 1, 
    "senid": 66, 
    "sent": "hERG gene codes for the subunit of a potassium channel (I Kr ) implicated in the ventricular repolarization. ", 
    "start": 5, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 54, 
    "c_start": 37, 
    "end": 10, 
    "mention": "potassium channel", 
    "pid": 1, 
    "senid": 66, 
    "sent": "hERG gene codes for the subunit of a potassium channel (I Kr ) implicated in the ventricular repolarization. ", 
    "start": 8, 
    "type": "Biologically_Active_Substance"
}
{
    "c_end": 57, 
    "c_start": 56, 
    "end": 12, 
    "mention": "I", 
    "pid": 1, 
    "senid": 66, 
    "sent": "hERG gene codes for the subunit of a potassium channel (I Kr ) implicated in the ventricular repolarization. ", 
    "start": 11, 
    "type": "Amino_Acid__Peptide__or_Protein"
}
{
    "c_end": 60, 
    "c_start": 58, 
    "end": 13, 
    "mention": "Kr", 
    "pid": 1, 
    "senid": 66, 
    "sent": "hERG gene codes for the subunit of a potassium channel (I Kr ) implicated in the ventricular repolarization. ", 
    "start": 12, 
    "type": "Geographic_Area"
}
{
    "c_end": 107, 
    "c_start": 81, 
    "end": 19, 
    "mention": "ventricular repolarization", 
    "pid": 1, 
    "senid": 66, 
    "sent": "hERG gene codes for the subunit of a potassium channel (I Kr ) implicated in the ventricular repolarization. ", 
    "start": 17, 
    "type": "Organ_or_Tissue_Function"
}
{
    "c_end": 28, 
    "c_start": 23, 
    "end": 5, 
    "mention": "shown", 
    "pid": 1, 
    "senid": 67, 
    "sent": "Experimentally, it was shown that hydroxyzine could be proarrhythmic by blocking hERG channels and therefore prolonging action potential duration, thus inducing TdP. ", 
    "start": 4, 
    "type": "Animal"
}
{
    "c_end": 45, 
    "c_start": 34, 
    "end": 7, 
    "mention": "hydroxyzine", 
    "pid": 1, 
    "senid": 67, 
    "sent": "Experimentally, it was shown that hydroxyzine could be proarrhythmic by blocking hERG channels and therefore prolonging action potential duration, thus inducing TdP. ", 
    "start": 6, 
    "type": "Organic_Chemical"
}
{
    "c_end": 80, 
    "c_start": 72, 
    "end": 12, 
    "mention": "blocking", 
    "pid": 1, 
    "senid": 67, 
    "sent": "Experimentally, it was shown that hydroxyzine could be proarrhythmic by blocking hERG channels and therefore prolonging action potential duration, thus inducing TdP. ", 
    "start": 11, 
    "type": "Mental_or_Behavioral_Dysfunction"
}
{
    "c_end": 85, 
    "c_start": 81, 
    "end": 13, 
    "mention": "hERG", 
    "pid": 1, 
    "senid": 67, 
    "sent": "Experimentally, it was shown that hydroxyzine could be proarrhythmic by blocking hERG channels and therefore prolonging action potential duration, thus inducing TdP. ", 
    "start": 12, 
    "type": "Gene_or_Genome"
}
{
    "c_end": 94, 
    "c_start": 86, 
    "end": 14, 
    "mention": "channels", 
    "pid": 1, 
    "senid": 67, 
    "sent": "Experimentally, it was shown that hydroxyzine could be proarrhythmic by blocking hERG channels and therefore prolonging action potential duration, thus inducing TdP. ", 
    "start": 13, 
    "type": "Spatial_Concept"
}
{
    "c_end": 136, 
    "c_start": 120, 
    "end": 19, 
    "mention": "action potential", 
    "pid": 1, 
    "senid": 67, 
    "sent": "Experimentally, it was shown that hydroxyzine could be proarrhythmic by blocking hERG channels and therefore prolonging action potential duration, thus inducing TdP. ", 
    "start": 17, 
    "type": "Cell_Function"
}
{
    "c_end": 145, 
    "c_start": 137, 
    "end": 20, 
    "mention": "duration", 
    "pid": 1, 
    "senid": 67, 
    "sent": "Experimentally, it was shown that hydroxyzine could be proarrhythmic by blocking hERG channels and therefore prolonging action potential duration, thus inducing TdP. ", 
    "start": 19, 
    "type": "Pharmacologic_Substance"
}
{
    "c_end": 160, 
    "c_start": 152, 
    "end": 23, 
    "mention": "inducing", 
    "pid": 1, 
    "senid": 67, 
    "sent": "Experimentally, it was shown that hydroxyzine could be proarrhythmic by blocking hERG channels and therefore prolonging action potential duration, thus inducing TdP. ", 
    "start": 22, 
    "type": "Functional_Concept"
}
{
    "c_end": 13, 
    "c_start": 7, 
    "end": 3, 
    "mention": "French", 
    "pid": 1, 
    "senid": 68, 
    "sent": "In the French pharmacovigilance database, we found 24 cases of QT prolongation mentioning hydroxyzine with a suspected accountability assumed in 7 cases. ", 
    "start": 2, 
    "type": "Language"
}
{
    "c_end": 31, 
    "c_start": 14, 
    "end": 4, 
    "mention": "pharmacovigilance", 
    "pid": 1, 
    "senid": 68, 
    "sent": "In the French pharmacovigilance database, we found 24 cases of QT prolongation mentioning hydroxyzine with a suspected accountability assumed in 7 cases. ", 
    "start": 3, 
    "type": "Research_Activity"
}
{
    "c_end": 40, 
    "c_start": 32, 
    "end": 5, 
    "mention": "database", 
    "pid": 1, 
    "senid": 68, 
    "sent": "In the French pharmacovigilance database, we found 24 cases of QT prolongation mentioning hydroxyzine with a suspected accountability assumed in 7 cases. ", 
    "start": 4, 
    "type": "Intellectual_Product"
}
{
    "c_end": 50, 
    "c_start": 45, 
    "end": 8, 
    "mention": "found", 
    "pid": 1, 
    "senid": 68, 
    "sent": "In the French pharmacovigilance database, we found 24 cases of QT prolongation mentioning hydroxyzine with a suspected accountability assumed in 7 cases. ", 
    "start": 7, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 59, 
    "c_start": 54, 
    "end": 10, 
    "mention": "cases", 
    "pid": 1, 
    "senid": 68, 
    "sent": "In the French pharmacovigilance database, we found 24 cases of QT prolongation mentioning hydroxyzine with a suspected accountability assumed in 7 cases. ", 
    "start": 9, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 78, 
    "c_start": 63, 
    "end": 13, 
    "mention": "QT prolongation", 
    "pid": 1, 
    "senid": 68, 
    "sent": "In the French pharmacovigilance database, we found 24 cases of QT prolongation mentioning hydroxyzine with a suspected accountability assumed in 7 cases. ", 
    "start": 11, 
    "type": "Finding"
}
{
    "c_end": 101, 
    "c_start": 90, 
    "end": 15, 
    "mention": "hydroxyzine", 
    "pid": 1, 
    "senid": 68, 
    "sent": "In the French pharmacovigilance database, we found 24 cases of QT prolongation mentioning hydroxyzine with a suspected accountability assumed in 7 cases. ", 
    "start": 14, 
    "type": "Organic_Chemical"
}
{
    "c_end": 118, 
    "c_start": 109, 
    "end": 18, 
    "mention": "suspected", 
    "pid": 1, 
    "senid": 68, 
    "sent": "In the French pharmacovigilance database, we found 24 cases of QT prolongation mentioning hydroxyzine with a suspected accountability assumed in 7 cases. ", 
    "start": 17, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 133, 
    "c_start": 119, 
    "end": 19, 
    "mention": "accountability", 
    "pid": 1, 
    "senid": 68, 
    "sent": "In the French pharmacovigilance database, we found 24 cases of QT prolongation mentioning hydroxyzine with a suspected accountability assumed in 7 cases. ", 
    "start": 18, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 141, 
    "c_start": 134, 
    "end": 20, 
    "mention": "assumed", 
    "pid": 1, 
    "senid": 68, 
    "sent": "In the French pharmacovigilance database, we found 24 cases of QT prolongation mentioning hydroxyzine with a suspected accountability assumed in 7 cases. ", 
    "start": 19, 
    "type": "Intellectual_Product"
}
{
    "c_end": 10, 
    "c_start": 3, 
    "end": 2, 
    "mention": "publish", 
    "pid": 1, 
    "senid": 69, 
    "sent": "We publish here the first clinical case of hydroxyzineassociated QT prolongation with drug dosage data. ", 
    "start": 1, 
    "type": "Occupational_Activity"
}
{
    "c_end": 25, 
    "c_start": 20, 
    "end": 5, 
    "mention": "first", 
    "pid": 1, 
    "senid": 69, 
    "sent": "We publish here the first clinical case of hydroxyzineassociated QT prolongation with drug dosage data. ", 
    "start": 4, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 34, 
    "c_start": 26, 
    "end": 6, 
    "mention": "clinical", 
    "pid": 1, 
    "senid": 69, 
    "sent": "We publish here the first clinical case of hydroxyzineassociated QT prolongation with drug dosage data. ", 
    "start": 5, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 39, 
    "c_start": 35, 
    "end": 7, 
    "mention": "case", 
    "pid": 1, 
    "senid": 69, 
    "sent": "We publish here the first clinical case of hydroxyzineassociated QT prolongation with drug dosage data. ", 
    "start": 6, 
    "type": "Conceptual_Entity"
}
{
    "c_end": 80, 
    "c_start": 65, 
    "end": 11, 
    "mention": "QT prolongation", 
    "pid": 1, 
    "senid": 69, 
    "sent": "We publish here the first clinical case of hydroxyzineassociated QT prolongation with drug dosage data. ", 
    "start": 9, 
    "type": "Finding"
}
{
    "c_end": 97, 
    "c_start": 86, 
    "end": 14, 
    "mention": "drug dosage", 
    "pid": 1, 
    "senid": 69, 
    "sent": "We publish here the first clinical case of hydroxyzineassociated QT prolongation with drug dosage data. ", 
    "start": 12, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 102, 
    "c_start": 98, 
    "end": 15, 
    "mention": "data", 
    "pid": 1, 
    "senid": 69, 
    "sent": "We publish here the first clinical case of hydroxyzineassociated QT prolongation with drug dosage data. ", 
    "start": 14, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 15, 
    "c_start": 4, 
    "end": 2, 
    "mention": "association", 
    "pid": 1, 
    "senid": 70, 
    "sent": "The association of hydroxyzine, especially at high posology, and others already well-known TdP risks factors (including hypokalemia and bradycardia) could induce QT prolongation and lifethreatening TdP. ", 
    "start": 1, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 30, 
    "c_start": 19, 
    "end": 4, 
    "mention": "hydroxyzine", 
    "pid": 1, 
    "senid": 70, 
    "sent": "The association of hydroxyzine, especially at high posology, and others already well-known TdP risks factors (including hypokalemia and bradycardia) could induce QT prolongation and lifethreatening TdP. ", 
    "start": 3, 
    "type": "Organic_Chemical"
}
{
    "c_end": 59, 
    "c_start": 46, 
    "end": 9, 
    "mention": "high posology", 
    "pid": 1, 
    "senid": 70, 
    "sent": "The association of hydroxyzine, especially at high posology, and others already well-known TdP risks factors (including hypokalemia and bradycardia) could induce QT prolongation and lifethreatening TdP. ", 
    "start": 7, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 71, 
    "c_start": 65, 
    "end": 12, 
    "mention": "others", 
    "pid": 1, 
    "senid": 70, 
    "sent": "The association of hydroxyzine, especially at high posology, and others already well-known TdP risks factors (including hypokalemia and bradycardia) could induce QT prolongation and lifethreatening TdP. ", 
    "start": 11, 
    "type": "Finding"
}
{
    "c_end": 90, 
    "c_start": 80, 
    "end": 14, 
    "mention": "well-known", 
    "pid": 1, 
    "senid": 70, 
    "sent": "The association of hydroxyzine, especially at high posology, and others already well-known TdP risks factors (including hypokalemia and bradycardia) could induce QT prolongation and lifethreatening TdP. ", 
    "start": 13, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 100, 
    "c_start": 95, 
    "end": 16, 
    "mention": "risks", 
    "pid": 1, 
    "senid": 70, 
    "sent": "The association of hydroxyzine, especially at high posology, and others already well-known TdP risks factors (including hypokalemia and bradycardia) could induce QT prolongation and lifethreatening TdP. ", 
    "start": 15, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 108, 
    "c_start": 101, 
    "end": 17, 
    "mention": "factors", 
    "pid": 1, 
    "senid": 70, 
    "sent": "The association of hydroxyzine, especially at high posology, and others already well-known TdP risks factors (including hypokalemia and bradycardia) could induce QT prolongation and lifethreatening TdP. ", 
    "start": 16, 
    "type": "Conceptual_Entity"
}
{
    "c_end": 119, 
    "c_start": 110, 
    "end": 19, 
    "mention": "including", 
    "pid": 1, 
    "senid": 70, 
    "sent": "The association of hydroxyzine, especially at high posology, and others already well-known TdP risks factors (including hypokalemia and bradycardia) could induce QT prolongation and lifethreatening TdP. ", 
    "start": 18, 
    "type": "Functional_Concept"
}
{
    "c_end": 131, 
    "c_start": 120, 
    "end": 20, 
    "mention": "hypokalemia", 
    "pid": 1, 
    "senid": 70, 
    "sent": "The association of hydroxyzine, especially at high posology, and others already well-known TdP risks factors (including hypokalemia and bradycardia) could induce QT prolongation and lifethreatening TdP. ", 
    "start": 19, 
    "type": "Finding"
}
{
    "c_end": 147, 
    "c_start": 136, 
    "end": 22, 
    "mention": "bradycardia", 
    "pid": 1, 
    "senid": 70, 
    "sent": "The association of hydroxyzine, especially at high posology, and others already well-known TdP risks factors (including hypokalemia and bradycardia) could induce QT prolongation and lifethreatening TdP. ", 
    "start": 21, 
    "type": "Pathologic_Function"
}
{
    "c_end": 161, 
    "c_start": 155, 
    "end": 25, 
    "mention": "induce", 
    "pid": 1, 
    "senid": 70, 
    "sent": "The association of hydroxyzine, especially at high posology, and others already well-known TdP risks factors (including hypokalemia and bradycardia) could induce QT prolongation and lifethreatening TdP. ", 
    "start": 24, 
    "type": "Functional_Concept"
}
{
    "c_end": 177, 
    "c_start": 162, 
    "end": 27, 
    "mention": "QT prolongation", 
    "pid": 1, 
    "senid": 70, 
    "sent": "The association of hydroxyzine, especially at high posology, and others already well-known TdP risks factors (including hypokalemia and bradycardia) could induce QT prolongation and lifethreatening TdP. ", 
    "start": 25, 
    "type": "Finding"
}
{
    "c_end": 197, 
    "c_start": 182, 
    "end": 29, 
    "mention": "lifethreatening", 
    "pid": 1, 
    "senid": 70, 
    "sent": "The association of hydroxyzine, especially at high posology, and others already well-known TdP risks factors (including hypokalemia and bradycardia) could induce QT prolongation and lifethreatening TdP. ", 
    "start": 28, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 11, 
    "c_start": 4, 
    "end": 2, 
    "mention": "present", 
    "pid": 1, 
    "senid": 71, 
    "sent": "The present work underlines the recent addition of hydroxyzine to the list of drugs with conditional risk of TdP and drugs to be avoided by patients with congenital long QT syndrome. ", 
    "start": 1, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 16, 
    "c_start": 12, 
    "end": 3, 
    "mention": "work", 
    "pid": 1, 
    "senid": 71, 
    "sent": "The present work underlines the recent addition of hydroxyzine to the list of drugs with conditional risk of TdP and drugs to be avoided by patients with congenital long QT syndrome. ", 
    "start": 2, 
    "type": "Occupational_Activity"
}
{
    "c_end": 38, 
    "c_start": 32, 
    "end": 6, 
    "mention": "recent", 
    "pid": 1, 
    "senid": 71, 
    "sent": "The present work underlines the recent addition of hydroxyzine to the list of drugs with conditional risk of TdP and drugs to be avoided by patients with congenital long QT syndrome. ", 
    "start": 5, 
    "type": "Temporal_Concept"
}
{
    "c_end": 47, 
    "c_start": 39, 
    "end": 7, 
    "mention": "addition", 
    "pid": 1, 
    "senid": 71, 
    "sent": "The present work underlines the recent addition of hydroxyzine to the list of drugs with conditional risk of TdP and drugs to be avoided by patients with congenital long QT syndrome. ", 
    "start": 6, 
    "type": "Functional_Concept"
}
{
    "c_end": 62, 
    "c_start": 51, 
    "end": 9, 
    "mention": "hydroxyzine", 
    "pid": 1, 
    "senid": 71, 
    "sent": "The present work underlines the recent addition of hydroxyzine to the list of drugs with conditional risk of TdP and drugs to be avoided by patients with congenital long QT syndrome. ", 
    "start": 8, 
    "type": "Organic_Chemical"
}
{
    "c_end": 83, 
    "c_start": 70, 
    "end": 14, 
    "mention": "list of drugs", 
    "pid": 1, 
    "senid": 71, 
    "sent": "The present work underlines the recent addition of hydroxyzine to the list of drugs with conditional risk of TdP and drugs to be avoided by patients with congenital long QT syndrome. ", 
    "start": 11, 
    "type": "Intellectual_Product"
}
{
    "c_end": 100, 
    "c_start": 89, 
    "end": 16, 
    "mention": "conditional", 
    "pid": 1, 
    "senid": 71, 
    "sent": "The present work underlines the recent addition of hydroxyzine to the list of drugs with conditional risk of TdP and drugs to be avoided by patients with congenital long QT syndrome. ", 
    "start": 15, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 105, 
    "c_start": 101, 
    "end": 17, 
    "mention": "risk", 
    "pid": 1, 
    "senid": 71, 
    "sent": "The present work underlines the recent addition of hydroxyzine to the list of drugs with conditional risk of TdP and drugs to be avoided by patients with congenital long QT syndrome. ", 
    "start": 16, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 122, 
    "c_start": 117, 
    "end": 21, 
    "mention": "drugs", 
    "pid": 1, 
    "senid": 71, 
    "sent": "The present work underlines the recent addition of hydroxyzine to the list of drugs with conditional risk of TdP and drugs to be avoided by patients with congenital long QT syndrome. ", 
    "start": 20, 
    "type": "Pharmacologic_Substance"
}
{
    "c_end": 125, 
    "c_start": 123, 
    "end": 22, 
    "mention": "to", 
    "pid": 1, 
    "senid": 71, 
    "sent": "The present work underlines the recent addition of hydroxyzine to the list of drugs with conditional risk of TdP and drugs to be avoided by patients with congenital long QT syndrome. ", 
    "start": 21, 
    "type": "Qualitative_Concept"
}
{
    "c_end": 148, 
    "c_start": 140, 
    "end": 26, 
    "mention": "patients", 
    "pid": 1, 
    "senid": 71, 
    "sent": "The present work underlines the recent addition of hydroxyzine to the list of drugs with conditional risk of TdP and drugs to be avoided by patients with congenital long QT syndrome. ", 
    "start": 25, 
    "type": "Patient_or_Disabled_Group"
}
{
    "c_end": 181, 
    "c_start": 154, 
    "end": 31, 
    "mention": "congenital long QT syndrome", 
    "pid": 1, 
    "senid": 71, 
    "sent": "The present work underlines the recent addition of hydroxyzine to the list of drugs with conditional risk of TdP and drugs to be avoided by patients with congenital long QT syndrome. ", 
    "start": 27, 
    "type": "Disease_or_Syndrome"
}
{
    "c_end": 15, 
    "c_start": 8, 
    "end": 3, 
    "mention": "reminds", 
    "pid": 1, 
    "senid": 72, 
    "sent": "It also reminds that recommended hydroxyzines posology must be respected, the risk of QT prolongation and syncope increases dramatically in case of an overdose. ", 
    "start": 2, 
    "type": "Therapeutic_or_Preventive_Procedure"
}
{
    "c_end": 32, 
    "c_start": 21, 
    "end": 5, 
    "mention": "recommended", 
    "pid": 1, 
    "senid": 72, 
    "sent": "It also reminds that recommended hydroxyzines posology must be respected, the risk of QT prolongation and syncope increases dramatically in case of an overdose. ", 
    "start": 4, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 54, 
    "c_start": 33, 
    "end": 7, 
    "mention": "hydroxyzines posology", 
    "pid": 1, 
    "senid": 72, 
    "sent": "It also reminds that recommended hydroxyzines posology must be respected, the risk of QT prolongation and syncope increases dramatically in case of an overdose. ", 
    "start": 5, 
    "type": "Clinical_Attribute"
}
{
    "c_end": 72, 
    "c_start": 63, 
    "end": 10, 
    "mention": "respected", 
    "pid": 1, 
    "senid": 72, 
    "sent": "It also reminds that recommended hydroxyzines posology must be respected, the risk of QT prolongation and syncope increases dramatically in case of an overdose. ", 
    "start": 9, 
    "type": "Social_Behavior"
}
{
    "c_end": 82, 
    "c_start": 78, 
    "end": 13, 
    "mention": "risk", 
    "pid": 1, 
    "senid": 72, 
    "sent": "It also reminds that recommended hydroxyzines posology must be respected, the risk of QT prolongation and syncope increases dramatically in case of an overdose. ", 
    "start": 12, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 101, 
    "c_start": 86, 
    "end": 16, 
    "mention": "QT prolongation", 
    "pid": 1, 
    "senid": 72, 
    "sent": "It also reminds that recommended hydroxyzines posology must be respected, the risk of QT prolongation and syncope increases dramatically in case of an overdose. ", 
    "start": 14, 
    "type": "Finding"
}
{
    "c_end": 113, 
    "c_start": 106, 
    "end": 18, 
    "mention": "syncope", 
    "pid": 1, 
    "senid": 72, 
    "sent": "It also reminds that recommended hydroxyzines posology must be respected, the risk of QT prolongation and syncope increases dramatically in case of an overdose. ", 
    "start": 17, 
    "type": "Sign_or_Symptom"
}
{
    "c_end": 123, 
    "c_start": 114, 
    "end": 19, 
    "mention": "increases", 
    "pid": 1, 
    "senid": 72, 
    "sent": "It also reminds that recommended hydroxyzines posology must be respected, the risk of QT prolongation and syncope increases dramatically in case of an overdose. ", 
    "start": 18, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 144, 
    "c_start": 140, 
    "end": 22, 
    "mention": "case", 
    "pid": 1, 
    "senid": 72, 
    "sent": "It also reminds that recommended hydroxyzines posology must be respected, the risk of QT prolongation and syncope increases dramatically in case of an overdose. ", 
    "start": 21, 
    "type": "Conceptual_Entity"
}
{
    "c_end": 159, 
    "c_start": 151, 
    "end": 25, 
    "mention": "overdose", 
    "pid": 1, 
    "senid": 72, 
    "sent": "It also reminds that recommended hydroxyzines posology must be respected, the risk of QT prolongation and syncope increases dramatically in case of an overdose. ", 
    "start": 24, 
    "type": "Injury_or_Poisoning"
}
{
    "c_end": 20, 
    "c_start": 9, 
    "end": 3, 
    "mention": "considering", 
    "pid": 1, 
    "senid": 73, 
    "sent": "Finally, considering the large use of the molecule, the recurrence of hydroxyzine-induced QT prolongation is probably underestimated.", 
    "start": 2, 
    "type": "Idea_or_Concept"
}
{
    "c_end": 30, 
    "c_start": 25, 
    "end": 5, 
    "mention": "large", 
    "pid": 1, 
    "senid": 73, 
    "sent": "Finally, considering the large use of the molecule, the recurrence of hydroxyzine-induced QT prolongation is probably underestimated.", 
    "start": 4, 
    "type": "Quantitative_Concept"
}
{
    "c_end": 37, 
    "c_start": 31, 
    "end": 7, 
    "mention": "use of", 
    "pid": 1, 
    "senid": 73, 
    "sent": "Finally, considering the large use of the molecule, the recurrence of hydroxyzine-induced QT prolongation is probably underestimated.", 
    "start": 5, 
    "type": "Functional_Concept"
}
{
    "c_end": 50, 
    "c_start": 42, 
    "end": 9, 
    "mention": "molecule", 
    "pid": 1, 
    "senid": 73, 
    "sent": "Finally, considering the large use of the molecule, the recurrence of hydroxyzine-induced QT prolongation is probably underestimated.", 
    "start": 8, 
    "type": "Substance"
}
{
    "c_end": 66, 
    "c_start": 56, 
    "end": 12, 
    "mention": "recurrence", 
    "pid": 1, 
    "senid": 73, 
    "sent": "Finally, considering the large use of the molecule, the recurrence of hydroxyzine-induced QT prolongation is probably underestimated.", 
    "start": 11, 
    "type": "Pathologic_Function"
}
{
    "c_end": 89, 
    "c_start": 70, 
    "end": 14, 
    "mention": "hydroxyzine-induced", 
    "pid": 1, 
    "senid": 73, 
    "sent": "Finally, considering the large use of the molecule, the recurrence of hydroxyzine-induced QT prolongation is probably underestimated.", 
    "start": 13, 
    "type": "Organic_Chemical"
}
{
    "c_end": 105, 
    "c_start": 90, 
    "end": 16, 
    "mention": "QT prolongation", 
    "pid": 1, 
    "senid": 73, 
    "sent": "Finally, considering the large use of the molecule, the recurrence of hydroxyzine-induced QT prolongation is probably underestimated.", 
    "start": 14, 
    "type": "Finding"
}
{
    "c_end": 117, 
    "c_start": 109, 
    "end": 18, 
    "mention": "probably", 
    "pid": 1, 
    "senid": 73, 
    "sent": "Finally, considering the large use of the molecule, the recurrence of hydroxyzine-induced QT prolongation is probably underestimated.", 
    "start": 17, 
    "type": "Idea_or_Concept"
}
